{"id":43156,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/agreement-and-plan-of-merger-xoom-com-inc-and-paralogic.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"agreement-and-plan-of-merger-xoom-com-inc-and-paralogic","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/agreement-and-plan-of-merger-xoom-com-inc-and-paralogic.html","title":{"rendered":"Agreement and Plan of Merger &#8211; Xoom.com Inc. and Paralogic Software Corp."},"content":{"rendered":"<pre>                                       \n--------------------------------------------------------------------------------\n\n                         AGREEMENT AND PLAN OF MERGER\n\n                                 by and among\n\n                                XOOM.com, Inc.\n\n                        Paralogic Software Corporation\n\n                                      and\n\n                                XMCM Sub, Inc.\n\n                                        \n\n\n                           Dated as of June 10, 1999\n\n--------------------------------------------------------------------------------\n\n                                       \n                               TABLE OF CONTENTS\n<\/pre>\n<table>\n<caption>\n                                                                                                                PAGE<br \/>\n                                                                                                                &#8212;-<br \/>\n<s>  <c>                                                                                                        <c><br \/>\n1.   The Merger; Effective Time&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    1<br \/>\n     1.1   The Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    1<br \/>\n     1.2   Effective Time of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    2<br \/>\n     1.3   The Aggregate Merger Consideration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    2<br \/>\n     1.4   Escrow&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    2<\/p>\n<p>2.   The Purchaser and the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    2<br \/>\n     2.1   Articles of Incorporation of the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    2<br \/>\n     2.2   Bylaws of the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    2<br \/>\n     2.3   Directors and Officers of the Surviving Corporation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    3<\/p>\n<p>3.   Treatment of Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    3<br \/>\n     3.1   Exchange of Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    3<br \/>\n     3.2   Adjustments to the Merger Consideration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    4<br \/>\n     3.3   Mechanics of Exchange&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    4<br \/>\n     3.4   No Further Rights in Company Common Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    6<br \/>\n     3.5   Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    6<br \/>\n     3.6   Supplementary Action&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    6<br \/>\n     3.7   Dissenting Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    6<\/p>\n<p>4.   Closing Conditions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    7<br \/>\n     4.1   Conditions Precedent to Obligations of the Purchaser and Merger Sub&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    7<br \/>\n     4.2   Conditions Precedent to Obligations of the Company and the Selling Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    9<\/p>\n<p>5.   Representations and Warranties of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    10<br \/>\n     5.1   Organization, Good Standing, Qualification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    10<br \/>\n     5.2   Articles of Incorporation and Bylaws; Records&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    11<br \/>\n     5.3   Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    11<br \/>\n     5.4   Authority; Binding Nature of Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    12<br \/>\n     5.5   Non-Contravention; Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    13<br \/>\n     5.6   Intellectual Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    13<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                       i<\/p>\n<table>\n<caption>\n                                                                                                                PAGE<br \/>\n                                                                                                                &#8212;-<br \/>\n<s>  <c>                                                                                                        <c><br \/>\n     5.7   Proceedings; Orders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    15<br \/>\n     5.8   Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    15<br \/>\n     5.9   Title to Assets&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    16<br \/>\n     5.10  Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    16<br \/>\n     5.11  Employees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    17<br \/>\n     5.12  Compliance with Legal Requirements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    18<br \/>\n     5.13  Governmental Authorizations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    18<br \/>\n     5.14  Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    18<br \/>\n     5.15  Securities Laws Compliance; Registration Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    20<br \/>\n     5.16  Finders and Brokers; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    20<br \/>\n     5.17  Environmental Compliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    21<br \/>\n     5.18  Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    21<br \/>\n     5.19  Related Party Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    22<br \/>\n     5.20  Absence of Changes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    22<br \/>\n     5.21  Powers of Attorney&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    23<br \/>\n     5.22  Benefit Plans; ERISA&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    23<br \/>\n     5.23  Full Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    25<br \/>\n     5.24  Due Diligence Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    26<\/p>\n<p>6.   Representations and Warranties of the Selling Shareholders; Investment<br \/>\n     Intent and Restrictions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    26<\/p>\n<p>7.   Representations and Warranties of the Purchaser and Merger Sub&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    29<br \/>\n     7.1   Organization, Good Standing, Qualification; Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    29<br \/>\n     7.2   Investment Representations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    29<br \/>\n     7.3   Purchaser Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    30<br \/>\n     7.4   Authority; Binding Nature of Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    30<br \/>\n     7.5   Non-Contravention; Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    31<br \/>\n     7.6   Legal Proceedings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    32<br \/>\n     7.7   Finders and Brokers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    32<br \/>\n     7.8   Reports and Financial Statements; Absence of Certain Changes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    32<br \/>\n     7.9   Compliance with Applicable Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    33<br \/>\n     7.10  Complete Copies of Requested Reports&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    33<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                       ii<\/p>\n<table>\n<caption>\n                                                                                                                PAGE<br \/>\n                                                                                                                &#8212;-<br \/>\n<s>  <c>                                                                                                        <c><br \/>\n     7.11  Full Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    33<br \/>\n     7.12  Contracts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    33<\/p>\n<p>8.   Pre-Closing Covenants of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    34<br \/>\n     8.1   Corporate Proceedings; Shareholder Approval&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    34<br \/>\n     8.2   Access and Investigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    34<br \/>\n     8.3   Operation of Business&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    35<br \/>\n     8.4   Filings and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    36<br \/>\n     8.5   Notification; Updates to Disclosure Schedule&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    37<br \/>\n     8.6   No Negotiation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    38<\/p>\n<p>9.   Pre-Closing Covenants of the Purchaser&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    38<br \/>\n     9.1   Corporate Proceedings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    38<br \/>\n     9.2   Access and Investigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    39<br \/>\n     9.3   Filings and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    39<br \/>\n     9.4   Notification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    40<\/p>\n<p>10.  Other Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    40<br \/>\n     10.1  Registration of Company Options&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    40<br \/>\n     10.2  Confidentiality&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    40<br \/>\n     10.3  Public Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    40<br \/>\n     10.4  No Inconsistent Action&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    41<br \/>\n     10.5  Restrictive Legend&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    41<br \/>\n     10.6  Market Stand-Off&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    41<br \/>\n     10.7  Certain Tax Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    42<br \/>\n     10.8  Preparation of Audited Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    44<\/p>\n<p>11.  Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    45<br \/>\n     11.1  Termination Events&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    45<br \/>\n     11.2  Termination Procedures&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    45<br \/>\n     11.3  Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    46<br \/>\n     11.4  Exclusivity of Termination Rights&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    46<\/p>\n<p>12.  Indemnification, etc&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    46<br \/>\n     12.1  Survival of Representations and Covenants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    46<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                      iii<\/p>\n<table>\n<caption>\n                                                                                                                PAGE<br \/>\n                                                                                                                &#8212;-<br \/>\n<s>  <c>                                                                                                        <c><br \/>\n     12.2  Indemnification by the Selling Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    47<br \/>\n     12.3  No Contribution&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    48<br \/>\n     12.4  Setoff&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    48<br \/>\n     12.5  Defense of Third-Party Claims&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    48<br \/>\n     12.6  Exercise of Remedies by Indemnitees Other than the Purchaser and by the Selling Shareholders&#8230;..    49<\/p>\n<p>13.  Non-Solicitation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    50<\/p>\n<p>14.  Purchaser&#8217;s Tax Indemnity&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    50<\/p>\n<p>15.  Miscellaneous&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    51<br \/>\n     15.1  Further Assurances&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    51<br \/>\n     15.2  Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    51<br \/>\n     15.3  Attorneys&#8217; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    51<br \/>\n     15.4  Transfer Taxes; Final Tax Return&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    51<br \/>\n     15.5  Governing Law; Arbitration&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    51<br \/>\n     15.6  Successors and Assigns&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    52<br \/>\n     15.7  Entire Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    52<br \/>\n     15.8  Separability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    52<br \/>\n     15.9  Amendments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    52<br \/>\n     15.10 Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   52<br \/>\n     15.11 Publicity and Use of Confidential Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   54<br \/>\n     15.12 Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   54<br \/>\n     15.13 Delays or Omissions; Waivers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   54<br \/>\n     15.14 Remedies Cumulative; Specific Performance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   55<br \/>\n     15.15 Headings&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   55<br \/>\n     15.16 Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   55<br \/>\n<\/c><\/c><\/s><\/caption>\n<\/table>\n<p>                                       iv<\/p>\n<p>                         AGREEMENT AND PLAN OF MERGER<\/p>\n<p>     THIS AGREEMENT AND PLAN OF MERGER (the &#8220;AGREEMENT&#8221;) is entered into as<br \/>\nof June 10, 1999, by and among XOOM.com, Inc., a Delaware corporation (the<br \/>\n&#8220;PURCHASER&#8221;), Paralogic Software Corporation, a California corporation (the<br \/>\n&#8220;COMPANY&#8221;), and XMCM Sub, Inc., a California corporation and a wholly-owned<br \/>\nsubsidiary of the Purchaser (&#8220;MERGER SUB&#8221;), the Company and Merger Sub<br \/>\nsometimes being hereinafter collectively referred to as the &#8220;CONSTITUENT<br \/>\nCORPORATIONS,&#8221; and the undersigned individuals and Entities listed on<br \/>\nSchedule I attached hereto (collectively, the &#8220;SELLING SHAREHOLDERS&#8221;).<br \/>\nCertain capitalized terms in this Agreement are defined in Exhibit A attached<br \/>\nhereto.<\/p>\n<p>                                   RECITALS<\/p>\n<p>  A. The Board of Directors of the Purchaser, Merger Sub and the Company each<br \/>\n     have determined that it is in the best interests of their respective<br \/>\n     stockholders and shareholders, as the case may be, for the Purchaser to<br \/>\n     acquire the Company by the merger of Merger Sub with and into the<br \/>\n     Company upon the terms, and subject to the conditions, set forth herein<br \/>\n     (the &#8220;MERGER&#8221;).<\/p>\n<p>  B. For federal income tax purposes, it is intended that the Merger<br \/>\n     constitute a reorganization under the provisions of Section 368 of the<br \/>\n     Internal Revenue Code of 1986, as amended (the &#8220;CODE&#8221;) and that this<br \/>\n     Agreement shall constitute a plan of reorganization for purposes of<br \/>\n     Section 368 of the Code.<\/p>\n<p>                                   AGREEMENT<\/p>\n<p>     The Purchaser, the Company and Merger Sub, intending to be legally<br \/>\nbound, agree as follows:<\/p>\n<p>1.   The Merger; Effective Time.<\/p>\n<p>     1.1  The Merger.<\/p>\n<p>     Subject to the terms and conditions of this Agreement, at the Effective<br \/>\nTime (as defined in Section 1.2 hereof), Merger Sub shall be merged with and<br \/>\ninto the Company, the Company shall be the surviving corporation in such<br \/>\nMerger (the &#8220;SURVIVING CORPORATION&#8221;), and will retain its existing name, and<br \/>\nthe separate existence of Merger Sub shall thereupon cease.  The Merger shall<br \/>\nhave the effects set forth in Sections 1107 and 1108 of the General<br \/>\nCorporation Law of the State of California.  Without limiting the generality<br \/>\nof the foregoing, and subject thereto, at the Effective Time all property,<br \/>\nrights, powers, privileges and franchises of Merger Sub shall vest in the<br \/>\nCompany as the Surviving Corporation, and all debts, liabilities and duties<br \/>\nof Merger Sub shall become the debts, liabilities and duties of the Surviving<br \/>\nCorporation. Immediately following the Effective Time, the Surviving<br \/>\nCorporation shall be a wholly-owned subsidiary of the Purchaser.<\/p>\n<p>                                       1<\/p>\n<p>     1.2  Effective Time of the Merger.<\/p>\n<p>     When used in this Agreement, the term &#8220;EFFECTIVE TIME&#8221; with respect to<br \/>\nthe Merger shall mean the date and time when an Agreement of Merger has been<br \/>\naccepted for filing by the Secretary of State of California, which filing<br \/>\nshall be made, using the Purchaser&#8217;s Best Efforts after the Closing, within<br \/>\ntwo (2) days after the Closing, but in no event later than five (5) days<br \/>\nafter the Closing; provided, that, the Company has met all the closing<br \/>\nconditions in Section 4.1 hereof; and provided further, that the Company&#8217;s<br \/>\nsole remedy for the Purchaser&#8217;s failure to file such Agreement of Merger<br \/>\nshall be to terminate this Agreement.<\/p>\n<p>     1.3  The Aggregate Merger Consideration.<\/p>\n<p>     The Purchaser shall acquire all of the outstanding shares of Company<br \/>\nCommon Stock for an aggregate of 745,858 shares of Purchaser Stock (as<br \/>\nadjusted for any stock splits, dividends, combinations or the like and any<br \/>\nadjustment pursuant to Section 3.2 hereof) (as adjusted, the &#8220;MERGER<br \/>\nCONSIDERATION&#8221;).  As part of the Merger Consideration, all options issued and<br \/>\noutstanding under the Company&#8217;s 1998 Stock Incentive Plan (the &#8220;OPTION PLAN&#8221;)<br \/>\nshall be assumed as described in Section 3.1(c) hereof and each Selling<br \/>\nShareholder shall be allocated the portion of the Merger Consideration set<br \/>\nforth on Schedule I attached hereto in exchange for the shares of Company<br \/>\nCommon Stock held by such Selling Shareholder as of the Effective Time.<\/p>\n<p>     1.4  Escrow.<\/p>\n<p>     As a source for the payment of the Selling Shareholders&#8217; indemnification<br \/>\nobligations set forth herein and in the Escrow Agreement, the Purchaser will<br \/>\ndeliver to Escrow Agent under an Escrow Agreement (the &#8220;ESCROW AGREEMENT&#8221;) in<br \/>\nsubstantially the form attached as Exhibit B, an amount equal to ten percent<br \/>\n(10%) of the aggregate Merger Consideration payable to the Selling<br \/>\nShareholders, prior to any adjustment thereto pursuant to Section 3.2(c)<br \/>\nhereof (the &#8220;HOLDBACK AMOUNT&#8221;).  The Selling Shareholders shall have all<br \/>\nrights to vote, receive dividends and all other rights as a stockholder of<br \/>\nthe Purchaser with respect to the Holdback Amount.<\/p>\n<p>2.   The Purchaser and the Surviving Corporation.<\/p>\n<p>     2.1  Articles of Incorporation of the Surviving Corporation.<\/p>\n<p>     The Articles of Incorporation of the Company as in effect at the<br \/>\nEffective Time shall be the Articles of Incorporation of the Surviving<br \/>\nCorporation until amended in accordance with applicable law.<\/p>\n<p>     2.2  Bylaws of the Surviving Corporation.<\/p>\n<p>     The Bylaws of Merger Sub as in effect at the Effective Time shall be the<br \/>\nBylaws of the Surviving Corporation until amended in accordance with<br \/>\napplicable law.<\/p>\n<p>                                       2<\/p>\n<p>     2.3  Directors and Officers of the Surviving Corporation.<\/p>\n<p>          (a) The directors of Merger Sub at the Effective Time shall be the<br \/>\ninitial directors of the Surviving Corporation and shall hold office from the<br \/>\nEffective Time until their respective successors are duly elected or<br \/>\nappointed and qualified in the manner provided in the Articles of<br \/>\nIncorporation and Bylaws of the Surviving Corporation, or as otherwise<br \/>\nprovided by law.<\/p>\n<p>          (b) The officers of Merger Sub at the Effective Time shall be the<br \/>\ninitial officers of the Surviving Corporation and shall hold office from the<br \/>\nEffective Time until removed or until their respective successors are duly<br \/>\nelected or appointed and qualified in the manner provided in the Articles of<br \/>\nIncorporation and Bylaws of the Surviving Corporation, or as otherwise<br \/>\nprovided by law.<\/p>\n<p>3.   Treatment of Shares.<\/p>\n<p>     3.1  Exchange of Shares.<\/p>\n<p>     At the Effective Time, by virtue of the Merger and without any action on<br \/>\nthe part of the holders thereof:<\/p>\n<p>          (a) Each share of Merger Sub&#8217;s common stock, no par value, which<br \/>\nshall be outstanding immediately prior to the Effective Time of the Merger,<br \/>\nshall be converted into one share of common stock, no par value, of Surviving<br \/>\nCorporation.<\/p>\n<p>          (b) Each share of Company Common Stock outstanding immediately<br \/>\nprior to the Effective Time shall at the Effective Time, by virtue of the<br \/>\nMerger and without any action on the part of the holder thereof, be cancelled<br \/>\nand converted into the right to receive a portion of the Merger Consideration<br \/>\nequal to the quotient of (i) the aggregate Merger Consideration divided by<br \/>\n(ii) the sum of (A) the number of shares of Company Common Stock outstanding<br \/>\nimmediately prior to the Effective Time plus (B) the number of Company<br \/>\nOptions issued and outstanding pursuant to the Option Plan immediately prior<br \/>\nto the Closing Date (such quotient, the &#8220;EXCHANGE RATIO&#8221;).<\/p>\n<p>          (c) At the Effective Time, all options issued and outstanding under<br \/>\nthe Option Plan (each, a &#8220;COMPANY OPTION&#8221;) shall be assumed by the Purchaser<br \/>\nin accordance with provisions described below.<\/p>\n<p>                (i)   At the Effective Time, each Company Option, whether<br \/>\nvested or unvested, shall be, in connection with the Merger, assumed by the<br \/>\nPurchaser. Each Company Option so assumed by the Purchaser under this<br \/>\nAgreement shall continue to have, and be subject to, the same terms and<br \/>\nconditions set forth in the Option Plan and\/or as provided in the respective<br \/>\noption agreements governing such Company Option immediately prior to the<br \/>\nEffective Time, except that (A) such Company Option shall be exercisable for<br \/>\nthat number of whole shares of Purchaser Stock equal to the product of the<br \/>\nnumber of shares of Company Common Stock that were issuable upon exercise of<br \/>\nsuch Company Option immediately prior to the Effective Time multiplied by the<br \/>\nExchange Ratio (subject to final adjustment after final calculation of the <\/p>\n<p>                                       3<\/p>\n<p>Merger Consideration), rounded down to the nearest whole number of shares of<br \/>\nPurchaser Stock and (B) the per share exercise price for the shares of<br \/>\nPurchaser Stock issuable upon exercise of such assumed Company Option shall<br \/>\nbe equal to the quotient determined by dividing the exercise price per share<br \/>\nof Company Common Stock at which such Company Option was exercisable<br \/>\nimmediately prior to the Effective Time by the Exchange Ratio, rounded up to<br \/>\nthe nearest cent.<\/p>\n<p>                (ii)  It is the intention of the parties that the Company<br \/>\nOptions assumed by the Purchaser qualify following the Effective Time as<br \/>\nincentive stock options as defined in Section 422 of the Code to the extent<br \/>\nsuch options qualified as incentive stock options immediately prior to the<br \/>\nEffective Time.<\/p>\n<p>        (d) No fraction of a share of Purchaser Stock shall be issued in the<br \/>\nMerger. In lieu of fractional shares, the Selling Shareholders, upon<br \/>\nsurrender of their Certificates as set forth in Section 3.3 hereof, shall be<br \/>\npaid an amount in cash, without interest, rounded to the nearest cent,<br \/>\ndetermined by multiplying the fractional interest to which such Shareholder<br \/>\nwould otherwise be entitled by $70.<\/p>\n<p>        (e) The shares of Purchaser Stock issued in connection with the<br \/>\nTransactions will not be registered under the Securities Act. Such shares may<br \/>\nnot be transferred or resold thereafter, except in compliance with the terms<br \/>\nof this Agreement and the other Transactional Agreements and following<br \/>\nregistration under the Securities Act or in reliance on an exemption from<br \/>\nregistration under the Securities Act.<\/p>\n<p>   3.2  Adjustments to the Merger Consideration.<\/p>\n<p>   The number of shares of Purchaser Stock set forth in Section 1.3 hereof<br \/>\nshall be subject to the following adjustments:<\/p>\n<p>        (a) The number of shares of Purchaser Stock set forth in Section 1.3<br \/>\nhereof shall be reduced by the number of shares obtained by dividing (i) the<br \/>\namount of any fees payable by the Company to the Purchaser, as of the<br \/>\nClosing, under that Amended and Restated License Agreement between the<br \/>\nPurchaser and the Company dated as of March 16, 1999, by (ii) $70.<\/p>\n<p>        (b) The number of shares of Purchaser Stock set forth in Section 1.3<br \/>\nhereof shall be increased by the number of shares obtained by dividing (i) the<br \/>\namount of the proceeds, if any, to be received by the Company upon exercise<br \/>\nof any options issued pursuant to the Option Plan on or after May 3, 1999 but<br \/>\nprior to the Closing Date, by (ii) $70.<\/p>\n<p>   3.3  Mechanics of Exchange.<\/p>\n<p>        (a) On the Closing Date, each Selling Shareholder shall receive a<br \/>\nletter of transmittal instructing the Selling Shareholder how to exchange his<br \/>\nor her Company Common Stock for Purchaser Stock. On the first business day<br \/>\nfollowing the Effective Time, each Selling Shareholder shall surrender the<br \/>\ncertificate or certificates evidencing Company Common Stock (the<br \/>\n&#8220;CERTIFICATES&#8221;) to the Purchaser for cancellation in exchange for such<br \/>\nSelling Shareholder&#8217;s<\/p>\n<p>                                       4<\/p>\n<p>allocable portion of the Merger Consideration, less such Selling<br \/>\nShareholder&#8217;s pro rata portion of the Holdback Amount. It shall be a<br \/>\ncondition of payment that the Certificates so surrendered shall be properly<br \/>\nendorsed or otherwise in proper form for transfer to the Purchaser.<\/p>\n<p>     (b) From and after the Closing Date, there shall be no transfers on the<br \/>\nstock transfer books of the Company of Company Common Stock. If, after the<br \/>\nEffective Time, Certificates formerly representing Company Common Stock set<br \/>\nforth on Schedule I are presented to the Surviving Corporation for payment,<br \/>\nthey shall be cancelled and exchanged for the applicable portion of the<br \/>\nMerger Consideration in accordance with the procedures set forth in this<br \/>\nsection.<\/p>\n<p>     (c) At or prior to the Effective Time, the Purchaser shall deliver<br \/>\nirrevocably to the Escrow Agent shares of Purchaser Stock in an aggregate<br \/>\namount equal to the Holdback Amount.<\/p>\n<p>     (d) In the event that any Certificate shall have been lost, stolen or<br \/>\ndestroyed, upon the making of an affidavit of that fact by the Selling<br \/>\nShareholder claiming such Certificate to be lost, stolen or destroyed, the<br \/>\nPurchaser will issue or cause to be issued in exchange for such lost, stolen<br \/>\nor destroyed Certificate the portion of the Merger Consideration for which<br \/>\nthe shares of Company Common Stock represented by the Certificate are<br \/>\nexchanged in accordance with this Section 3. When authorizing such issuance<br \/>\nin exchange therefor, the Purchaser may, in its discretion and as a condition<br \/>\nprecedent to the issuance thereof, require such Selling Shareholder to give<br \/>\nthe Purchaser a bond in such sum as it may direct as indemnity, or such other<br \/>\nform of indemnity as it may direct, against any claim that may be made<br \/>\nagainst the Purchaser with respect to the Certificate alleged to have been<br \/>\nlost, stolen or destroyed.<\/p>\n<p>     (e) The Purchaser may, at its option, meet its obligations under this<br \/>\nSection 3.3 through a bank or trust company selected by the Purchaser to act<br \/>\nas exchange agent in connection with the Transactions.<\/p>\n<p>     (f) If any certificate for Purchaser Stock is to be issued in a name<br \/>\nother than that in which the Certificate surrendered in exchange therefor is<br \/>\nregistered, it shall be a condition of such exchange that the Person<br \/>\nrequesting such exchange shall (i) pay to the Purchaser any transfer or other<br \/>\ntaxes required by reason of the issuance of certificates for such securities<br \/>\nin a name other than that of the registered holder of the Certificate<br \/>\nsurrendered, or (ii) establish to the satisfaction of the Purchaser that such<br \/>\ntaxes have been paid or are not applicable.<\/p>\n<p>     (g) Notwithstanding anything in this Agreement to the contrary, neither<br \/>\nthe Purchaser nor any other party hereto shall be liable to a holder of<br \/>\nshares of Company Common Stock for any portion of the Merger Consideration,<br \/>\nor dividend on shares of Purchaser Stock issued as part of the Merger<br \/>\nConsideration, or in accordance with Section 3.1, the cash payment for any<br \/>\nfractional interests, delivered to a public official pursuant to applicable<br \/>\nescheat laws following the passage of time specified therein.<\/p>\n<p>                                       5<\/p>\n<p>     3.4  No Further Rights in Company Common Stock.<\/p>\n<p>     All cash, cash equivalents or securities received by each Selling<br \/>\nShareholder pursuant to this Agreement shall be deemed to have been delivered<br \/>\nand received in full satisfaction of all rights pertaining to such Selling<br \/>\nShareholder&#8217;s shares of Company Common Stock.  At the Effective Time, the<br \/>\nSelling Shareholders shall cease to have any rights with respect to shares of<br \/>\nstock, and their sole right shall be to receive the Merger Consideration.<\/p>\n<p>     3.5  Closing.<\/p>\n<p>     The closing of the Transactions (the &#8220;CLOSING&#8221;) shall take place at the<br \/>\noffices of Morrison &amp; Foerster llp, 425 Market Street, San Francisco,<br \/>\nCalifornia 94105-2482, at 9:00 a.m., local time, on the later of (x) June 15,<br \/>\n1999 or (y) the second business day after the day on which all of the<br \/>\nconditions set forth in Sections 4.1 and 4.2 hereof are satisfied or waived,<br \/>\nor at such other date, time and place as the parties shall otherwise agree<br \/>\n(the date of such Closing, the &#8220;CLOSING DATE&#8221;).<\/p>\n<p>     3.6  Supplementary Action.<\/p>\n<p>     If at any time after the Effective Time, any further assignments or<br \/>\nassurances in law or any other things are necessary or desirable to vest or<br \/>\nto perfect or confirm of record in the Surviving Corporation the title to any<br \/>\nproperty or rights of either Constituent Corporation, or otherwise to carry<br \/>\nout the provisions of this Agreement, the officers and directors of the<br \/>\nSurviving Corporation are hereby authorized and empowered on behalf of the<br \/>\nConstituent Corporations, in the name of and on behalf of either Constituent<br \/>\nCorporation as appropriate, to execute and deliver any and all things<br \/>\nnecessary or proper to vest or to perfect or confirm title to such property<br \/>\nor rights in the Surviving Corporation, and otherwise to carry out the<br \/>\npurposes and provisions of this Agreement.<\/p>\n<p>     3.7  Dissenting Shares<\/p>\n<p>          (a)  If holders of Company Common Stock are entitled to dissent<br \/>\nfrom the Merger and demand appraisal of the Company Common Stock under<br \/>\napplicable law (each Person electing to exercise such rights, a &#8220;DISSENTING<br \/>\nHOLDER&#8221;), any shares of Company Common Stock held by a Dissenting Holder as<br \/>\nto which appraisal has been so demanded in accordance with applicable law<br \/>\n(&#8220;DISSENTING SHARES&#8221;) shall not be exchanged as described in Section 3.1, but<br \/>\nshall from and after the Effective Time represent only the right to receive<br \/>\nsuch consideration as may be determined to be due such Dissenting Holder<br \/>\npursuant to applicable law; provided, that each share of Company Common Stock<br \/>\nheld by a Dissenting Holder who shall, after the Effective Time, withdraw its<br \/>\ndemand for appraisal or lose its rights of appraisal with respect to such<br \/>\nshares of stock, in either case pursuant to applicable law, shall not be<br \/>\ndeemed a Dissenting Share, but shall be deemed to be converted, as of the<br \/>\nEffective Time, into the applicable portion of the Merger Consideration.<\/p>\n<p>          (b)  The Company shall give the Purchaser prompt notice of any<br \/>\nwritten demands for appraisal of any shares of Company Common Stock,<br \/>\nwithdrawals of such demands or failures<\/p>\n<p>                                       6<\/p>\n<p>to perfect appraisal rights resulting in a loss of such rights, and any other<br \/>\ninstruments received by the Company which relate to any such demand for<br \/>\nappraisal. The Company shall not voluntarily make any payment with respect to<br \/>\nany demands or potential demands for appraisal of Company Common Stock or<br \/>\noffer to settle or settle any such demands or potential demands. The<br \/>\nPurchaser shall be responsible for any settlement of claims with respect to<br \/>\nany Dissenting Shares, which settlements may be paid in cash, Purchaser Stock<br \/>\nor such other consideration as the Purchaser may determine, except as<br \/>\notherwise required under applicable law.<\/p>\n<p>4.   Closing Conditions.<\/p>\n<p>     4.1  Conditions Precedent to Obligations of the Purchaser and Merger Sub.<\/p>\n<p>     The Purchaser&#8217;s and Merger Sub&#8217;s obligations to consummate the Merger<br \/>\nand to take the other actions required to be taken by the Purchaser and<br \/>\nMerger Sub at the Closing are subject to the satisfaction, at or prior to the<br \/>\nClosing, of each of the following conditions.<\/p>\n<p>          (a) the representations and warranties made by the Selling<br \/>\nShareholde and the Company in Section 5 hereof or in any other Transactional<br \/>\nAgreement shall have been true and accurate in all material respects as of<br \/>\nthe date of this Agreement and as of the Closing Date as though made on and<br \/>\nas of the Closing Date, without giving effect to any Disclosure Schedule<br \/>\nUpdate;<\/p>\n<p>          (b) all covenants, agreements and conditions contained in this<br \/>\nAgreement or in any other Transactional Agreement to be observed by the<br \/>\nSelling Shareholders and\/or the Company on or prior to the Closing shall have<br \/>\nbeen performed or complied with in all material respects;<\/p>\n<p>          (c) the Selling Shareholders or the Company, as the case may be,<br \/>\nshall have delivered the following documents to the Purchaser:<\/p>\n<p>                 (i)   the Escrow Agreement, duly executed by the Selling<br \/>\nShareholders;<\/p>\n<p>                 (ii)  a Registration Rights Agreement in the form of Exhibit<br \/>\nC (the &#8220;RIGHTS AGREEMENT&#8221;), duly executed by the Selling Shareholders;<\/p>\n<p>                 (iii) a countersigned employment offer letter and an<br \/>\nexecuted Proprietary Information, Non-Disclosure and Non-Solicitation<br \/>\nAgreement substantially in the forms of Exhibits D-1 and D-2, respectively,<br \/>\nduly executed by each of the Key Employees;<\/p>\n<p>                 (iv)  a Non-Competition and Non-Solicitation Agreement duly<br \/>\nexecuted by Vijay and Sheena Vaidyanathan in substantially the form of<br \/>\nExhibit E;<\/p>\n<p>                 (v)   the legal opinion of Pillsbury Madison &amp; Sutro LLP,<br \/>\ncounsel to the Selling Shareholders and the Company, dated the Closing Date,<br \/>\nin substantially the form of Exhibit F;<\/p>\n<p>                                       7<\/p>\n<p>                 (vi)  written confirmation from Pillsbury Madison &amp; Sutro<br \/>\nLLP confirming that the Company has paid in full all legal fees, including<br \/>\nlegal fees relating to these Transactions incurred prior to and including the<br \/>\nday immediately preceding the Closing;<\/p>\n<p>                 (vii) a certificate (the &#8220;SELLING SHAREHOLDERS CLOSING<br \/>\nCERTIFICATE&#8221; and the &#8220;COMPANY CLOSING CERTIFICATE,&#8221; respectively) executed by<br \/>\nthe Selling Shareholders and a senior executive officer of the Company,<br \/>\nrespectively, dated as of the Closing Date, and certifying to the<br \/>\nsatisfaction of the conditions specified in Sections 4.1(a) and (b);<\/p>\n<p>                 (viii) the written resignations of the members of the<br \/>\nCompany Board;<\/p>\n<p>                 (ix)   written evidence reasonably satisfactory to the<br \/>\nPurchaser and its counsel of the grant of Company Options to the employees of<br \/>\nthe Company as set forth on Schedule II attached hereto;<\/p>\n<p>                 (x)    written evidence reasonably satisfactory to the<br \/>\nPurchaser and its counsel of the conversion of all of the Company Preferred<br \/>\nStock into Company Common Stock;<\/p>\n<p>                 (xi) such other documents reasonably satisfactory to the<br \/>\nPurchaser as the Purchaser may request in good faith for the purpose of<br \/>\n(A) evidencing the accuracy of any representation or warranty made by the<br \/>\nCompany or the Selling Shareholders, (B) evidencing the compliance by the<br \/>\nCompany or the Selling Shareholders with, or the performance by the Company<br \/>\nor the Selling Shareholders of, any covenant or obligation set forth in this<br \/>\nAgreement or any other Transactional Agreement, (C) evidencing the satisfaction<br \/>\nof the conditions set forth in this Section 4.1, or (D) otherwise facilitating<br \/>\nthe consummation or performance of any of the Transactions;<\/p>\n<p>          (d) each of the Key Employees shall have accepted employment with<br \/>\nthe Purchaser (or one of the Purchaser&#8217;s subsidiaries);<\/p>\n<p>          (e) to the satisfaction of the Purchaser and its counsel, the offer<br \/>\nand sale of Purchaser Stock pursuant to the terms of this Agreement shall<br \/>\ncomply with an exemption from registration under the Securities Act and\/or<br \/>\nany applicable federal or state securities laws and regulations;<\/p>\n<p>          (f) the Company and each of the holders of Company Options shall<br \/>\nhave executed and delivered an amended Option Agreement in the Form of<br \/>\nExhibit G and provided the Purchaser with a copy thereof, providing that no<br \/>\nadditional acceleration of options shall occur upon closing of the<br \/>\ntransactions described in the Agreement and Plan of Contribution, Investment<br \/>\nand Merger, dated as of May 9, 1999 among National Broadcasting Company,<br \/>\nInc., GE Investments Subsidiary, Inc., the Purchaser and others;<\/p>\n<p>          (g) all corporate and other proceedings required to be taken on the<br \/>\npart of the Company and the Selling Shareholders in connection with this<br \/>\nAgreement, the Transactional Agreements and the Transactions, and all<br \/>\ndocuments incident thereto, shall be reasonably satisfactory in form and in<br \/>\nsubstance to the Purchaser and its counsel;<\/p>\n<p>                                       8<\/p>\n<p>          (h) except for the Selling Shareholder listed on Schedule III, all<br \/>\nof the Selling Shareholders shall have executed this Agreement;<\/p>\n<p>          (i) the Company&#8217;s Board of Directors shall have ratified or<br \/>\napproved the execution of this Agreement and the other Transactional<br \/>\nAgreements by the Company and shall have approved the consummation of the<br \/>\nTransactions;<\/p>\n<p>          (j) each of the Consents identified or required to be identified in<br \/>\nPart 5.5 of the Disclosure Schedule shall have been obtained and shall be in<br \/>\nfull force and effect;<\/p>\n<p>          (k) there shall have been no material adverse change in the<br \/>\nCompany&#8217;s business, condition, assets, liabilities, operations or financial<br \/>\nperformance since the date of this Agreement;<\/p>\n<p>          (l) there shall not have been commenced or expressly threatened<br \/>\nagainst the Company or any of its affiliates any Proceeding (i) involving any<br \/>\nchallenge to, or seeking damages or other relief in connection with, any of<br \/>\nthe Transactions, or (ii) that is likely to have the effect of preventing,<br \/>\ndelaying, making illegal or otherwise interfering with any of the<br \/>\nTransactions or have a material adverse effect on the Company;<\/p>\n<p>          (m) no Person shall have made or expressly threatened any claim<br \/>\nasserting that such Person (i) may be the holder or the beneficial owner, or<br \/>\nmay have the right to acquire or to obtain beneficial ownership of, any<br \/>\ncapital stock or other securities of the Company, or (ii) may be entitled to<br \/>\nall or any portion of the Merger Consideration;<\/p>\n<p>          (n) neither the consummation nor the performance of any of the<br \/>\nTransactions will, directly or indirectly (with or without notice or lapse of<br \/>\ntime), contravene or conflict with or result in a violation of, or cause the<br \/>\nPurchaser or the Company, or any Person affiliated with the Purchaser or the<br \/>\nCompany, to suffer any material adverse consequence under, (i) any applicable<br \/>\nlegal requirement or Order, or (ii) any legal requirement or Order that has<br \/>\nbeen proposed by or before any Governmental Body; and<\/p>\n<p>          (o) All of the Preferred Stock issued by the Company owned by<br \/>\nChristopher and Christina Kitze shall have been purchased at cost by either<br \/>\nthe Company or a Selling Shareholder.<\/p>\n<p>     4.2  Conditions Precedent to Obligations of the Company and the Selling<br \/>\n          Shareholders.<\/p>\n<p>     The Company&#8217;s obligation to take the actions required to be taken by the<br \/>\nCompany at the Closing, is subject to the satisfaction, at or prior to the<br \/>\nClosing, of each of the following conditions (any of which may be waived by<br \/>\nthe Company, in whole or in part.<\/p>\n<p>          (a) the representations and warranties made by the Purchaser and<br \/>\nMerger Sub in Section 7 and in any other Transactional Agreement shall have<br \/>\nbeen true and correct in all<\/p>\n<p>                                       9<\/p>\n<p>material respects as of the date of this Agreement and as of the Closing Date<br \/>\nas though made on and as of the Closing Date;<\/p>\n<p>          (b) all covenants, agreements and conditions contained in this<br \/>\nAgreement or in any other Transactional Agreement to be observed by the<br \/>\nPurchaser and Merger Sub on or prior to the Closing shall have been performed<br \/>\nor complied with in all material respects;<\/p>\n<p>          (c) the Purchaser shall have delivered the following documents to<br \/>\nthe Selling Shareholders and\/or the Company, as the case may be, duly<br \/>\nexecuted by the Purchaser:<\/p>\n<p>                (i)   the Escrow Agreement;<\/p>\n<p>                (ii)  the Rights Agreement;<\/p>\n<p>                (iii) binding offers of employment by the Purchaser as set<br \/>\nforth in Section 4.1(c);<\/p>\n<p>                (iv)  the legal opinion of Morrison &amp; Foerster LLP, counsel<br \/>\nto the Purchaser, dated the Closing Date, in substantially the form of<br \/>\nExhibit H; and<\/p>\n<p>                (v)   a certificate (the &#8220;PURCHASER CLOSING CERTIFICATE&#8221;)<br \/>\nexecuted by a senior executive officer of the Purchaser, dated as of the<br \/>\nClosing Date and (A) certifying to the satisfaction of the conditions<br \/>\nspecified in Sections 4.2(a) and (b); and (B) certifying to and attaching a<br \/>\ncopy of the adoption of a resolution by the Purchaser&#8217;s Board of Directors<br \/>\nclarifying that the Transactions will be treated as exempt transactions under<br \/>\nSection 16 of the Exchange Act; and<\/p>\n<p>          (d) all corporate and other proceedings required to be taken on the<br \/>\npart of the Purchaser and Merger Sub in connection with the Transactions,<br \/>\nshall have been completed.<\/p>\n<p>5.   Representations and Warranties of the Company.<\/p>\n<p>     Except as specifically set forth in the disclosure schedule provided by<br \/>\nthe Company and attached hereto (the &#8220;COMPANY DISCLOSURE SCHEDULE&#8221;), the<br \/>\nparts of which are numbered to correspond to the section numbers of this<br \/>\nAgreement, the Company hereby represents and warrants to each Indemnitee as<br \/>\nfollows:<\/p>\n<p>     5.1 Organization, Good Standing, Qualification.<\/p>\n<p>         (a) The Company is a corporation duly organized, validly existing<br \/>\nand in good standing under the laws of the State of California and is<br \/>\nqualified to conduct business in the State of California. The Company is not<br \/>\nqualified to transact business in any other jurisdiction. The Company has all<br \/>\nrequisite corporate power and authority to own and operate its properties and<br \/>\nassets and to carry out the provisions hereof and to carry on its business as<br \/>\ncurrently conducted.<\/p>\n<p>                                       10<\/p>\n<p>          (b) The Company has never approved, or commenced any Proceeding, or<br \/>\nmade any election contemplating, the dissolution or liquidation of the<br \/>\nCompany or the winding up or cessation of the Company&#8217;s business or affairs.<\/p>\n<p>          (c) The Company has no subsidiaries and does not own, beneficially<br \/>\nor otherwise, any shares or other securities of, or any other direct or<br \/>\nindirect interest of any nature in, any Entity.<\/p>\n<p>          (d) The Company was never operated as a sole proprietorship, or any<br \/>\nother business entity, prior to its incorporation.<\/p>\n<p>     5.2  Articles of Incorporation and Bylaws; Records.<\/p>\n<p>          (a) The Company has delivered to the Purchaser accurate and<br \/>\ncomplete copies of:<\/p>\n<p>               (i)   the Company&#8217;s Articles of Incorporation and Bylaws,<br \/>\nincluding all amendments thereto, as currently in effect;<\/p>\n<p>               (ii)  the stock records of the Company; and<\/p>\n<p>               (iii) the minutes and other records of the meetings and other<br \/>\nproceedings (including any actions taken by written consent or otherwise<br \/>\nwithout a meeting) of the shareholders of the Company, the Company Board and<br \/>\nall committees of the Company Board.<\/p>\n<p>There have been no meetings or other proceedings of the shareholders of the<br \/>\nCompany, the Company Board or any committee of the Company Board that are not<br \/>\nmemorialized in such minutes or other records.<\/p>\n<p>        (b) The Company has never conducted any business under or otherwise<br \/>\nused, for any purpose or in any jurisdiction, any fictitious name, assumed<br \/>\nname, trade name or other name, other than the names listed on Part 5.2 of<br \/>\nthe Disclosure Schedule.<\/p>\n<p>        (c) There has not been any violation of the Company&#8217;s Articles of<br \/>\nIncorporation or Bylaws or any material violation of any resolution adopted<br \/>\nby the Company&#8217;s shareholders, the Company Board or any committee of the<br \/>\nCompany Board.<\/p>\n<p>     5.3  Capitalization.<\/p>\n<p>          (a) The authorized capital stock of the Company consists of Seven<br \/>\nMillion Four Hundred Thousand (7,400,000) shares of capital stock, comprised<br \/>\nof Seven Million (7,000,000) shares of Common Stock, of which Four Million<br \/>\nNine Hundred Ninety-Two Thousand Seven Hundred Twenty-Six (4,992,726) shares<br \/>\nare issued and outstanding, and Four Hundred Thousand (400,000) shares of<br \/>\nPreferred Stock, all of which are designated Series A Preferred Stock, of<br \/>\nwhich Two Hundred Fourteen Thousand Two Hundred Forty-two (214,242) shares<br \/>\nare issued and outstanding (the &#8220;COMPANY PREFERRED STOCK&#8221;), all of which<br \/>\nCompany Preferred Stock shall be converted into Company Common Stock<br \/>\nconditioned upon the Closing and immediately<\/p>\n<p>                                       11<\/p>\n<p>prior to the Effective Time. No other shares of capital stock are issued or<br \/>\noutstanding. All issued and outstanding shares of the Company&#8217;s capital stock<br \/>\nhave been duly authorized and validly issued and are fully paid and<br \/>\nnonassessable. Schedule II accurately sets forth (i) the names of the<br \/>\nemployees\/consultants who have been granted Company Options; (ii) the number<br \/>\nof Company Options held by such employees as of the date of this Agreement;<br \/>\nand\/or (iii) the number of Company Options to be granted to such<br \/>\nemployees\/consultants prior to the Closing.<\/p>\n<p>          (b) Except as set forth on Schedule II or Part 5.3 of the<br \/>\nDisclosure Schedule, there is no:<\/p>\n<p>                 (i)   outstanding subscription, option, call, warrant or<br \/>\nright (whether or not currently exercisable) to acquire any shares of the<br \/>\ncapital stock or other securities of the Company;<\/p>\n<p>                 (ii)  outstanding security, instrument or obligation that is<br \/>\nor may become convertible into or exchangeable for any shares of the capital<br \/>\nstock or other securities of the Company; or<\/p>\n<p>                 (iii) to the knowledge of the Company, condition or<br \/>\ncircumstance that may directly or indirectly give rise to or provide a basis<br \/>\nfor a claim by any Person to the effect that such Person is entitled to<br \/>\nacquire or receive any shares of capital stock or other securities of the<br \/>\nCompany.<\/p>\n<p>          (c) The Company has never repurchased, redeemed or otherwise<br \/>\nreacquired (or agreed, committed or offered (in writing or otherwise) to<br \/>\nrepurchase, redeem or otherwise reacquire) any shares of capital stock or<br \/>\nother securities, except from employees of the Company pursuant to the terms<br \/>\nof the Option Plan.<\/p>\n<p>     5.4  Authority; Binding Nature of Agreements.<\/p>\n<p>     The Company has the corporate power and authority to enter into and to<br \/>\nperform its obligations under this Agreement and the other Transactional<br \/>\nAgreements to which it is or is contemplated to be a party, and the<br \/>\nexecution, delivery and performance by the Company of this Agreement and such<br \/>\nTransactional Agreements have been duly authorized by all necessary action on<br \/>\nthe part of the Company Board and its shareholders.  This Agreement and the<br \/>\nother Transactional Agreements constitute, or upon execution and delivery<br \/>\nwill constitute, the legal, valid and binding obligations of the Company,<br \/>\nenforceable against the Company in accordance with their respective terms,<br \/>\nexcept to the extent that enforceability may be limited by applicable<br \/>\nbankruptcy, reorganization, insolvency, moratorium or other laws affecting<br \/>\nthe enforcement of creditor&#8217;s rights generally and by general principles of<br \/>\nequity regardless of whether such enforceability is considered in a<br \/>\nProceeding at law or in equity.<\/p>\n<p>                                       12<\/p>\n<p>     5.5  Non-Contravention; Consents.<\/p>\n<p>     The execution and delivery of this Agreement and the other Transactional<br \/>\nAgreements, and the consummation of the Transactions, by the Company will<br \/>\nnot, directly or indirectly (with or without notice or lapse of time):<\/p>\n<p>          (a) contravene, conflict with or result in a material violation of<br \/>\n(i) the Company&#8217;s Articles of Incorporation or Bylaws, or (ii) any resolution<br \/>\nadopted by the Company Board or any committee thereof or the shareholders of<br \/>\nthe Company;<\/p>\n<p>          (b) to the knowledge of the Company, contravene, conflict with or<br \/>\nresult in a violation of, or give any Governmental Body or other Person the<br \/>\nright to challenge any of the Transactions or to exercise any remedy or<br \/>\nobtain any relief under, any legal requirement or any Order to which the<br \/>\nCompany or any assets owned or used by it are subject;<\/p>\n<p>          (c) to the knowledge of the Company, cause any material assets<br \/>\nowned or used by the Company to be reassessed or revalued by any taxing<br \/>\nauthority or other Governmental Body;<\/p>\n<p>          (d) to the knowledge of the Company, contravene, conflict with or<br \/>\nresult in a material violation of any of the terms or requirements of, or<br \/>\ngive any Governmental Body the right to revoke, withdraw, suspend, cancel,<br \/>\nterminate or modify, any Governmental Authorization that is held by the<br \/>\nCompany or any of its employees or that otherwise relates to the Company&#8217;s<br \/>\nbusiness or to any of the assets owned or used by the Company;<\/p>\n<p>          (e) contravene, conflict with or result in a material violation or<br \/>\nmaterial breach of, or material default under, any Company Contract;<\/p>\n<p>          (f) give any Person the right to any payment by the Company or give<br \/>\nrise to any acceleration or change in the award, grant, vesting or<br \/>\ndetermination of options, warrants, rights, severance payments or other<br \/>\ncontingent obligations of any nature whatsoever of the Company in favor of<br \/>\nany Person, in any such case as a result of the change in control of the<br \/>\nCompany or otherwise resulting from the Transactions; or<\/p>\n<p>          (g) result in the imposition or creation of any material<br \/>\nencumbrance upon or with respect to any asset owned or used by the Company.<br \/>\nExcept as set forth in Part 5.5 of the Disclosure Schedule, the Company will<br \/>\nnot be required to make any filing with or give any notice to, or obtain any<br \/>\nConsent from, any Person in connection with the execution and delivery of<br \/>\nthis Agreement and the other Transactional Agreements or the consummation or<br \/>\nperformance of any of the Transactions.<\/p>\n<p>     5.6  Intellectual Property.<\/p>\n<p>          (a) Part 5.6 of the Disclosure Schedule sets forth a complete list,<br \/>\nin all material respects, of all patents, registered trademarks, registered<br \/>\ncopyrights, registered maskworks, registered trade names and registered<br \/>\nservice marks, and any applications therefor in respect of<\/p>\n<p>                                       13<\/p>\n<p>any of the foregoing, included in the Company&#8217;s Proprietary Assets, and<br \/>\nspecifies, where applicable, the jurisdictions in which each such Proprietary<br \/>\nAsset has been issued or filed, including the respective registration or<br \/>\napplication numbers and the names of all owners. Part 5.6 also sets forth a<br \/>\ncomplete list of all material licenses, sublicenses and other agreements to<br \/>\nwhich the Company is a party and pursuant to which the Company or any other<br \/>\nPerson is authorized to use any of the Company&#8217;s Proprietary Assets<br \/>\n(excluding object code and end-user licenses granted to end-users in the<br \/>\nOrdinary Course of business that permit use of software products without a<br \/>\nright to modify, distribute or sublicense the same (&#8220;END-USER LICENSES&#8221;)) or<br \/>\nother trade secrets material to the Company, and includes the identity of all<br \/>\nparties thereto, a general description of the nature and subject matter<br \/>\nthereof, the applicable royalty and the term thereof. The management of the<br \/>\nCompany, after diligent investigation, is not aware of any violation of any<br \/>\nlicense, sublicense or agreement described on such list except such<br \/>\nviolations as do not materially impair the Company&#8217;s rights under such<br \/>\nlicense, sublicense or agreement. Except as set forth in Part 5.6 the<br \/>\nexecution and delivery of this Agreement by the Company, and the consummation<br \/>\nof the Transactions, (i) will not cause the Company to be in material<br \/>\nviolation or default under any such license, sublicense or agreement, (ii) will<br \/>\nnot entitle any other party to any such license, sublicense or agreement to<br \/>\nterminate or modify such license, sublicense or agreement or (iii) will not<br \/>\nrequire the Company to repay any funds already received by it from a third<br \/>\nparty.<\/p>\n<p>     (b) Except as set forth in Part 5.6, the Company has all right, title<br \/>\nand interest in and to the Company&#8217;s Proprietary Assets, and any rights<br \/>\n(without being contractually obligated to pay any compensation to any third<br \/>\nparty in respect thereof) necessary for the use thereof or the material<br \/>\ncovered thereby in connection with the services or products in respect of<br \/>\nwhich the Company&#8217;s Proprietary Assets are being used by the Company.<\/p>\n<p>     (c) Except as set forth in Part 5.6, to the knowledge of the management<br \/>\nof the Company, there is no material unauthorized use, infringement or<br \/>\nmisappropriation of any of the Company&#8217;s Proprietary Assets by any third<br \/>\nparty, including any employee or former employee of the Company.<\/p>\n<p>     (d) The Company has not entered into any agreement under which the<br \/>\nCompany is restricted from selling, licensing or otherwise distributing any<br \/>\nof its products to any class of customers, in any geographic area, during any<br \/>\nperiod of time or in any segment of the market.<\/p>\n<p>     (e) Each employee and consultant identified on the Disclosure Schedule<br \/>\nhas executed the Company&#8217;s form of proprietary information and invention<br \/>\nagreement in substantially the form provided to the Purchaser and its counsel.<\/p>\n<p>                                       14<\/p>\n<p>     5.7  Proceedings; Orders.<\/p>\n<p>          (a) There is no pending Proceeding, and, to the Company&#8217;s<br \/>\nknowledge, no Person has threatened to commence any Proceeding nor are there<br \/>\nany valid grounds, to the knowledge of the Company, for any bona fide claims<br \/>\nthat would give rise to a Proceeding:<\/p>\n<p>               (i)  that involve the Company, including its use of the<br \/>\nProprietary Assets referred to in Section 5.6 hereof; or<\/p>\n<p>               (ii) that challenge, or that may have the effect of<br \/>\npreventing, delaying, making illegal or otherwise interfering with, any of<br \/>\nthe Transactions or the Company&#8217;s ability to comply with, or perform its<br \/>\nobligations and covenants under, the Transactional Agreements, and, to the<br \/>\nknowledge of the Company, no event has occurred, and no claim, dispute or<br \/>\nother condition or circumstance exists, that might directly or indirectly<br \/>\ngive rise to or serve as a basis for the commencement of any such Proceeding.<\/p>\n<p>          (b) The Company has delivered to the Purchaser accurate and<br \/>\ncomplete copies of all pleadings, correspondence and other written materials<br \/>\nto which the Company has access that relate to the Proceedings identified in<br \/>\nPart 5.7 of the Disclosure Schedule, if any.<\/p>\n<p>          (c) There is no Order to which the Company, or any of the assets<br \/>\nowned or used by the Company, is subject.<\/p>\n<p>          (d) To the Company&#8217;s knowledge, no officer or employee of the<br \/>\nCompany is subject to any Order that prohibits such officer or employee from<br \/>\nengaging in or continuing any conduct, activity or practice relating to the<br \/>\nCompany&#8217;s business.<\/p>\n<p>     5.8  Financial Statements.<\/p>\n<p>          (a) The Company has delivered to the Purchaser the following<br \/>\nfinancial statements and notes (collectively, the &#8220;FINANCIAL STATEMENTS&#8221;),<br \/>\nwhich are attached as Exhibit I:<\/p>\n<p>                 (i)  the unaudited balance sheet of the Company as of<br \/>\nDecember 31, 1998, and the related unaudited statements of operations,<br \/>\nchanges in shareholders&#8217; equity and cash flows of the Company for the period<br \/>\nended December 31, 1998, together with the notes thereto; and<\/p>\n<p>                 (ii) the unaudited consolidated balance sheet of the Company<br \/>\nas of March 31, 1999 (the &#8220;UNAUDITED INTERIM BALANCE SHEET&#8221;), and the related<br \/>\nunaudited statements of operations, changes in shareholders&#8217; equity and cash<br \/>\nflows of the Company for the three (3) months then ended March 31, 1999.<\/p>\n<p>        (b) All the Financial Statements are accurate and complete in all<br \/>\nmaterial respects, and the dollar amount of each line item included in the<br \/>\nFinancial Statements is accurate in all material respects. The Financial<br \/>\nStatements are in accordance with the books and records of the Company and<br \/>\npresent fairly the financial position of the Company as of the respective<br \/>\ndates<\/p>\n<p>                                       15<\/p>\n<p>thereof and the results of operations of the Company, changes in<br \/>\nshareholders&#8217; equity and cash flows for the periods covered thereby. The<br \/>\nFinancial Statements have been prepared in accordance with GAAP, applied on a<br \/>\nconsistent basis throughout the periods covered.<\/p>\n<p>          (c) As of the date of this Agreement, the Company has no<br \/>\nliabilities in excess of Ten Thousand Dollars ($10,000), individually or in<br \/>\nthe aggregate, except for liabilities identified as such in the &#8220;Liabilities&#8221;<br \/>\ncolumn of the Unaudited Interim Balance Sheet.<\/p>\n<p>     5.9  Title to Assets.<\/p>\n<p>          (a) The Company owns, and has good, valid and marketable title to,<br \/>\nall assets purported to be owned by it, free and clear of any material<br \/>\nencumbrances, except liens for current taxes and assessments not delinquent.<\/p>\n<p>          (b) Part 5.9(b) of the Disclosure Schedule identifies all<br \/>\nequipment, furniture, fixtures, improvements and other tangible assets owned<br \/>\nby the Company with a value over Ten Thousand Dollars ($10,000), and sets<br \/>\nforth the original cost and book value of each of said assets.<\/p>\n<p>          (c) Each asset identified in Part 5.9(b) of the Disclosure Schedule:<\/p>\n<p>                (i) is free of material defects and in good condition and<br \/>\nrepair, consistent with its age and intended use (ordinary wear and tear<br \/>\nexcepted); and<\/p>\n<p>                (ii) is adequate for the uses to which it is being put.<\/p>\n<p>          (d) The Company does not own any real property or any interest in<br \/>\nreal property, except for the leaseholds created under the real property<br \/>\nleases identified in Part 5.9(d) of the Disclosure Schedule (the &#8220;LEASED<br \/>\nPREMISES&#8221;). Part 5.9(d) of the Disclosure Schedule lists the premises covered<br \/>\nby said leases. The Company enjoys peaceful and undisturbed possession of<br \/>\nsuch premises.<\/p>\n<p>          (e) Part 5.9(e) of the Disclosure Schedule identifies all assets<br \/>\nthat are leased or licensed to the Company that have a value in excess of Ten<br \/>\nThousand Dollars ($10,000). All leases pursuant to which the Company leases<br \/>\nreal or personal property are in good standing and are valid and effective in<br \/>\naccordance with their respective terms and, to the knowledge of the Company,<br \/>\nthere exists no default thereunder.<\/p>\n<p>     5.10 Contracts.<\/p>\n<p>          (a) Part 5.10 of the Disclosure Schedule identifies and describes<br \/>\neach material Company Contract. The Company has delivered to the Purchaser<br \/>\naccurate and complete copies of all Company Contracts identified in Part 5.10<br \/>\nof the Disclosure Schedule, including all amendments thereto.<\/p>\n<p>          (b) To the Company&#8217;s knowledge, each Company Contract is currently<br \/>\nvalid and in full force and effect, and is enforceable by the Company in<br \/>\naccordance with its terms, except<\/p>\n<p>                                       16<\/p>\n<p>to the extent that enforceability may be limited by applicable bankruptcy,<br \/>\nreorganization, insolvency, moratorium or other laws affecting the enforcement<br \/>\nof creditor&#8217;s rights generally and by general principles of equity regardless of<br \/>\nwhether such enforceability is considered in a Proceeding at law or in equity.<\/p>\n<p>          (c) The Company is not in material default under any Company Contract,<br \/>\nand, to the knowledge of the Company, (i) no Person has violated or breached, or<br \/>\ndeclared or committed any material default under, any Company Contract; and (ii)<br \/>\nthe Company has not waived any of its rights under any material Company<br \/>\nContract.<\/p>\n<p>          (d) (i) The Company has never guaranteed or otherwise agreed to cause,<br \/>\ninsure or become liable for, and has never pledged any of its assets to secure,<br \/>\nthe performance or payment of any obligation or other Liability of any other<br \/>\nPerson; and (ii) the Company has never been a party to or bound by any material<br \/>\njoint venture agreement, partnership agreement, profit-sharing agreement, cost-<br \/>\nsharing agreement, loss-sharing agreement or similar Contract.<\/p>\n<p>          (e) No Person is renegotiating any amount paid or payable to the<br \/>\nCompany under any Company Contract or any other material term or provision of<br \/>\nany Company Contract.<\/p>\n<p>          (f) Part 5.10(f) of the Disclosure Schedule identifies, and provides<br \/>\nan accurate and complete description of, each proposed Company Contract as to<br \/>\nwhich any bid, offer, written proposal, term sheet or similar document has been<br \/>\nsubmitted to or received by the Company and is outstanding.<\/p>\n<p>          (g) No party to any Company Contract has notified the Company to the<br \/>\neffect that the Company has failed to perform a material obligation thereunder.<\/p>\n<p>     5.11 Employees.<\/p>\n<p>          (a) Part 5.11(a) of the Disclosure Schedule contains a list of all<br \/>\nemployees of the Company as of the date of this Agreement and their respective<br \/>\ntitles and annualized compensation and any written or oral commitments to the<br \/>\nemployees regarding the material terms and conditions of their employment.<\/p>\n<p>          (b) Part 5.11(b) of the Disclosure Schedule contains a list of Persons<br \/>\nwho are currently performing services for the Company business and are<br \/>\nclassified as &#8220;consultants&#8221; or &#8220;independent contractors,&#8221; and the respective<br \/>\ncompensation of each such &#8220;consultant&#8221; or &#8220;independent contractor.&#8221;<\/p>\n<p>          (c) The Company has no collective bargaining agreements or union<br \/>\ncontracts with any of its employees. To the knowledge of the Company, there is<br \/>\nno labor union-organizing activity pending or threatened with respect to the<br \/>\nCompany. The employment of each of the Company&#8217;s employees is terminable by the<br \/>\nCompany at will; and no employee has any agreement or contract, written or<br \/>\nverbal, regarding his or her employment.<\/p>\n<p>                                       17<\/p>\n<p>          (d) To the Company&#8217;s knowledge, no employee of the Company, nor any<br \/>\nconsultant or independent contractor with whom the Company has contracted, is<br \/>\nin violation of any term of any employment contract, proprietary information<br \/>\nagreement or any other agreement relating to the right of such individual to be<br \/>\nemployed by, or to contract with, the Company because of the nature of the<br \/>\nbusiness to be conducted by the Company.  The Company has not received any<br \/>\nnotice (written or otherwise) alleging that any such violation has occurred.  No<br \/>\nemployee of the Company has been granted the right to continued employment by<br \/>\nthe Company or to any material compensation following termination of employment<br \/>\nwith the Company.  To the knowledge of the Company, no officer or key employee,<br \/>\nor any group of employees, has given notice of his, her or their intent to<br \/>\nterminate his, her or their employment with the Company, and no employee of the<br \/>\nCompany has received an offer to join a business that is or likely would be<br \/>\ncompetitive with the Company&#8217;s business.<\/p>\n<p>     5.12 Compliance with Legal Requirements.<\/p>\n<p>          (a) The Company is in full compliance with each material legal<br \/>\nrequirement that is applicable to it or to the conduct of its business or the<br \/>\nownership or use of any of its assets.<\/p>\n<p>          (b) The Company has not received, at any time, any notice from any<br \/>\nGovernmental Body or any other Person regarding (i) any actual, alleged,<br \/>\npossible or potential violation of, or failure to comply with, any legal<br \/>\nrequirement by the Company, or (ii) any actual, alleged, possible or potential<br \/>\nobligation on the part of the Company to undertake, or to bear all or any<br \/>\nportion of the cost of, any cleanup or any remedial, corrective or response<br \/>\naction of any nature relating to Hazardous Materials, except to the extent<br \/>\nnoncompliance would not materially adversely effect the Company&#8217;s business<br \/>\nprospects or financial condition.<\/p>\n<p>     5.13 Governmental Authorizations.<\/p>\n<p>          (a) Part 5.13 of the Disclosure Schedule identifies each Governmental<br \/>\nAuthorization held by the Company.  The Company has delivered to the Purchaser<br \/>\naccurate and complete copies of all such Governmental Authorizations, including<br \/>\nall renewals thereof and all amendments thereto.  Each Governmental<br \/>\nAuthorization identified or required to be identified in Part 5.13 of the<br \/>\nDisclosure Schedule is valid and in full force and effect.<\/p>\n<p>          (b) The Governmental Authorizations identified in Part 5.13 of the<br \/>\nDisclosure Schedule constitute all the Governmental Authorizations necessary (i)<br \/>\nto enable the Company to conduct its business in the manner in which its<br \/>\nbusiness is currently being conducted, and (ii) to permit the Company to own and<br \/>\nuse its assets in the manner in which they are currently owned and used.<\/p>\n<p>     5.14 Tax Matters.<\/p>\n<p>          (a) Except to the extent set forth in Part 5.14 of the Disclosure<br \/>\nSchedule, each Tax required to have been paid, or claimed by any Governmental<br \/>\nBody to be payable, by the Company (whether pursuant to any Tax Return or<br \/>\notherwise) has been duly paid in full on a timely basis. Any Tax required to<br \/>\nhave been withheld or collected by the Company has been <\/p>\n<p>                                       18<\/p>\n<p>duly withheld and collected, and (to the extent required) each such Tax has been<br \/>\npaid to the appropriate Governmental Body. The Company has complied with all<br \/>\ninformation reporting and backup withholding requirements, including maintenance<br \/>\nof required records with respect thereto, in connection with amounts paid or<br \/>\nowing to any employee, creditor, independent contractor, or other third party.<\/p>\n<p>          (b) Part 5.14 of the Disclosure Schedule accurately identifies all Tax<br \/>\nReturns required to be filed by or on behalf of the Company with any<br \/>\nGovernmental Body with respect to any taxable period ending on or before the<br \/>\nClosing Date (&#8220;COMPANY RETURNS&#8221;).  All Company Returns (i) have been, or will<br \/>\nbe, filed when due, and (ii) have been, or will be when filed, accurately and<br \/>\ncompletely prepared pursuant to applicable law.  All amounts shown on the<br \/>\nCompany Returns to be due on or before the Closing Date, and all amounts<br \/>\notherwise payable in connection with the Company Returns on or before the<br \/>\nClosing Date, have been paid on or before the Closing Date.  The Company has<br \/>\ndelivered to the Purchaser copies of all Company Returns filed for the fiscal<br \/>\nperiods ended on or before the date hereof.<\/p>\n<p>          (c) The Company&#8217;s Liability for unpaid Taxes for all periods ending on<br \/>\nor before the date of the Financial Statements does not, in the aggregate,<br \/>\nexceed the amount of the current Liability accruals for Taxes (excluding<br \/>\nreserves for deferred taxes) reported in the Financial Statements. The Company<br \/>\nwill establish reserves adequate for the payment of all Taxes for the period<br \/>\nfrom December 31, 1998 through the Closing Date, and the Company will disclose<br \/>\nthe dollar amount of such reserves to the Purchaser on or prior to the Closing<br \/>\nDate.<\/p>\n<p>          (d) Part 5.14 of the Disclosure Schedule identifies each examination<br \/>\nor audit of any Company Return that has been conducted by any Governmental Body<br \/>\nfor the fiscal periods ended on or before the date hereof. The Company has<br \/>\ndelivered to the Purchaser copies of all audit reports and similar documents (to<br \/>\nwhich the Company has access) relating to Company Returns. No extension or<br \/>\nwaiver of the limitation period applicable to any of the Company Returns has<br \/>\nbeen granted (by the Company or any other Person), and no such extension or<br \/>\nwaiver has been requested from the Company.<\/p>\n<p>          (e) No claim or other Proceeding is pending or has been threatened in<br \/>\nwriting or orally (formally or informally) against or with respect to the<br \/>\nCompany in respect of any Tax.  The Company has not entered into or become bound<br \/>\nby any agreement or consent pursuant to Section 341(f) of the Code.  The Company<br \/>\nhas not been, and will not be, required to include any adjustment in taxable<br \/>\nincome for any tax period (or portion thereof) pursuant to Section 481 or 263A<br \/>\nof the Code or any comparable provision under state or foreign Tax laws as a<br \/>\nresult of transactions or events occurring, or accounting methods employed,<br \/>\nprior to the Closing.  The Company has never been in a &#8220;consolidated group&#8221;<br \/>\nwithin the meaning of Treasury Regulations Section 1.1502-1(h), and is not<br \/>\nliable for Taxes incurred by any individual, trust, corporation, partnership or<br \/>\nany other Entity either as a transferee, pursuant to Treasury Regulations<br \/>\nSection 1.1502-6, or pursuant to any other provision of federal, territorial,<br \/>\nstate, local or foreign law or regulations.  Except as set forth in Part 5.14 of<br \/>\nthe Disclosure Schedule, the Company is not a party to any joint venture,<br \/>\npartnership or other arrangement or contract which could be treated as a<br \/>\npartnership for United States federal income tax purposes.  None of the assets<br \/>\nof the <\/p>\n<p>                                       19<\/p>\n<p>Company (i) directly or indirectly secures any debt the interest on which is<br \/>\ntax-exempt under Section 103(a) of the Code or (ii) is &#8220;tax-exempt use property&#8221;<br \/>\nwithin the meaning of Section 168(h) of the Code. The Company has not<br \/>\nparticipated in an international boycott as defined in Code Section 999. The<br \/>\nCompany does not have a &#8220;permanent establishment,&#8221; as defined in any applicable<br \/>\nTax treaty or convention of the United States of America, or fixed place of<br \/>\nbusiness in any foreign country. The Company is not, nor has it ever been, an &#8220;S<br \/>\ncorporation,&#8221; within the meaning of Section 1361(a) of the Code.<\/p>\n<p>          (f) The Company is not party to any agreement, plan, arrangement or<br \/>\nother Contract covering any employee or independent contractor or former<br \/>\nemployee or independent contractor of the Company that, individually or<br \/>\ncollectively, could give rise directly or indirectly to the payment of any<br \/>\namount that would not be deductible pursuant to Section 280G or Section 162(m)<br \/>\nof the Code. Except as set forth in Part 5.14 of the Disclosure Schedule, the<br \/>\nCompany is not, and has never been, a party to or bound by any tax indemnity<br \/>\nagreement, tax-sharing agreement, tax allocation agreement or similar Contract,<br \/>\nand has not otherwise assumed the tax Liability of any other Person under<br \/>\ncontract.<\/p>\n<p>          (g) The Company is not a United States real property holding<br \/>\ncorporation within the meaning of Section 897(c)(2) of the Code and has not been<br \/>\na United States real property holding corporation within the applicable period<br \/>\nspecified in Section 897(c)(1)(A)(ii) of the Code.<\/p>\n<p>          (h) The Company has no net operating losses or other tax attributes<br \/>\ncurrently subject to limitation under Code Section 382, 383 or 384, or the<br \/>\nfederal consolidated return regulations.<\/p>\n<p>          (i) The Company&#8217;s final 1999 U.S. income tax return to be prepared<br \/>\npursuant to Section 14.4(b) will contain, in all material respects, an accurate<br \/>\nand complete description of the Company&#8217;s tax basis in its assets, its current<br \/>\nand accumulated earnings and profits, its tax carryovers, and any tax elections.<\/p>\n<p>     5.15 Securities Laws Compliance; Registration Rights.<\/p>\n<p>     The Company has complied with all federal and state securities laws in<br \/>\nconnection with all offers and sales of securities issued by the Company prior<br \/>\nto the date of this Agreement.  The Company has not heretofore granted any<br \/>\npurchaser of its securities the right to require the Company to register any<br \/>\nsecurities under the Securities Act or to qualify for any exemption thereunder.<\/p>\n<p>     5.16 Finders and Brokers; Fees.<\/p>\n<p>          (a) Neither the Company nor any Person acting on behalf of the Company<br \/>\nhas engaged any finder, broker, intermediary or any similar Person in connection<br \/>\nwith the Transactions.<\/p>\n<p>                                       20<\/p>\n<p>          (b) The Company has not entered into a contract or other agreement<br \/>\nthat provides that a fee shall be paid to any Person or Entity if the<br \/>\nTransactions are consummated.<\/p>\n<p>     5.17 Environmental Compliance.<\/p>\n<p>     To the knowledge of the Company, the Company is, and has been at all times,<br \/>\nin compliance in all material respects with all Environmental Laws, the<br \/>\nviolation of which would have a material adverse effect on the Company&#8217;s<br \/>\nbusiness, assets or operations.<\/p>\n<p>     5.18 Insurance.<\/p>\n<p>          (a) Part 5.18 of the Disclosure Schedule sets forth each insurance<br \/>\npolicy maintained by or at the expense of, or for the direct or indirect benefit<br \/>\nof, the Company.<\/p>\n<p>          (b) The Company has delivered to the Purchaser copies of all of the<br \/>\ninsurance policies identified in Part 5.18 of the Disclosure Schedule (including<br \/>\nall renewals thereof and endorsements thereto) and binders relating thereto.<\/p>\n<p>          (c) Each of the policies identified in Part 5.18 of the Disclosure<br \/>\nSchedule is in full force and effect. All of the information contained in the<br \/>\napplications submitted in connection with said policies was (at the times said<br \/>\napplications were submitted) accurate and complete, and all premiums and other<br \/>\namounts owing with respect to said policies have been paid in full on a timely<br \/>\nbasis. Each of the policies identified in Part 5.18 of the Disclosure Schedule<br \/>\nwill continue in full force and effect following the Closing, and the Company<br \/>\nhas performed all of its material obligations under each policy to which it is a<br \/>\nparty or that provides coverage to it or any of its directors or officers in<br \/>\nconnection with their performance of services to the Company.<\/p>\n<p>          (d) There is no pending claim under or based upon any of the policies<br \/>\nidentified in Part 5.18 of the Disclosure Schedule, and no event has occurred,<br \/>\nand no condition or circumstance exists, that might (with or without notice or<br \/>\nlapse of time) directly or indirectly give rise to or serve as a basis for any<br \/>\nsuch claim.<\/p>\n<p>          (e) The Company has not received:<\/p>\n<p>              (i)    any notice or other communication (in writing or otherwise)<br \/>\nregarding the actual or possible cancellation or invalidation of any of the<br \/>\npolicies identified in Part 5.18 of the Disclosure Schedule or regarding any<br \/>\nactual or possible adjustment in the amount of the premiums payable with respect<br \/>\nto any of said policies; or<\/p>\n<p>              (ii)   any notice or other communication (in writing or otherwise)<br \/>\nregarding any actual or possible refusal of coverage under, or any actual or<br \/>\npossible rejection of any claim under, any of the policies identified in Part<br \/>\n5.18 of the Disclosure Schedule.<\/p>\n<p>                                       21<\/p>\n<p>     5.19 Related Party Transactions.<\/p>\n<p>          (a) No Related Party has, and no Related Party has at any time since<br \/>\nDecember 31, 1998, had, any direct or indirect material interest of any nature<br \/>\nin any material asset of the Company or any Company Contract.<\/p>\n<p>          (b) No Related Party is, or has at any time since December 31, 1998,<br \/>\nbeen, indebted to the Company for an amount, individually or in the aggregate,<br \/>\nin excess of Ten Thousand Dollars ($10,000).<\/p>\n<p>          (c) Since December 31, 1998, no Related Party has entered into, or has<br \/>\nhad any direct or indirect material financial interest in, any Company Contract,<br \/>\ntransaction or business dealing of any nature involving the Company.<\/p>\n<p>          (d) No Related Party is competing, or has at any time since December<br \/>\n31, 1998, competed, directly or indirectly, with the Company in any market<br \/>\nserved by the Company.<\/p>\n<p>     5.20 Absence of Changes.<\/p>\n<p>     Since April 30, 1999:<\/p>\n<p>          (a) there has not been any material adverse change in the Company&#8217;s<br \/>\nbusiness, assets, Liabilities or operations and, to the knowledge of the<br \/>\nCompany, no event has occurred that is likely to have a material adverse effect<br \/>\non the Company&#8217;s business, assets, Liabilities or operations;<\/p>\n<p>          (b) the Company has not declared, accrued, set aside or paid any<br \/>\ndividend or made any other distribution in respect of any shares of capital<br \/>\nstock;<\/p>\n<p>          (c) the Company has not amended its Articles of Incorporation or<br \/>\nBylaws and has not effected or been a party to any Acquisition Transaction,<br \/>\nrecapitalization, reclassification of shares, stock split, reverse stock split<br \/>\nor similar transaction;<\/p>\n<p>          (d) the Company has not made any individual capital expenditure in<br \/>\nexcess of Twenty-Five Thousand Dollars ($25,000);<\/p>\n<p>          (e) the Company has not pledged or hypothecated any of its material<br \/>\nassets or otherwise permitted any of its material assets to become subject to<br \/>\nany encumbrance;<\/p>\n<p>          (f) the Company has not made any loan or advance to any Person;<\/p>\n<p>          (g) the Company has not paid any bonus or made any profit-sharing or<br \/>\nsimilar payment to, or increased the amount of the wages, salary, commissions,<br \/>\nfringe benefits or other compensation or remuneration payable to, any of its<br \/>\ndirectors, officers or employees;<\/p>\n<p>          (h) there has been no resignation or termination of employment of any<br \/>\nofficer or key employee of the Company;<\/p>\n<p>                                       22<\/p>\n<p>          (i) there has been no borrowing or agreement to borrow by the Company<br \/>\nor material change in the contingent obligations of the Company by way of<br \/>\nguaranty, endorsement, indemnity, warranty or otherwise or grant of a mortgage<br \/>\nor security interest in any property of the Company;<\/p>\n<p>          (j) the Company has not discharged any encumbrance or discharged, paid<br \/>\nor forgiven any indebtedness or other Liability in excess of Twenty-Five<br \/>\nThousand Dollars ($25,000), individually or in the aggregate, except for<br \/>\naccounts payable that (i) are reflected as current Liabilities in the<br \/>\n&#8220;Liabilities&#8221; column of the Unaudited Interim Balance Sheet or have been<br \/>\nincurred by the Company since the date of the Unaudited Interim Balance Sheet in<br \/>\nthe Ordinary Course of Business, and (ii) have been discharged or paid in the<br \/>\nOrdinary Course of Business;<\/p>\n<p>          (k) the Company has not released or waived any material right or<br \/>\nclaim;<\/p>\n<p>          (l) the Company has not changed any of its methods of accounting or<br \/>\naccounting practices in any respect;<\/p>\n<p>          (m) the Company has not received notice that there has been a loss of,<br \/>\nor cancellation of a material order by, any customer of the Company; and<\/p>\n<p>          (n) the Company has not agreed, committed or offered (in writing or<br \/>\notherwise), and has not attempted, to take any of the actions referred to in<br \/>\nclauses (c) through (m) above.<\/p>\n<p>     5.21 Powers of Attorney.<\/p>\n<p>     The Company has not given a power of attorney to any Person.<\/p>\n<p>     5.22 Benefit Plans; ERISA.<\/p>\n<p>          (a) Part 5.22 of the Disclosure Schedule lists (i) all &#8220;employee<br \/>\nbenefit plans&#8221; within the meaning of Section 3(3) of ERISA, (ii) all<br \/>\nemployment agreements, including, but not limited to, any individual benefit<br \/>\narrangement, policy or practice with respect to any current or former<br \/>\nemployee or director of the Company or Member of the Controlled Group, and<br \/>\n(iii) all other employee benefit, bonus or other incentive compensation,<br \/>\nstock option, stock purchase, stock appreciation, severance pay, lay-off or<br \/>\nreduction in force, change in control, sick pay, vacation pay, salary<br \/>\ncontinuation, retainer, leave of absence, educational assistance, service<br \/>\naward, employee discount, and fringe benefit plans, arrangements, policies or<br \/>\npractices, whether legally binding or not, which the Company or any Member of<br \/>\nthe Controlled Group maintains, contributes to or has any obligation to or<br \/>\nLiability for (collectively, the &#8220;PLANS&#8221;).<\/p>\n<p>          (b) None of the Plans is a Defined Benefit Plan, and neither the<br \/>\nCompany nor any Member of the Controlled Group has ever sponsored, maintained<br \/>\nor contributed to, or ever been obligated to contribute to, a Defined Benefit<br \/>\nPlan that could reasonably be expected to result in a material amount of<br \/>\nLiability under Title IV of ERISA.<\/p>\n<p>                                       23<\/p>\n<p>          (c) None of the Plans is a Multiemployer Plan, and neither the Company<br \/>\nnor any Member of the Controlled Group has ever contributed to, or ever been<br \/>\nobligated to contribute to, a Multiemployer Plan that could reasonably be<br \/>\nexpected to result in a material amount of Liability under Title IV of ERISA.<\/p>\n<p>          (d) The Company does not maintain or contribute to any welfare benefit<br \/>\nplan which provides health benefits to an employee after the employee&#8217;s<br \/>\ntermination of employment or retirement except as required under Section 4980B<br \/>\nof the Code and Sections 601 through 608 of ERISA or comparable California law.<\/p>\n<p>          (e) Each Plan that is an &#8220;employee benefit plan,&#8221; as defined in<br \/>\nSection 3(3) of ERISA, complies in all material respects by its terms and in<br \/>\noperation with the requirements provided by any and all statutes, orders or<br \/>\ngovernmental rules or regulations currently in effect and applicable to the<br \/>\nPlan, including but not limited to ERISA and the Code.<\/p>\n<p>          (f) All reports, forms and other documents required to be filed with<br \/>\nany government entity with respect to any Plan (including, without limitation,<br \/>\nsummary plan descriptions, Forms 5500 and summary annual reports) have been<br \/>\ntimely filed and are accurate.<\/p>\n<p>          (g) Each Plan intended to qualify under Section 401(a) of the Code is<br \/>\nthe subject of a favorable determination letter issued by the Internal Revenue<br \/>\nService. To the Company&#8217;s knowledge, nothing has occurred since the date of the<br \/>\nInternal Revenue Service&#8217;s favorable determination letter that could adversely<br \/>\naffect the qualification of the Plan and its related trust. The Company and each<br \/>\nMember of the Controlled Group have timely and properly applied for a written<br \/>\ndetermination by the Internal Revenue Service on the qualification of each such<br \/>\nPlan and its related trust under Section 401(a) of the Code, as amended by the<br \/>\nTax Reform Act of 1986 and subsequent legislation enacted through the date<br \/>\nhereof, and Section 501 of the Code.<\/p>\n<p>          (h) All contributions owed for all periods ending prior to the Closing<br \/>\nDate (including periods from the first day of the current plan year to the<br \/>\nClosing Date) under any Plan have been or will be made prior to the Closing Date<br \/>\nby the Company in accordance with past practice and the recommended contribution<br \/>\nin any applicable actuarial report.<\/p>\n<p>          (i) All insurance premiums have been paid in full, subject only to<br \/>\nnormal retrospective adjustments in the Ordinary Course, with regard to the<br \/>\nPlans for plan years ending on or before the Closing Date.<\/p>\n<p>          (j) With respect to each Plan:<\/p>\n<p>              (i)    no prohibited transactions (as defined in Section 406 or<br \/>\n407 of ERISA or Section 4975 of the Code) have occurred for which an exemption<br \/>\nis not available that could reasonably be expected to result in a material<br \/>\namount of Liability to the Company;<\/p>\n<p>              (ii)   no actions or claims (other than routine claims for<br \/>\nbenefits made in the Ordinary Course of Plan administration for which Plan<br \/>\nadministrative review procedures have not been exhausted) are pending,<br \/>\nthreatened or imminent against or with respect to the Plan, <\/p>\n<p>                                       24<\/p>\n<p>any employer who is participating (or who has participated) in the Plan or any<br \/>\nfiduciary (as defined in Section 3(21) of ERISA) of the Plan that could<br \/>\nreasonably be expected to result in a material amount of Liability to the<br \/>\nCompany;<\/p>\n<p>              (iii)  no facts exist which could give rise to any such action or<br \/>\nclaim; and<\/p>\n<p>              (iv)   the Plan provides that it may be amended or terminated at<br \/>\nany time and, except for benefits protected under Section 411(d) of the Code,<br \/>\nall benefits payable to current, terminated employees or any beneficiary may be<br \/>\namended or terminated by the Company at any time without a material amount of<br \/>\nLiability.<\/p>\n<p>          (k) Neither the Company nor any Member of the Controlled Group has any<br \/>\nPlan-related Liability or is threatened with any Liability (whether joint or<br \/>\nseveral) (i) for any excise tax imposed by Section 4971, 4975, 4976, 4977 or<br \/>\n4979 of the Code, or (ii) for a fine under Section 502 of ERISA that could<br \/>\nreasonably be expected to result in a material amount of Liability to the<br \/>\nCompany.<\/p>\n<p>          (l) All the &#8220;group health plans&#8221; (as defined in Section 607(1) or<br \/>\n733(a)(1) of ERISA or Section 4980B(g)(2) of the Code) that are part of the<br \/>\nPlans listed in the Disclosure Schedule are in material compliance with the<br \/>\ncontinuation of group health coverage provisions contained in Section 4980B of<br \/>\nthe Code and Sections 601 through 608 of ERISA.<\/p>\n<p>          (m) Copies of all documents creating or evidencing any Plan listed in<br \/>\nthe Disclosure Schedule, and all reports, forms and other documents required to<br \/>\nbe filed with any governmental entity (including, without limitation, summary<br \/>\nplan descriptions, Forms 5500 and summary annual reports for all plans subject<br \/>\nto ERISA), have been delivered or made available to the Purchaser. There are no<br \/>\nnegotiations, demands or proposals which are pending or have been made which<br \/>\nconcern matters now covered, or that would be covered, by any Plan listed in the<br \/>\nDisclosure Schedule.<\/p>\n<p>          (n) All expenses and Liabilities relating to contributions required by<br \/>\nlaw and the terms of the Plans described in the Disclosure Schedule have been,<br \/>\nand on the Closing Date will be, fully and properly accrued on the Company&#8217;s<br \/>\nbooks and records and disclosed in accordance with GAAP and in Plan financial<br \/>\nstatements.<\/p>\n<p>     5.23 Full Disclosure.<\/p>\n<p>          (a) This Agreement (including all Schedules and Exhibits hereto), does<br \/>\nnot contain nor will it contain any untrue statement of material fact; and does<br \/>\nnot omit nor will it omit to state any material fact necessary to make any of<br \/>\nthe representations, warranties or other statements or information contained<br \/>\nherein, when read collectively, not misleading.<\/p>\n<p>          (b) All the information set forth in the Disclosure Schedule is<br \/>\naccurate and complete in all material respects.<\/p>\n<p>                                       25<\/p>\n<p>     5.24 Due Diligence Information.<\/p>\n<p>     The Company has provided the Purchaser and the Purchaser&#8217;s representatives<br \/>\nwith full and complete access to all of the Company&#8217;s records and other<br \/>\ndocuments and data, and has produced all documents and related materials in<br \/>\nresponse to the reasonable requests of the Purchaser.<\/p>\n<p>6.   Representations and Warranties of the Selling Shareholders; Investment<br \/>\n     Intent and Restrictions.<\/p>\n<p>     Each Selling Shareholder, severally and not jointly, represents and<br \/>\nwarrants as follows:<\/p>\n<p>          (a) The Selling Shareholder owns, beneficially and of record, that<br \/>\nnumber of shares of Company Common Stock specified opposite the Selling<br \/>\nShareholder&#8217;s name on Schedule I attached hereto, free and clear of any<br \/>\nencumbrances.<\/p>\n<p>          (b) The Selling Shareholder has the absolute and unrestricted right,<br \/>\npower and authority to enter into and to perform his or her respective<br \/>\nobligations under this Agreement and the other Transactional Agreements to which<br \/>\nhe or she is contemplated to be a party. This Agreement and the other<br \/>\nTransactional Agreements constitute, or upon execution and delivery will<br \/>\nconstitute, the legal, valid and binding obligations of the Selling Shareholder,<br \/>\nenforceable against him or her in accordance with their respective terms, except<br \/>\nto the extent that enforceability may be limited by applicable bankruptcy,<br \/>\nreorganization, insolvency, moratorium or other laws affecting the enforcement<br \/>\nof creditor&#8217;s rights generally and by general principles of equity regardless of<br \/>\nwhether such enforceability is considered in a Proceeding at law or in equity.<\/p>\n<p>          (c) To the knowledge of the Selling Shareholder, the execution and<br \/>\ndelivery of this Agreement and the other Transactional Agreements, and the<br \/>\nconsummation of the Transactions, by the Selling Shareholder will not, directly<br \/>\nor indirectly (with or without notice or lapse of time), contravene, conflict<br \/>\nwith or result in a violation of, or give any Governmental Body or other Person<br \/>\nthe right to challenge any of the Transactions or to exercise any remedy or<br \/>\nobtain any relief under, any legal requirement or any Order to which the Selling<br \/>\nShareholder is subject.<\/p>\n<p>          (d) There is no pending Proceeding, and, to the knowledge of the<br \/>\nSelling Shareholder, no Person has threatened to commence any Proceeding, that<br \/>\nchallenges, or that may have the effect of preventing, delaying or making<br \/>\nillegal, the Selling Shareholder&#8217;s ability to comply with or perform his or her<br \/>\nobligations and covenants under the Transactional Agreements; and, to the<br \/>\nknowledge of the Selling Shareholder, no event has occurred, and no claim,<br \/>\ndispute or other condition or circumstance exists, that might directly or<br \/>\nindirectly give rise to or serve as a basis for the commencement of any such<br \/>\nProceeding.<\/p>\n<p>          (e) The Selling Shareholder is not subject to any Order that relates<br \/>\nto the Company&#8217;s business or to any of the assets owned or used by the Company.<\/p>\n<p>                                       26<\/p>\n<p>          (f) To the knowledge of the Selling Shareholder, there is no proposed<br \/>\nOrder that, if issued or otherwise put into effect, may have a material adverse<br \/>\neffect on the ability of the Selling Shareholder to comply with or perform any<br \/>\ncovenant or obligation under this Agreement and the other Transactional<br \/>\nAgreements.<\/p>\n<p>          (g) Neither the Selling Shareholder nor any Person acting on his or<br \/>\nher behalf has negotiated with any finder, broker, intermediary or any similar<br \/>\nPerson in connection with the transactions contemplated herein.<\/p>\n<p>     With respect to Purchaser Stock, each Selling Shareholder further<br \/>\nrepresents and warrants as follows:<\/p>\n<p>          (h) Except as set forth in Part 6 of the Disclosure Schedule, the<br \/>\nSelling Shareholder is an &#8220;accredited investor&#8221; as that term is defined in Rule<br \/>\n501(a) of Regulation D of the Securities Act.<\/p>\n<p>          (i) The Selling Shareholder, by reason of his or her business and<br \/>\nfinancial experience, has such knowledge, sophistication and experience in<br \/>\nfinancial and business matters and in making investment decisions of this type<br \/>\nthat he or she is capable of (i) evaluating the merits and risks of an<br \/>\ninvestment in Purchaser Stock and making an informed investment decision, (ii)<br \/>\nprotecting his or her own interest and (iii) bearing the economic risk of such<br \/>\ninvestment. If the Selling Shareholder retained a purchaser&#8217;s representative<br \/>\nwith respect to the investment in Purchaser Stock that may be made hereby, then<br \/>\nthe Selling Shareholder shall, prior to or at the Closing, (A) acknowledge in<br \/>\nwriting such representation and (B) cause such representative to deliver a<br \/>\ncertificate to the Purchaser containing such representations as are reasonably<br \/>\nrequested by the Purchaser.<\/p>\n<p>          (j) The Selling Shareholder is acquiring Purchaser Stock for<br \/>\ninvestment for the Selling Shareholder&#8217;s own account, not as a nominee or agent<br \/>\nand not with a view to, or any intention of, a resale or distribution thereof,<br \/>\nin whole or in part, or the grant of any participation therein. The Selling<br \/>\nShareholder understands that the Purchaser Stock has not been registered under<br \/>\nthe Securities Act or state securities laws by reason of a specific exemption<br \/>\nfrom the registration provisions of the Securities Act and applicable state<br \/>\nsecurities laws that depends upon, among other things, the bona fide nature of<br \/>\nthe investment intent and the accuracy of the Selling Shareholder&#8217;s<br \/>\nrepresentations as expressed in this Agreement. The Selling Shareholder has not<br \/>\nbeen formed for the specific purpose of acquiring Purchaser Stock. The Selling<br \/>\nShareholder further understands that the Purchaser shall have no obligation to<br \/>\nregister Purchaser Stock under the Securities Act or any state securities laws<br \/>\nor to take any action that would make available any exemption from the<br \/>\nregistration requirements of such laws, except pursuant to the Rights Agreement.<br \/>\nThe Selling Shareholder hereby acknowledges that because of the restrictions on<br \/>\ntransfer or assignment of Purchaser Stock to be issued in connection with the<br \/>\nMerger hereunder, the Selling Shareholder may have to bear the economic risk of<br \/>\nthe investment commitment in Purchaser Stock for an indefinite period of time.<\/p>\n<p>          (k) The Selling Shareholder will observe and comply with the<br \/>\nSecurities Act and the rules and regulations promulgated thereunder, as now in<br \/>\neffect and as from time to time <\/p>\n<p>                                       27<\/p>\n<p>amended, in connection with any offer, sale, pledge, transfer or other<br \/>\ndisposition of Purchaser Stock. In furtherance of the foregoing, and in addition<br \/>\nto any restrictions contained in this Agreement or the other Transactional<br \/>\nAgreements, the Selling Shareholder will not offer to sell, exchange, transfer,<br \/>\npledge, or otherwise dispose of any Purchaser Stock unless at such time at least<br \/>\none of the following is satisfied:<\/p>\n<p>              (i)    a registration statement under the Securities Act covering<br \/>\nPurchaser Stock proposed to be sold, transferred or otherwise disposed of,<br \/>\ndescribing the manner and terms of the proposed sale, transfer or other<br \/>\ndisposition, and containing a current prospectus, shall have been filed with the<br \/>\nSEC and made effective under the Securities Act;<\/p>\n<p>              (ii)   such transaction shall be permitted pursuant to the<br \/>\nprovisions of Rule 144;<\/p>\n<p>              (iii)  counsel representing the Selling Shareholder, satisfactory<br \/>\nto the Purchaser, shall have advised the Purchaser in a written opinion letter<br \/>\nreasonably satisfactory to the Purchaser and its counsel, and upon which the<br \/>\nPurchaser and its counsel may rely, that no registration under the Securities<br \/>\nAct would be required in connection with the proposed sale, transfer or other<br \/>\ndisposition; or<\/p>\n<p>              (iv)   an authorized representative of the SEC shall have rendered<br \/>\nwritten advice to the Selling Shareholder (sought by the Selling Shareholder or<br \/>\ncounsel to the Selling Shareholder, with a copy thereof and of all other related<br \/>\ncommunications delivered to the Purchaser) to the effect that the SEC would take<br \/>\nno action, or that the staff of the SEC would not recommend that the SEC take<br \/>\naction, with respect to the proposed sale, transfer or other disposition if<br \/>\nconsummated.<\/p>\n<p>          (l) The Selling Shareholder understands that an investment in<br \/>\nPurchaser Stock involves substantial risks. The Selling Shareholder has been<br \/>\ngiven the opportunity to make a thorough investigation of the proposed<br \/>\nactivities of the Purchaser and, upon request to the Purchaser, has been<br \/>\nfurnished with materials relating to the Purchaser and its proposed activities,<br \/>\nincluding, without limitation, a copy of the Purchaser&#8217;s Registration Statement<br \/>\non Form S-1 dated April 9, 1999 (the &#8220;REGISTRATION STATEMENT&#8221;) and the Purchaser<br \/>\nSEC Reports. The Selling Shareholder has been afforded the opportunity to obtain<br \/>\nany additional information deemed necessary by the Selling Shareholder to verify<br \/>\nthe accuracy of any representations made or information conveyed to the Selling<br \/>\nShareholder. The Selling Shareholder confirms that all documents, records and<br \/>\nbooks pertaining to its investment in Purchaser Stock and requested by the<br \/>\nSelling Shareholder have been made available or delivered to the Selling<br \/>\nShareholder. The Selling Shareholder has had an opportunity to ask questions of<br \/>\nand receive answers from the Purchaser, or from a Person or Persons acting on<br \/>\nthe Purchaser&#8217;s behalf, concerning the terms and conditions of this investment.<br \/>\nThe Selling Shareholder has relied upon, and is making his or her investment<br \/>\ndecision based upon, the Registration Statement and other information publicly<br \/>\navailable about the Purchaser.<\/p>\n<p>          (m) The Selling Shareholder has no knowledge of any causes of action<br \/>\nor other claims that could have been or in the future might be asserted by the<br \/>\nSelling Shareholder against <\/p>\n<p>                                       28<\/p>\n<p>the Company or any of its predecessors, successors, assigns, directors,<br \/>\nemployees, agents or representatives arising out of facts or circumstances<br \/>\noccurring at any time on or prior to the date hereof and in any way relating to<br \/>\nany duty or obligation of the Company or any of such other parties to the<br \/>\nSelling Shareholder.<\/p>\n<p>          (n) The Selling Shareholder expressly acknowledges that with respect<br \/>\nto any potential short-swing profit liability pursuant to Section 16(b) of the<br \/>\nExchange Act, the Selling Shareholder has not relied on any statement or<br \/>\nrepresentation by Morrison &amp; Foerster, LLP, counsel to the Purchaser.<\/p>\n<p>          (o) Each Selling Shareholder is a &#8220;United States person,&#8221; within the<br \/>\nmeaning of Section 7701(a)(30) of the Code.<\/p>\n<p>7.   Representations and Warranties of the Purchaser and Merger Sub.<\/p>\n<p>     Except as specifically set forth in the disclosure schedule provided by the<br \/>\nPurchaser to the Selling Shareholders attached hereto (the &#8220;PURCHASER&#8217;S<br \/>\nDISCLOSURE SCHEDULE&#8221;), the parts of which are numbered to correspond to the<br \/>\nsection numbers of this Agreement, the Purchaser and Merger Sub, jointly and<br \/>\nseverally, hereby represent and warrant to the Selling Shareholders as follows:<\/p>\n<p>     7.1  Organization, Good Standing, Qualification; Capitalization.<\/p>\n<p>          (a) The Purchaser is a corporation duly organized, validly existing<br \/>\nand in good standing under the laws of the State of Delaware, is qualified to<br \/>\nconduct business and is in both corporate and tax good standing under the laws<br \/>\nof each jurisdiction in which the nature of its business or the ownership or<br \/>\nleasing of its properties requires such qualification. The Purchaser has all the<br \/>\nrequisite corporate power and authority to own and operate its properties and<br \/>\nassets and to carry out the provisions hereof and thereof and to carry on its<br \/>\nbusiness as currently conducted.<\/p>\n<p>          (b) Merger Sub is a corporation duly organized, validly existing and<br \/>\nin good standing under the laws of the State of California, is qualified to<br \/>\nconduct business and is in both corporate and tax good standing under the laws<br \/>\nof each jurisdiction in which the nature of its business or the ownership or<br \/>\nleasing of its properties requires such qualification. Merger Sub has all the<br \/>\nrequisite corporate power and authority to own and operate its properties and<br \/>\nassets and to carry out the provisions hereof and thereof, and to carry on its<br \/>\nbusiness as currently conducted.<\/p>\n<p>          (c) The description of the outstanding shares of Purchaser&#8217;s<br \/>\nauthorized capital stock in the Purchaser&#8217;s Annual Report on Form 10-K for the<br \/>\nyear ended December 31, 1998 (the &#8220;FORM 10-K&#8221;) is true and correct.<\/p>\n<p>7.2  Investment Representations.<\/p>\n<p>          (a) The Purchaser understands that the Company Common Stock has not<br \/>\nbeen registered under the Securities Act. The Purchaser also understands that<br \/>\nthe Company Common <\/p>\n<p>                                       29<\/p>\n<p>Stock is being offered and sold pursuant to an exemption from registration<br \/>\ncontained in the Securities Act based in part upon the Purchaser&#8217;s<br \/>\nrepresentations contained in this Section 7.2.<\/p>\n<p>          (b) The Purchaser is acquiring the Company Common Stock for the<br \/>\nPurchaser&#8217;s own account for investment only, and not with the current intention<br \/>\nof making a public distribution thereof.<\/p>\n<p>          (c) The Purchaser represents that by reason of its, or of its<br \/>\nmanagement&#8217;s, business or financial experience, the Purchaser has the capacity<br \/>\nto protect its own interests in connection with the Transactions contemplated in<br \/>\nthis Agreement and the other Transactional Agreements. The Purchaser is able to<br \/>\nbear the loss of its entire investment in the Company. The Purchaser is not a<br \/>\ncorporation, partnership or other entity specifically formed for the purpose of<br \/>\nconsummating this transaction.<\/p>\n<p>          (d) The Purchaser is an accredited investor as that term is defined in<br \/>\nRule 501(a) of Regulation D, promulgated pursuant to the Securities Act.<\/p>\n<p>     7.3  Purchaser Stock.<\/p>\n<p>     The Purchaser Stock to be issued to the Selling Shareholders and upon<br \/>\nexercise of the Company Options assumed by the Purchaser, when issued in<br \/>\nconnection with this Agreement and the other Transactional Agreements, will be<br \/>\nduly authorized, validly issued and nonassessable.<\/p>\n<p>     7.4  Authority; Binding Nature of Agreements.<\/p>\n<p>          (a) The execution, delivery and performance of this Agreement and the<br \/>\nTransactional Agreements, and all other agreements and instruments contemplated<br \/>\nto be executed and delivered by the Purchaser or Merger Sub, as the case may be,<br \/>\nin connection herewith, have been duly authorized by all necessary action on the<br \/>\npart of the Purchaser and Merger Sub and their respective boards of directors.<\/p>\n<p>          (b) This Agreement, the other Transactional Agreements, and all other<br \/>\nagreements and instruments contemplated to be executed and delivered by the<br \/>\nPurchaser or Merger Sub each constitute the legal, valid and binding obligations<br \/>\nof the Purchaser and Merger Sub, enforceable against the Purchaser and Merger<br \/>\nSub in accordance with their terms, except to the extent that enforceability may<br \/>\nbe limited by applicable bankruptcy, reorganization, insolvency, moratorium or<br \/>\nother laws affecting the enforcement of creditor&#8217;s rights generally and by<br \/>\ngeneral principles of equity regardless of whether such enforceability is<br \/>\nconsidered in a Proceeding at law or in equity.<\/p>\n<p>                                       30<\/p>\n<p>     7.5  Non-Contravention; Consents.<\/p>\n<p>     The execution and delivery of this Agreement and the other Transactional<br \/>\nAgreements, and the consummation of the Transactions, by the Purchaser and<br \/>\nMerger Sub will not, directly or indirectly (with or without notice or lapse of<br \/>\ntime):<\/p>\n<p>          (a) contravene, conflict with or result in a material violation of (i)<br \/>\nthe Purchaser&#8217;s and Merger Sub&#8217;s Certificate or Articles of Incorporation or<br \/>\nBylaws, or (ii) any resolution adopted by the Purchaser Board and Merger Sub<br \/>\nBoard or any committee thereof or the stockholders of the Purchaser and Merger<br \/>\nSub;<\/p>\n<p>          (b) to the knowledge of the Purchaser and Merger Sub, contravene,<br \/>\nconflict with or result in a material violation of, or give any Governmental<br \/>\nBody the right to challenge any of the Transactions or to exercise any remedy or<br \/>\nobtain any relief under, any legal requirement or any Order to which the<br \/>\nPurchaser and Merger Sub or any material assets owned or used by them are<br \/>\nsubject;<\/p>\n<p>          (c) to the knowledge of the Purchaser and Merger Sub, cause any<br \/>\nmaterial assets owned or used by the Purchaser and Merger Sub to be reassessed<br \/>\nor revalued by any taxing authority or other Governmental Body;<\/p>\n<p>          (d) to the knowledge of the Purchaser and Merger Sub, contravene,<br \/>\nconflict with or result in a material violation of any of the terms or<br \/>\nrequirements of, or give any Governmental Body the right to revoke, withdraw,<br \/>\nsuspend, cancel, terminate or modify, any Governmental Authorization that is<br \/>\nheld by the Purchaser or Merger Sub or any of their respective employees or that<br \/>\notherwise relates to the Purchaser&#8217;s and Merger Sub&#8217;s business or to any of the<br \/>\nmaterial assets owned or used by the Purchaser and Merger Sub;<\/p>\n<p>          (e) contravene, conflict with or result in a material violation or<br \/>\nmaterial breach of, or material default under, any Purchaser Contract;<\/p>\n<p>          (f) give any Person the right to any payment by the Purchaser or<br \/>\nMerger Sub or give rise to any acceleration or change in the award, grant,<br \/>\nvesting or determination of options, warrants, rights, severance payments or<br \/>\nother contingent obligations of any nature whatsoever of the Purchaser or Merger<br \/>\nSub in favor of any Person, in any such case as a result of the change in<br \/>\ncontrol of Merger Sub or otherwise resulting from the Transactions; or<\/p>\n<p>          (g) result in the imposition or creation of any material encumbrance<br \/>\nupon or with respect to any material asset owned or used by the Purchaser and<br \/>\nMerger Sub.<\/p>\n<p>Except as set forth in Part 7.5 of the Disclosure Schedule and as contemplated<br \/>\nin this Agreement and the other Transactional Agreements, the Purchaser and<br \/>\nMerger Sub will not be required to make any filing with or give any notice to,<br \/>\nor obtain any Consent from, any Person in connection with the execution and<br \/>\ndelivery of this Agreement and the other Transactional Agreements or the<br \/>\nconsummation or performance of any of the Transactions.<\/p>\n<p>                                       31<\/p>\n<p>     7.6  Legal Proceedings.<\/p>\n<p>     The description of the Purchaser&#8217;s legal proceedings in the Form 10-K is<br \/>\ntrue and correct.<\/p>\n<p>     7.7  Finders and Brokers.<\/p>\n<p>     The Purchaser and Merger Sub will indemnify the Selling Shareholders and<br \/>\nthe Company and hold them harmless from any Liability or expense arising from<br \/>\nany claim for brokerage commissions, finder&#8217;s fees or other similar compensation<br \/>\nbased upon any agreement, arrangement or understanding made by or on behalf of<br \/>\nthe Purchaser or Merger Sub.<\/p>\n<p>     7.8  Reports and Financial Statements; Absence of Certain Changes.<\/p>\n<p>          (a) The Purchaser has filed all reports required to be filed with<br \/>\nthe SEC pursuant to the Exchange Act, if any, since its initial public<br \/>\noffering on December 9, 1998 (all such reports, including those to be filed<br \/>\nprior to the Closing Date, collectively, the &#8220;PURCHASER SEC REPORTS&#8221;), and<br \/>\nhas previously furnished or made available to the Company true and complete<br \/>\ncopies of all the Purchaser SEC Reports filed, if any, with respect to<br \/>\nperiods ending after December 9, 1998 (including any exhibits thereto) and<br \/>\nwill promptly deliver to the Company any Purchaser SEC Reports filed between<br \/>\nthe date hereof and the Effective Time. All of such Purchaser SEC Reports<br \/>\ncomplied at the time they were filed in all material respects with applicable<br \/>\nrequirements of the Securities Act and the Exchange Act and the rules and<br \/>\nregulations thereunder. None of such Purchaser SEC Reports, as of their<br \/>\nrespective dates (as amended through the date hereof), contained or, with<br \/>\nrespect to Purchaser SEC Reports filed after the date hereof and prior to the<br \/>\nClosing Date, will contain any untrue statement of a material fact or omitted<br \/>\nor, with respect to Purchaser SEC Reports filed after the date hereof and<br \/>\nprior to the Closing Date, will omit to state contain a material fact<br \/>\nrequired to be stated therein or necessary to make the statements therein, in<br \/>\nlight of the circumstances under which they were made, not misleading. The<br \/>\naudited financial statements of the Purchaser included in the Purchaser SEC<br \/>\nReports comply in all material respects with the published rules and<br \/>\nregulations of the SEC with respect thereto, and such audited financial<br \/>\nstatements (i) were prepared from the books and records of the Purchaser,<br \/>\n(ii) were prepared in accordance with GAAP applied on a consistent basis<br \/>\n(except as may be indicated therein or in the notes or schedules thereto) and<br \/>\n(iii) present fairly the financial position of the Purchaser as of the dates<br \/>\nthereof and the results of operations and cash flows for the periods then<br \/>\nended. The unaudited financial statements included in the Purchaser SEC<br \/>\nReports comply in all material respects with the published rules and<br \/>\nregulations of the SEC with respect thereto; and such unaudited financial<br \/>\nstatements (A) were prepared from the books and records of the Purchaser, (B)<br \/>\nwere prepared in accordance with GAAP, except as otherwise permitted under<br \/>\nthe Exchange Act and the rules and regulations thereunder, on a consistent<br \/>\nbasis (except as may be indicated therein or in the notes or schedules<br \/>\nthereto) and (C) present fairly the financial position of the Purchaser as of<br \/>\nthe dates thereof and the results of operations and cash flows for the<br \/>\nperiods then ended, subject to normal year-end adjustments and any other<br \/>\nadjustments described therein or in the notes or schedules thereto. The<br \/>\nforegoing representations and warranties shall also be deemed to be made with<br \/>\nrespect to all filings made with the SEC on or before the Effective Time.<\/p>\n<p>                                       32<\/p>\n<p>          (b) Except as specifically contemplated by this Agreement or reflected<br \/>\nin the Purchaser SEC Reports, since March 31, 1999 there has not been (i) any<br \/>\nchange or event having a material adverse effect on the Purchaser, (ii) any<br \/>\ndeclaration setting aside or payment of any dividend or distribution with<br \/>\nrespect to the common stock of the Purchaser other than consistent with past<br \/>\npractices, or (iii) any material change in the Purchaser&#8217;s accounting<br \/>\nprinciples, procedures or methods.<\/p>\n<p>     7.9  Compliance with Applicable Law.<\/p>\n<p>     Except as disclosed in the Purchaser SEC Reports filed prior to the date of<br \/>\nthis Agreement, the Purchaser holds all licenses, franchises, permits,<br \/>\nvariances, exemptions, orders, approvals and authorizations necessary for the<br \/>\nlawful conduct of its business under and pursuant to, and the business of the<br \/>\nPurchaser is not being conducted in violation of, any provision of any federal,<br \/>\nstate, local or foreign statute, law, ordinance, rule, regulation, judgment,<br \/>\ndecree, order, concession, grant, franchise, permit or license or other<br \/>\ngovernmental authorization or approval applicable to the Purchaser, except to<br \/>\nthe extent that the failure or violation would not in the aggregate have a<br \/>\nmaterial adverse effect.<\/p>\n<p>     7.10 Complete Copies of Requested Reports.<\/p>\n<p>     The Purchaser has delivered or made available (through public sources or<br \/>\ndirectly) true and complete copies of each document that has been reasonably<br \/>\nrequested by the Company or its counsel in connection with their legal and<br \/>\naccounting review of the Purchaser.<\/p>\n<p>     7.11 Full Disclosure.<\/p>\n<p>          (a) Neither this Agreement (including all Schedules and Exhibits<br \/>\nhereto) nor any of the Transactional Agreements contemplated to be executed and<br \/>\ndelivered by the Purchaser or Merger Sub in connection with this Agreement<br \/>\ncontains any untrue statement of material fact; and none of such documents omits<br \/>\nto state any material fact necessary to make any of the representations,<br \/>\nwarranties or other statements or information contained therein not misleading.<\/p>\n<p>          (b) All of the information regarding the Purchaser or Merger Sub and<br \/>\nthe business, condition, assets, Liabilities, operations, financial performance,<br \/>\nnet income and prospects of either that has been furnished to the Company or any<br \/>\nof its representatives by or on behalf of the Purchaser, Merger Sub or any of<br \/>\nthe Purchaser&#8217;s representatives, is accurate and complete in all material<br \/>\nrespects.<\/p>\n<p>     7.12 Contracts.<\/p>\n<p>          (a) Except as set forth in Part 7.12 of the Disclosure Schedule, no<br \/>\nPurchaser Contracts have come into existence since March 31, 1999 that will be<br \/>\nrequired to be filed as exhibits to the Purchaser&#8217;s Quarterly Report on Form 10-<br \/>\nQ for the quarter ended June 30, 1999.<\/p>\n<p>          (b) The Purchaser has previously made available for inspection and<br \/>\ncopying to the Company complete and correct copies (or, in the case of oral<br \/>\ncontracts, a complete and correct <\/p>\n<p>                                       33<\/p>\n<p>description) of each Purchaser Contract (and any amendments or supplements<br \/>\nthereto) listed on Part 7.12 of the Disclosure Schedule. Except as set forth on<br \/>\nPart 7.12 of the Disclosure Schedule, (i) each Purchaser Contract (including any<br \/>\nPurchaser Contract filed with the Purchaser SEC Reports) listed is in full force<br \/>\nand effect, (ii) neither the Purchaser nor, to its knowledge, any other party is<br \/>\nin material default under any such Purchaser Contract, and no event has occurred<br \/>\nwhich constitutes, or with the lapse of time or the giving of notice or both<br \/>\nwould constitute, a material default, (iii) the Purchaser has not expressly<br \/>\nwaived any of its material rights under any Purchaser Contract, (iv) to the<br \/>\nknowledge of the Purchaser, there are no material disputes or disagreements<br \/>\nbetween the Purchaser and any other party with respect to any such Purchaser<br \/>\nContract, and (v) each other party to each such Purchaser Contract has consented<br \/>\nor been given notice (or prior to the Closing Date shall have consented or been<br \/>\ngiven notice), where such consent or the giving of such notice is necessary,<br \/>\nsufficient that such Purchaser Contract shall remain in full force and effect<br \/>\nfollowing the consummation of the Transactions, without material modification of<br \/>\nthe rights or obligations of the Purchaser thereunder.<\/p>\n<p>8.   Pre-Closing Covenants of the Company.<\/p>\n<p>     8.1  Corporate Proceedings; Shareholder Approval.<\/p>\n<p>     The Company shall ensure that resolutions (in form satisfactory to the<br \/>\nPurchaser) of the Company Board approving or adopting, as applicable, all<br \/>\nnecessary further action of the Company Board, this Agreement, the other<br \/>\nTransactional Agreements and the Transactions and recommending approval by the<br \/>\nCompany&#8217;s shareholders of this Agreement, the other Transactional Agreements and<br \/>\nthe Transactions, are passed as necessary pursuant to applicable law.  In<br \/>\nfurtherance, and not in limitation, of the foregoing:<\/p>\n<p>          (a) the Company, acting through the Company Board, shall, in<br \/>\naccordance with all applicable legal requirements and its Articles of<br \/>\nIncorporation and Bylaws, (i) promptly and duly call, give notice of, convene<br \/>\nand hold as soon as practicable a meeting (or solicit an action by written<br \/>\nconsent in lieu thereof) of its shareholders for the purpose of voting to<br \/>\napprove and adopt the Merger and this Agreement and the other Transactional<br \/>\nAgreements to which the Company is a party, and (ii) recommend approval and<br \/>\nadoption of the Merger and this Agreement and the other Transactional Agreements<br \/>\nto which the Company is a party by the Company&#8217;s shareholders. The Company shall<br \/>\nconsult with the Purchaser as to the timing and procedures of such meeting (or<br \/>\nconsent solicitation).<\/p>\n<p>     8.2  Access and Investigation.<\/p>\n<p>     The Company shall ensure that, at all times during the Pre-Closing Period:<\/p>\n<p>          (a) The Company and its representatives provide the Purchaser and its<br \/>\nrepresentatives with such copies of existing books, records, Tax Returns, work<br \/>\npapers and other documents and information relating to the Company as the<br \/>\nPurchaser may reasonably request in good faith; and<\/p>\n<p>                                       34<\/p>\n<p>          (b) The Company and its representatives compile, and provide the<br \/>\nPurchaser and its representatives with, such additional financial, operating and<br \/>\nother data and information regarding the Company as the Purchaser may reasonably<br \/>\nrequest in good faith.<\/p>\n<p>     8.3  Operation of Business.<\/p>\n<p>     The Company, and with respect to subsections (a) and (b) below, the Selling<br \/>\nShareholders, shall ensure that, during the Pre-Closing Period:<\/p>\n<p>          (a) the Selling Shareholders do not directly or indirectly sell or<br \/>\notherwise transfer, or offer, agree or commit (in writing or otherwise) to sell<br \/>\nor otherwise transfer, any of their Company Common Stock or any interest in or<br \/>\nright relating to any of their Company Common Stock;<\/p>\n<p>          (b) the Selling Shareholders do not permit, or offer, agree or commit<br \/>\n(in writing or otherwise) to permit, any of the Company Common Stock to become<br \/>\nsubject, directly or indirectly, to any encumbrance;<\/p>\n<p>          (c) the Company conducts its operations exclusively in the Ordinary<br \/>\nCourse of Business and in the same manner as such operations have been conducted<br \/>\nprior to the date of this Agreement;<\/p>\n<p>          (d) the Company uses its Best Efforts to preserve intact its current<br \/>\nbusiness organization, keeps available the services of its current officers and<br \/>\nemployees and maintains its relations and goodwill with all suppliers,<br \/>\ncustomers, landlords, creditors, licensors, licensees, employees and other<br \/>\nPersons having business relationships with the Company;<\/p>\n<p>          (e) the Company keeps in full force all insurance policies identified<br \/>\nin Part 5.18 of the Disclosure Schedule;<\/p>\n<p>          (f) the Company immediately notifies the Purchaser of any inquiry,<br \/>\nproposal or offer from any Person relating to any Acquisition Transaction;<\/p>\n<p>          (g) the Company does not declare, accrue, set aside or pay any<br \/>\ndividend or make any other distribution in respect of any shares of capital<br \/>\nstock, and does not repurchase, redeem or otherwise reacquire any shares of<br \/>\ncapital stock or other securities, except for shares for which the Company has a<br \/>\nrepurchase right under the Option Plan;<\/p>\n<p>          (h) the Company does not sell or otherwise issue (or grant any<br \/>\nwarrants, options or other rights to purchase) any shares of capital stock or<br \/>\nany other securities, other than options to purchase up to the number of shares<br \/>\nof Company Common Stock pursuant to the Option Plan set forth on Schedule II<br \/>\nattached hereto and shares of Company Common Stock issuable upon conversion of<br \/>\noutstanding Company Preferred Stock, or unless approved in advance in writing by<br \/>\nthe Purchaser;<\/p>\n<p>                                       35<\/p>\n<p>          (i) the Company does not amend its Articles of Incorporation or<br \/>\nBylaws, and does not effect, or become a party to, any Acquisition Transaction,<br \/>\nrecapitalization, reclassification of shares, stock split, reverse stock split<br \/>\nor similar transaction, or enter into any transaction or take any other action<br \/>\nof the type referred to in Section 5.20(c) through (m);<\/p>\n<p>          (j) the Company does not form any subsidiary or acquire any equity<br \/>\ninterest or other interest in any other Entity;<\/p>\n<p>          (k) the Company does not make any capital expenditure, except for<br \/>\ncapital expenditures made in the Ordinary Course of Business that, when added to<br \/>\nall other capital expenditures made on behalf of the Company during the Pre-<br \/>\nClosing Period, do not exceed Ten Thousand Dollars ($10,000), unless approved in<br \/>\nadvance in writing by the Purchaser;<\/p>\n<p>          (l) the Company does not enter into, or permit any of the material<br \/>\nassets owned or used by the Company to become bound by, any Contract;<\/p>\n<p>          (m) the Company does not incur, assume or otherwise become subject to<br \/>\nany Liability, except for current Liabilities incurred in the Ordinary Course of<br \/>\nBusiness, unless approved in advance in writing by the Purchaser;<\/p>\n<p>          (n) the Company does not establish or adopt any employee benefit plan,<br \/>\nand does not pay any bonus or make any profit-sharing or similar payment to, or<br \/>\nincrease the amount of the wages, salary, commissions, fringe benefits or other<br \/>\ncompensation or remuneration payable to, any of its directors, officers or<br \/>\nemployees, other than annual adjustments made in the Ordinary Course of<br \/>\nBusiness;<\/p>\n<p>          (o) the Company does not change any of its methods of accounting or<br \/>\naccounting practices in any respect;<\/p>\n<p>          (p) the Company does not make any Tax election;<\/p>\n<p>          (q) the Company does not commence any Proceeding; and<\/p>\n<p>          (r) neither the Selling Shareholders nor the Company agrees, commits<br \/>\nor offers (in writing or otherwise) or attempts to take any of the actions<br \/>\ndescribed in the preceding clauses of this Section 8.3.<\/p>\n<p>     8.4  Filings and Consents.<\/p>\n<p>     The Company shall ensure that:<\/p>\n<p>          (a) each filing or notice required to be made or given (pursuant to<br \/>\nany applicable legal requirement, Order or Contract, or otherwise) by the<br \/>\nCompany or the Selling Shareholders in connection with the execution and<br \/>\ndelivery of any of the Transactional Agreements or in connection with the<br \/>\nconsummation or performance of any of the Transactions (including each of the<br \/>\nfilings and notices identified in Part 5.5 of the Disclosure Schedule) is made<br \/>\nor given as soon as possible after the date of this Agreement;<\/p>\n<p>                                       36<\/p>\n<p>          (b) each Consent required to be obtained (pursuant to any<br \/>\napplicable legal requirement, Order or Contract, or otherwise) by the Company<br \/>\nor the Selling Shareholders in connection with the execution and delivery of<br \/>\nany of the Transactional Agreements or in connection with the consummation or<br \/>\nperformance of any of the Transactions (including each of the Consents<br \/>\nidentified in Part 5.5 of the Disclosure Schedule) is obtained as soon as<br \/>\npossible after the date of this Agreement and remains in full force and<br \/>\neffect through the Closing Date;<\/p>\n<p>          (c) the Company promptly delivers to the Purchaser a copy of each<br \/>\nfiling made, each notice given and each Consent obtained by the Company or<br \/>\nthe Selling Shareholders during the Pre-Closing Period; and<\/p>\n<p>          (d) during the Pre-Closing Period, the Company and its<br \/>\nrepresentatives cooperate with the Purchaser and with the Purchaser&#8217;s<br \/>\nrepresentatives, and prepare and make available such documents and take such<br \/>\nother actions as the Purchaser may request in good faith, in connection with<br \/>\nany filing, notice or Consent that the Purchaser or Merger Sub is required or<br \/>\nelects to make, give or obtain.<\/p>\n<p>     8.5  Notification; Updates to Disclosure Schedule.<\/p>\n<p>          (a) During the Pre-Closing Period, the Company and the Selling<br \/>\nShareholders shall promptly notify the Purchaser in writing of:<\/p>\n<p>              (i)    the discovery by the Company or the Selling Shareholders<br \/>\nof any event, condition, fact or circumstance that constitutes a material<br \/>\nbreach of any representation or warranty made by the Company or the Selling<br \/>\nShareholders in this Agreement or in any of the other Transactional<br \/>\nAgreements; and<\/p>\n<p>              (ii)   any event, condition, fact or circumstance that may make<br \/>\nthe timely satisfaction of any of the conditions set forth in Section 4.1,<br \/>\nimpossible or unlikely.<\/p>\n<p>          (b) If any event, condition, fact or circumstance that is required<br \/>\nto be disclosed pursuant to Section 8.5(a) requires any change in the<br \/>\nDisclosure Schedule, or if any such event, condition, fact or circumstance<br \/>\nwould require such a change assuming the Disclosure Schedule were dated as of<br \/>\nthe date of the occurrence, existence or discovery of such event, condition,<br \/>\nfact or circumstance, then the Company and the Selling Shareholders shall<br \/>\npromptly deliver to the Purchaser an update to the Disclosure Schedule (a<br \/>\n&#8220;DISCLOSURE SCHEDULE UPDATE&#8221;) specifying such change. Such Disclosure<br \/>\nSchedule Update shall be deemed to supplement or amend the Disclosure<br \/>\nSchedule for the purpose of (i) determining the accuracy of any of the<br \/>\nrepresentations and warranties made by the Company or the Selling<br \/>\nShareholders in this Agreement as of the Closing, or (ii) determining whether<br \/>\nthe conditions set forth in Section 4.1 have been satisfied; unless objected<br \/>\nto in writing by the Purchaser.<\/p>\n<p>          (c) If any Disclosure Schedule Update to this Agreement prepared by<br \/>\nor on behalf of the Selling Shareholders and the Company is supplemented or<br \/>\namended after the execution of this Agreement due to such matter(s) that,<br \/>\nindividually or in the aggregate, result in a material adverse effect on the<br \/>\nbusiness, condition, assets, Liabilities, operations, financial performance or <\/p>\n<p>                                       37<\/p>\n<p>net income of the Company, and the Purchaser objects to such Disclosure<br \/>\nSchedule Update, the Purchaser may elect at its sole option to (i) terminate<br \/>\nthis Agreement, (ii) proceed with the Closing, or (iii) negotiate a reduction<br \/>\nof the Merger Consideration which shall be determined by the parties in good<br \/>\nfaith, regardless of whether such matter existed or was known as of the date<br \/>\nhereof or arose and became known thereafter; provided, however, that if the<br \/>\nPurchaser elects to proceed with the Closing, the Purchaser shall not be<br \/>\nentitled to bring a claim against the Company or the Selling Shareholders<br \/>\nwith respect to any Disclosure Schedule Update.<\/p>\n<p>     8.6  No Negotiation.<\/p>\n<p>     Neither the Company nor any of its employees, directors,<br \/>\nrepresentatives, affiliates or advisors (including, without limitation,<br \/>\nlegal, accounting, financial and investment banking advisors) will directly<br \/>\nor indirectly on behalf of the Company or the Selling Shareholders:<\/p>\n<p>          (a) enter into any agreement (or grant any option or right) to<br \/>\nsell, transfer or otherwise dispose of the shares of capital stock or the<br \/>\nassets of the Company or issue any controlling interest in shares of capital<br \/>\nstock of the Company, directly or indirectly, to any Person, other than<br \/>\nCompany Options and shares issuable upon exercise of the Company Options in<br \/>\nthe Ordinary Course of Business;<\/p>\n<p>          (b) hold any discussion with, or provide any information to, any<br \/>\nPerson concerning the Company in connection therewith; or<\/p>\n<p>          (c) respond to any inquiry made by any Person concerning a proposed<br \/>\nacquisition of any assets or capital stock of the Company, except to advise<br \/>\nsuch Person that the Company has entered into this Agreement.  The Company<br \/>\nand the Selling Shareholders further agree to advise the Purchaser<br \/>\nimmediately upon receiving any inquiry from any such Person.  If the Company<br \/>\nreceives a bona fide offer concerning a proposed acquisition of any assets or<br \/>\ncapital stock of the Company, the Company shall, in addition to notifying the<br \/>\nPurchaser of the receipt of such offer, identify the identity of the proposed<br \/>\nbuyer.<\/p>\n<p>9.   Pre-Closing Covenants of the Purchaser.<\/p>\n<p>     9.1  Corporate Proceedings.<\/p>\n<p>     The Purchaser shall ensure that resolutions (in form satisfactory to the<br \/>\nPurchaser) of the Purchaser Board approving or adopting, as applicable, all<br \/>\nnecessary further action of the Purchaser Board, this Agreement, the other<br \/>\nTransactional Agreements and the Transactions and recommending approval by<br \/>\nthe Purchaser&#8217;s stockholders of this Agreement, the other Transactional<br \/>\nAgreements and the Transactions, are passed as necessary pursuant to<br \/>\napplicable law.<\/p>\n<p>                                       38<\/p>\n<p>     9.2  Access and Investigation.<\/p>\n<p>     The Purchaser shall ensure that, at all times during the Pre-Closing<br \/>\nPeriod:<\/p>\n<p>          (a) the Purchaser and its representatives provide the Company and<br \/>\nits representatives with free and complete access at reasonable times to the<br \/>\nPurchaser&#8217;s premises and assets and to all existing books, records, Tax<br \/>\nReturns, work papers and other documents and information relating to the<br \/>\nPurchaser;<\/p>\n<p>          (b) the Purchaser and its representatives provide the Company and<br \/>\nits representatives with such copies of existing books, records, Tax Returns,<br \/>\nwork papers and other documents and information relating to the Purchaser as<br \/>\nthe Company may request in good faith; and<\/p>\n<p>          (c) the Purchaser and its representatives compile, and provide the<br \/>\nCompany and its representatives with, such additional financial, operating<br \/>\nand other data and information regarding the Purchaser as the Company may<br \/>\nrequest in good faith.<\/p>\n<p>     9.3  Filings and Consents.<\/p>\n<p>     The Purchaser shall ensure that:<\/p>\n<p>          (a) each filing or notice required to be made or given (pursuant to<br \/>\nany applicable legal requirement, Order or Contract, or otherwise) by the<br \/>\nPurchaser or Merger Sub in connection with the execution and delivery of any<br \/>\nof the Transactional Agreements or in connection with the consummation or<br \/>\nperformance of any of the Transactions is made or given as soon as possible<br \/>\nafter the date of this Agreement;<\/p>\n<p>          (b) each Consent required to be obtained (pursuant to any<br \/>\napplicable legal requirement Order or Contract, or otherwise) by the<br \/>\nPurchaser or Merger Sub in connection with the execution and delivery of any<br \/>\nof the Transactional Agreements or in connection with the consummation or<br \/>\nperformance of any of the Transactions is obtained as soon as possible after<br \/>\nthe date of this Agreement and remains in full force and effect through the<br \/>\nClosing Date;<\/p>\n<p>          (c) the Purchaser promptly delivers to the Company a copy of each<br \/>\nfiling made, each material notice given and each material Consent obtained by<br \/>\nthe Purchaser or Merger Sub during the Pre-Closing Period; and<\/p>\n<p>          (d) during the Pre-Closing Period, the Purchaser and Merger Sub and<br \/>\ntheir representatives cooperate with the Company and its representatives, and<br \/>\nprepare and make available such documents and take such other actions as the<br \/>\nCompany may request in good faith, in connection with any filing, notice or<br \/>\nConsent that the Company is required or elects to make, give or obtain.<\/p>\n<p>                                       39<\/p>\n<p>     9.4  Notification.<\/p>\n<p>     During the Pre-Closing Period, each of the Purchaser and Merger Sub<br \/>\nshall promptly notify the Company in writing of:<\/p>\n<p>          (a) the discovery by the Purchaser of any event, condition, fact or<br \/>\ncircumstance that constitutes a breach of any representation or warranty made<br \/>\nby the Purchaser or Merger Sub in this Agreement or in any of the other<br \/>\nTransactional Agreements;<\/p>\n<p>          (b) any breach of any covenant or obligation of the Purchaser or<br \/>\nMerger Sub; and<\/p>\n<p>          (c) any event, condition, fact or circumstance that may make the<br \/>\ntimely satisfaction of any of the conditions set forth in Section 4.2,<br \/>\nimpossible or unlikely.<\/p>\n<p>10.  Other Agreements.<\/p>\n<p>     10.1 Registration of Company Options.<\/p>\n<p>     The Purchaser agrees that as soon as reasonably practicable after the<br \/>\nClosing Date, but in no event later than fifteen (15) days following the<br \/>\nClosing Date, it will cause to be filed one or more registration statements<br \/>\non Form S-8 under the Securities Act, or amendments to its existing<br \/>\nregistration statements on Form S-8, in order to register the shares of<br \/>\nPurchaser Stock issuable upon exercise of the aforesaid converted Company<br \/>\nOptions.<\/p>\n<p>     10.2 Confidentiality.<\/p>\n<p>     Each of the parties hereto hereby agrees to and reaffirms the terms and<br \/>\nprovisions of the Mutual Nondisclosure Agreement by and between the Purchaser<br \/>\nand the Company, dated as of April 15, 1999.<\/p>\n<p>     10.3 Public Disclosure.<\/p>\n<p>     Unless otherwise required by law (including, without limitation,<br \/>\nsecurities laws) or, as to the Purchaser, by the rules and regulations of the<br \/>\nNational Association of Securities Dealers, Inc., prior to the Effective<br \/>\nTime, no disclosure (whether or not in response to an inquiry) of the subject<br \/>\nmatter of this Agreement or any Transactional Agreement shall be made by any<br \/>\nparty hereto unless approved by the Purchaser and the Company prior to<br \/>\nrelease; provided, that such approval shall not be unreasonably withheld,<br \/>\nprovided, further, that the parties agree and understand that certain<br \/>\ndisclosures regarding the Transactions may be made to (a) employees of the<br \/>\nPurchaser and the Company, (b) third parties whose consent or approval may be<br \/>\nrequired in connection with the Transactions, and (c) the professional<br \/>\nadvisors of Purchaser, the Company and the Selling Shareholders, in each case<br \/>\nwithout any prior written consent.<\/p>\n<p>                                       40<\/p>\n<p>     10.4 No Inconsistent Action.<\/p>\n<p>     None of the Purchaser, the Company or the Selling Shareholders shall<br \/>\ntake any action inconsistent with the treatment of the Merger as a<br \/>\nreorganization under Section 368(a) of the Code.<\/p>\n<p>     10.5 Restrictive Legend.<\/p>\n<p>     All certificates representing Purchaser Stock deliverable to the Selling<br \/>\nShareholders pursuant to this Agreement and any certificates subsequently<br \/>\nissued with respect thereto or in substitution therefor, unless a sale,<br \/>\ntransfer or other disposition pursuant to one or more of the alternative<br \/>\nconditions set forth in Section 6(l) shall have occurred, or unless the<br \/>\nconditions of paragraph (k) of Rule 144 promulgated under the Securities Act<br \/>\nshall have been satisfied, shall bear a legend substantially as follows, in<br \/>\naddition to any legend the Purchaser determines is required pursuant to any<br \/>\napplicable legal requirement:<\/p>\n<p>     &#8220;The shares represented by this certificate may not be offered, sold,<br \/>\n     pledged, transferred or otherwise disposed of except in accordance with<br \/>\n     the requirements of the Securities Act of 1933, as amended, and the<br \/>\n     other conditions specified in that certain Agreement and Plan of Merger<br \/>\n     dated as of June 10, 1999, a copy of which Agreement and Plan of Merger<br \/>\n     XOOM.com, Inc. will furnish, without charge, to the holder of this<br \/>\n     certificate upon written request therefor.&#8221;<\/p>\n<p>     The Purchaser, at its discretion, may cause a stop-transfer order to be<br \/>\nplaced with its transfer agent(s) with respect to the certificates for<br \/>\nPurchaser Stock but not as to the certificates for any part of Purchaser<br \/>\nStock as to which said legend is no longer appropriate when one or more of<br \/>\nthe alternatives set forth in Section 6(l) shall have been satisfied or the<br \/>\nconditions of paragraph (k) of Rule 144 promulgated under the Securities Act<br \/>\nshall have been satisfied. Such legend(s) shall be promptly removed when<br \/>\nPurchaser Stock delivered to the Selling Shareholders pursuant to this<br \/>\nAgreement has been registered.<\/p>\n<p>     10.6 Market Stand-Off.<\/p>\n<p>     Notwithstanding anything in this Agreement to the contrary, in<br \/>\nconnection with any public offering of the capital stock of the Purchaser (a<br \/>\n&#8220;FOLLOW-ON OFFERING&#8221;), each Selling Shareholder agrees that, if requested by<br \/>\nthe managing underwriter of the Follow-On Offering, such Selling Shareholder<br \/>\nshall not, directly or indirectly, sell, offer, contract to sell, grant any<br \/>\noption to purchase, transfer the economic risk of ownership in, make any<br \/>\nshort sale, pledge or otherwise dispose of, any Purchaser Stock, without the<br \/>\nprior written consent of the Purchaser and the managing underwriters of the<br \/>\nFollow-On Offering, for a period of ninety (90) days from the effective date<br \/>\nof the registration statement under the Securities Act relating to such<br \/>\nFollow-On Offering and to the extent otherwise permissible under the<br \/>\nrequirements for a tax-free Merger; provided, however, that (a) all officers,<br \/>\ndirectors and 5% stockholders of the Purchaser shall enter into similar<br \/>\nagreements; (b) shares of Purchaser Stock shall be released from this<br \/>\nrestriction to the extent such shares are registered pursuant to the Rights<br \/>\nAgreement; and (c) shares of Purchaser Stock shall be released from this<br \/>\nrestriction to the extent any other shares are released <\/p>\n<p>                                       41<\/p>\n<p>from similar restrictions. This restriction shall be binding upon any<br \/>\ntransferee of Purchaser Stock, and the certificates for Purchaser Stock shall<br \/>\nbear a legend to such effect. In order to enforce the foregoing covenant, the<br \/>\nPurchaser may impose stop-transfer instructions with respect to Purchaser<br \/>\nStock until the end of such period.<\/p>\n<p>     10.7 Certain Tax Matters.<\/p>\n<p>          (a) Notwithstanding anything to the contrary in Section 12.5, the<br \/>\nSelling Shareholders shall have the right (but not the obligation), at their<br \/>\nown expense, to control, defend, settle, compromise or prosecute in any<br \/>\nmanner any audit, examination, investigation, hearing or other proceeding<br \/>\nwith respect to any Company Return involving only periods ending on or before<br \/>\nthe Closing Date; provided, however, that the Selling Shareholders shall not<br \/>\nsettle, or compromise any such audit, etc. without the Purchaser&#8217;s timely and<br \/>\nreasonable prior written consent. Nothing in this Section 10.7(a) shall be<br \/>\nconstrued to increase the Selling Shareholders&#8217; maximum indemnification<br \/>\nlimitation as set forth in Sections 12.2(a) and 12.5.<\/p>\n<p>          (b) Except as expressly provided in Section 10.7(a), Section 12.5<br \/>\nshall determine the procedures for defending any other tax audit,<br \/>\nexamination, investigation, hearing or other proceeding with respect to any<br \/>\nCompany Return.<\/p>\n<p>          (c) The Purchaser further represents, warrants and covenants as<br \/>\nfollows:<\/p>\n<p>              (i)    The Purchaser agrees to report the Merger as a<br \/>\nreorganization within the meaning of Section 368(a) of the Code, unless<br \/>\notherwise required by law or unless advised in writing by counsel to the<br \/>\nCompany that the Merger will not qualify as such a reorganization.<\/p>\n<p>              (ii)   Prior to the Merger, the Purchaser will be in &#8220;control&#8221;<br \/>\nof Merger Sub within the meaning of Section 368(c) of the Code.<\/p>\n<p>              (iii)  The Purchaser has no plan or intention to cause the<br \/>\nSurviving Corporation to issue additional shares of stock after the Merger,<br \/>\nor take any other action, that would result in the Purchaser losing control<br \/>\nof the Surviving Corporation.<\/p>\n<p>              (iv)   Except for (A) repurchases or redemptions of Purchaser<br \/>\nStock that are consistent with past practices and purchase programs that were<br \/>\nnot created or modified in connection with the Merger, (B) possible<br \/>\nrepurchases of unvested shares of employees or consultants in connection with<br \/>\nthe termination of their services, and (C) possible reacquisitions of<br \/>\nPurchaser Stock pursuant to the Escrow Agreement, neither the Purchaser or<br \/>\nany &#8220;related person&#8221; of the Purchaser (within the meaning of Treasury<br \/>\nRegulations Section 1.368-1(e)(3)) has any plan or intention to repurchase or<br \/>\nredeem any of the Purchaser Stock to be issued in the Merger in exchange for<br \/>\nshares of Company capital stock.<\/p>\n<p>              (v)    Neither the Purchaser nor any &#8220;related person&#8221; of the<br \/>\nPurchaser (within the meaning of Treasury Regulations Section 1.368-1(e)(3))<br \/>\nowns or has at any time during the past years owned any capital stock of the<br \/>\nCompany.<\/p>\n<p>                                       42<\/p>\n<p>              (vi)   The Purchaser has no plan or intention to liquidate the<br \/>\nSurviving Corporation; to merge the Surviving Corporation with the Purchaser<br \/>\nor into any other corporation; to sell, distribute or otherwise dispose of<br \/>\nthe capital stock of the Surviving Corporation; or to cause the Surviving<br \/>\nCorporation to sell or otherwise dispose of any of its assets (or of any of<br \/>\nthe assets acquired from Merger Sub) except for dispositions made in the<br \/>\nOrdinary Course of Business or transfers permitted under Section 368(a)(2)(C)<br \/>\nof the Code or prescribed by Treasury Regulations Section 1.368-1(d) that<br \/>\nwill not affect the Company&#8217;s satisfaction of the &#8220;continuity of business<br \/>\nenterprise&#8221; requirement under Section 368 of the Code.<\/p>\n<p>              (vii)  Merger Sub has no assets and will have no liabilities<br \/>\nassumed by the Company, nor will it transfer to the Company, in the Merger,<br \/>\nany assets subject to liabilities. Following the Merger, the historic<br \/>\nbusiness of the Surviving Corporation will be continued, or a significant<br \/>\nportion of the Surviving Corporation&#8217;s historic business assets will be used<br \/>\nin a business.<\/p>\n<p>              (viii) Following the Merger, the Purchaser and the Surviving<br \/>\nCorporation will comply with the record-keeping and information-filing<br \/>\nrequirements of Section 1.368-3 of the Treasury Regulations.<\/p>\n<p>              (ix)   None of the employee compensation received by any<br \/>\nSelling Shareholder who is or will be an employee of the Company or the<br \/>\nPurchaser is or will be separate consideration for, or allocable to, any of<br \/>\nhis or her shares of Company Stock to be surrendered in the Merger.  None of<br \/>\nthe Purchaser Stock received by any Selling Shareholder in the Merger who is<br \/>\nor will be an employee of the Company or the Purchaser will be separate<br \/>\nconsideration for, or allocable to, any employment, consulting or similar<br \/>\narrangement.  Any compensation paid or to be paid to any Selling Shareholder<br \/>\nwho is or will be an employee of or who will provide advisory services for<br \/>\nthe Company, Merger Sub, the Purchaser or any affiliate thereof after the<br \/>\nMerger will be determined by bargaining at arm&#8217;s length.<\/p>\n<p>          (d) The Selling Shareholders further represent, warrant and<br \/>\ncovenant as follows:<\/p>\n<p>              (i)    The Selling Shareholders agree to report the Merger as a<br \/>\n&#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, unless<br \/>\notherwise required by law or unless advised in writing by counsel to the<br \/>\nSelling Shareholders that the Merger does not constitute such a<br \/>\nreorganization.<\/p>\n<p>              (ii)   Following the Merger, the Selling Shareholders will<br \/>\ncomply with the record-keeping and information filing requirements of Section<br \/>\n1.368-3 of the Treasury Regulations.<\/p>\n<p>              (iii)  Except for 37,878 shares of Series A Preferred Stock,<br \/>\nrepresenting less than one percent (1%) of the total outstanding capital<br \/>\nstock of the Company, which will be redeemed prior to the Effective Time by<br \/>\nthe Company, the Company has not and will not prior to the Merger redeem or<br \/>\nmake any extraordinary distribution (within the meaning of Treasury<br \/>\nRegulations Section 1.368-1T(e)(1)(ii)(A)) with respect to any Company<br \/>\ncapital stock in connection with the Merger; no &#8220;related person&#8221; of the<br \/>\nCompany (within the meaning of<\/p>\n<p>                                       43<\/p>\n<p>Treasury Regulations Section 1.368-1(e)(3)) has purchased or will purchase<br \/>\nprior to the Effective Time any Company capital stock in connection with the<br \/>\nMerger. The redemption of such shares of Series A Preferred Stock shall be<br \/>\nmade solely with the Company&#8217;s funds and the Company will not be reimbursed<br \/>\nby the Purchaser or a related Person of the Purchaser.<\/p>\n<p>              (iv)   After the Merger, the Company will hold at least ninety<br \/>\npercent (90%) of the fair market value of its net assets and at least seventy<br \/>\npercent (70%) of the fair market value of its gross assets held immediately<br \/>\nprior to the Merger. For purposes of this Section 10.7, amounts paid by the<br \/>\nCompany to dissenters, amounts paid by the Company to shareholders who<br \/>\nreceive cash or other property, amounts used by the Company to pay<br \/>\nreorganization expenses, and all redemptions and distributions (except for<br \/>\nregular, normal dividends) made by the Company will be included as assets of<br \/>\nthe Company immediately prior to the Merger.<\/p>\n<p>              (v)    The Liabilities of the Company, if any, and the<br \/>\nLiabilities to which the assets of the Company are subject, if any, were or<br \/>\nwill be incurred by the Company in the Ordinary Course of Business.<\/p>\n<p>              (vi)   Except as otherwise provided in Section 14.2, the<br \/>\nCompany and each of the Selling Shareholders will pay any of their own<br \/>\nexpenses incurred in connection with the Merger.<\/p>\n<p>              (vii)  The Company is not under the jurisdiction of a court in<br \/>\na &#8220;title 11 or similar case,&#8221; within the meaning of Section 368(a)(3)(A) of<br \/>\nthe Code.<\/p>\n<p>              (viii) The Company is not an investment company for purposes of<br \/>\nSection 368(a)(2)(F) of the Code.<\/p>\n<p>              (ix)   None of the employee compensation received by any<br \/>\nSelling Shareholder who is or will be an employee of the Company or the<br \/>\nPurchaser is or will be separate consideration for, or allocable to, any of<br \/>\nhis or her shares of Company Stock to be surrendered in the Merger.  None of<br \/>\nthe Purchaser Stock received by any Selling Shareholder in the Merger who is<br \/>\nor will be an employee of the Company or the Purchaser will be separate<br \/>\nconsideration for, or allocable to, any employment, consulting or similar<br \/>\narrangement.  Any compensation paid or to be paid to any Selling Shareholder<br \/>\nwho is or will be an employee of or who will provide advisory services for<br \/>\nthe Company, Merger Sub, the Purchaser or any affiliate thereof after the<br \/>\nMerger will be determined by bargaining at arm&#8217;s length.<\/p>\n<p>              (x)    The Company&#8217;s business conducted immediately before the<br \/>\nEffective Time will be its &#8220;historic business&#8221; and its assets held<br \/>\nimmediately before the Effective Time will be its &#8220;historic business assets&#8221;<br \/>\nfor purposes of Section 368 of the Code.<\/p>\n<p>     10.8 Preparation of Audited Financial Statements.<\/p>\n<p>     As promptly as possible after the Closing, the parties will cooperate<br \/>\nwith each other and with Ernst &amp; Young LLP (&#8220;ERNST &amp; YOUNG&#8221;) to prepare<br \/>\naudited financial statements of the <\/p>\n<p>                                       44<\/p>\n<p>Company for the year ended December 31, 1998 and the period ended May 31, 1999<br \/>\n(i) prepared in accordance with GAAP; and (ii) audited by Ernst &amp; Young (the<br \/>\n&#8220;AUDITED FINANCIAL STATEMENTS&#8221;). The cost for preparation of such report shall<br \/>\nbe borne by the Purchaser and the Purchaser and the Selling Shareholders will<br \/>\nhave the right to review and comment on the Audited Financial Statements,<br \/>\nprovided, that Ernst &amp; Young&#8217;s final report shall be final and binding upon the<br \/>\nparties. The Purchaser agrees that such report shall be available to the Company<br \/>\nat no charge and it shall remain the property of the Company for its use should<br \/>\nthe Merger terminate for any reason.<\/p>\n<p>11.  Termination.<\/p>\n<p>     11.1 Termination Events.<\/p>\n<p>     This Agreement may be terminated prior to Closing:<\/p>\n<p>          (a) by the Purchaser if there is a material breach of any covenant or<br \/>\nobligation of the Company or the Selling Shareholders and such breach has not<br \/>\nbeen cured within ten (10) business days after written notice of such breach is<br \/>\ngiven to the Company except if the Company or the Selling Shareholders, as<br \/>\napplicable, have initiated efforts to cure such breach and the Purchaser, in its<br \/>\nsole discretion, is satisfied that such breach can be cured within a reasonable<br \/>\nperiod of time;<\/p>\n<p>          (b) by the Purchaser, pursuant to Section 8.5(c)(i) hereof;<\/p>\n<p>          (c) by the Company if there is a material breach of any covenant or<br \/>\nobligation of the Purchaser and such breach has not been cured within ten (10)<br \/>\nbusiness days after written notice of such breach is given to the Purchaser,<br \/>\nexcept if the Purchaser has initiated efforts to cure such breach and the<br \/>\nCompany, in its sole discretion, is satisfied that such breach can be cured<br \/>\nwithin a reasonable period of time;<\/p>\n<p>          (d) by either the Purchaser or the Company if the Closing has not<br \/>\ntaken place on or before July 1, 1999; provided, however, that the right to<br \/>\nterminate this Agreement under this Section 11.1(d) shall not be available to<br \/>\nany party whose intentional failure to fulfill any obligation under this<br \/>\nAgreement has been the cause of or has resulted in the failure of the Merger to<br \/>\noccur on or before such date; or<\/p>\n<p>          (e) by the mutual consent of the Purchaser and the Company.<\/p>\n<p>     11.2 Termination Procedures.<\/p>\n<p>     If the Purchaser wishes to terminate this Agreement pursuant to Section<br \/>\n11.1(a), Section 11.1(b) or Section 11.1(d), the Purchaser shall deliver to the<br \/>\nCompany and the Selling Shareholders a written notice stating that the Purchaser<br \/>\nis terminating this Agreement and setting forth a brief description of the basis<br \/>\non which the Purchaser is terminating this Agreement.  If the Company wishes to<br \/>\nterminate this Agreement pursuant to Section 11.1(c) or Section 11.1(d), the<br \/>\nCompany shall deliver to the Purchaser a written notice stating that the Company<br \/>\nis terminating <\/p>\n<p>                                       45<\/p>\n<p>this Agreement and setting forth a brief description of the basis on which the<br \/>\nCompany is terminating this Agreement.<\/p>\n<p>     11.3 Effect of Termination.<\/p>\n<p>     If this Agreement is terminated pursuant to Section 11.1, all further<br \/>\nobligations of the parties under this Agreement shall terminate; provided, that<br \/>\neach party shall remain liable for any breaches of this Agreement prior to its<br \/>\ntermination and provided, further, that Sections 10.2, 10.3, 11, 14.2, 14.3 and<br \/>\n14.11 shall survive the termination of this Agreement.<\/p>\n<p>     11.4 Exclusivity of Termination Rights.<\/p>\n<p>     Except to the extent termination occurs due to the bad faith of another<br \/>\nparty, the termination rights and obligations provided in this Section 11 shall<br \/>\nbe deemed to be exclusive.  Subject to the provisions of Section 11.3, the<br \/>\nparties shall not have any other or further Liabilities to or with respect to<br \/>\none another by reason of this Agreement or its termination.<\/p>\n<p>12.  Indemnification, etc.<\/p>\n<p>     12.1 Survival of Representations and Covenants.<\/p>\n<p>          (a) The Purchaser agrees that all rights to indemnification or<br \/>\nexculpation now existing in favor of the employees, agents, directors or<br \/>\nofficers of the Company (the &#8220;Company Indemnified Parties&#8221;) as provided in its<br \/>\nArticles of Incorporation or Bylaws of the Company, except to the extent limited<br \/>\nby Section 12.3 hereof, shall continue in full force and effect for a period of<br \/>\nsix (6) years from the Closing Date; provided, however, that in the event any<br \/>\nclaim or claims are asserted or made within such six-year period, all rights to<br \/>\nindemnification in respect of any such claim or claims shall continue until<br \/>\ndisposition of any and all such claims. Any determination required to be made<br \/>\nwith respect to whether a Company Indemnified Party&#8217;s conduct complies with the<br \/>\nstandards set forth in the Articles of Incorporation or Bylaws of the Company or<br \/>\notherwise shall be made by independent counsel selected by the Company<br \/>\nIndemnified Party reasonably satisfactory to the Purchaser (whose fees and<br \/>\nexpenses shall be paid by the Purchaser).<\/p>\n<p>          (b) The representations, warranties, covenants and obligations of each<br \/>\nparty set forth in this Agreement shall survive the Merger only to the extent<br \/>\nprovided in the sentence immediately following and shall remain operative and in<br \/>\nfull force and effect regardless of any investigation made by or information<br \/>\nfurnished to or on behalf of any other party hereto, any person controlling any<br \/>\nsuch party or any of their officers or directors, whether prior to or after the<br \/>\nexecution of this Agreement, and any subsequent Acquisition Transaction effected<br \/>\nby or otherwise involving the Purchaser.  Except in the case of fraud, all<br \/>\nrepresentations, warranties and covenants of the parties in this Agreement or<br \/>\nany other Transactional Agreement shall terminate on the earlier of the first<br \/>\nanniversary of the Closing Date or ten days after the completion and delivery of<br \/>\nPurchaser&#8217;s audited financial statements for the year ending December 31, 1999<br \/>\n(the &#8220;INDEMNIFICATION TERMINATION DATE&#8221;).  In the case of fraud, the<\/p>\n<p>                                       46<\/p>\n<p>Indemnification Termination Date shall be upon the expiration of the applicable<br \/>\nstatute of limitations.<\/p>\n<p>          (c) For purposes of this Agreement, although each statement or other<br \/>\nitem of information set forth in the Disclosure Schedule qualifies the<br \/>\nrepresentations and warranties, all such statements and other items of<br \/>\ninformation set forth in the Disclosure Schedule shall be deemed to qualify all<br \/>\napplicable representations and warranties and to be a representation and<br \/>\nwarranty made by the Company under this Agreement<\/p>\n<p>          (d) The representations, warranties, covenants and obligations of the<br \/>\nCompany and the Selling Shareholders are made to the Purchaser and for the<br \/>\nbenefit of each Purchaser Indemnitee (as defined in Section 12.2 hereof.<\/p>\n<p>     12.2 Indemnification by the Selling Shareholders.<\/p>\n<p>          (a) Subject to this Section 12.2 and Section 12.6, the Selling<br \/>\nShareholders covenant and agree to defend, indemnify and hold harmless the<br \/>\nPurchaser and each of its officers, directors, employees, agents and<br \/>\nrepresentatives (collectively the &#8220;PURCHASER INDEMNITEES&#8221; and individually each,<br \/>\na &#8220;PURCHASER INDEMNITEE&#8221;) from and against, and shall compensate and reimburse<br \/>\neach of the Purchaser Indemnitees for, any Damages which are suffered or<br \/>\nincurred by any of the Purchaser Indemnitees (regardless of whether such Damages<br \/>\nrelate to any third-party claim) directly or indirectly arising or resulting<br \/>\nfrom or connected with any breach of any representation or warranty made by the<br \/>\nCompany or the Selling Shareholders in this Agreement. Notwithstanding the<br \/>\nforegoing, except for rights to equitable relief and Damages resulting from<br \/>\nfraud on the part of a Selling Shareholder, each Selling Shareholder&#8217;s Liability<br \/>\nunder this section and\/or for breaches of this Agreement or any claim or Damages<br \/>\narising out of or relating to this Agreement, whether in contract, tort or under<br \/>\nany other legal theory, shall be solely and exclusively limited to, and shall in<br \/>\nno event exceed, such Selling Shareholder&#8217;s pro rata share of the Holdback<br \/>\nAmount. In the case of Damages resulting from fraud, each Selling Shareholder&#8217;s<br \/>\nLiability shall be solely and exclusively limited to, and shall in no event<br \/>\nexceed, the pro rata share of the Merger Consideration paid to such Selling<br \/>\nShareholder, less any claims paid to Purchaser from the Escrow Account.<\/p>\n<p>          (b) After the Closing, no Person shall be required to indemnify any<br \/>\nIndemnitee with respect to any claim for indemnification pursuant to Section<br \/>\n12.2(a) unless and until the aggregate amount of indemnifiable Damages suffered<br \/>\nby all Indemnitees subject to indemnification pursuant to this Agreement exceeds<br \/>\nFifty Thousand Dollars ($50,000) (the &#8220;THRESHOLD&#8221;), at which point the<br \/>\nindemnifying Person shall indemnify the full amount of such claims and all<br \/>\nclaims thereafter, subject to any other applicable limitations in this Section<br \/>\n12.2 on the indemnifying Person&#8217;s indemnification obligations.  The aggregation<br \/>\nof claims must only reach the Threshold once, and after such point the<br \/>\nIndemnitees may seek indemnification for all claims which may arise under this<br \/>\nSection 12.2.<\/p>\n<p>          (c) The number of shares of Purchaser Stock to be released to the<br \/>\nPurchaser pursuant to the terms of the Escrow Agreement shall be calculated by<br \/>\ndividing the dollar amount <\/p>\n<p>                                       47<\/p>\n<p>of the Damages incurred by the Average Purchaser Stock Price prior to the date<br \/>\nwhen the Escrow Agent makes a payment to a Purchaser Indemnitee.<\/p>\n<p>          (d) No party shall be required to make any indemnification payment<br \/>\nhereunder unless a claim is initiated prior to the Indemnification Termination<br \/>\nDate.<\/p>\n<p>     12.3 No Contribution.<\/p>\n<p>     With respect to the matters for which a Purchaser Indemnitee or any other<br \/>\nIndemnitee is entitled to indemnification pursuant to Section 12.2(a), each<br \/>\nSelling Shareholder hereby waives, and acknowledges and agrees that he or she<br \/>\nshall not have and shall not exercise or assert, against the Purchaser, the<br \/>\nCompany, or any Purchaser Indemnitee, or attempt to exercise or assert, any<br \/>\nright of contribution or right of indemnity or any other right or remedy in<br \/>\nconnection with any indemnification obligation to the Purchaser or any Purchaser<br \/>\nIndemnitee to which such Selling Shareholder may become subject under this<br \/>\nAgreement (whether as a Selling Shareholder or in a capacity as a former<br \/>\ndirector, officer, agent or employee of the Company).  It is the intention of<br \/>\nthe parties that after the Closing the remedy for the Purchaser or any Purchaser<br \/>\nIndemnitee seeking indemnification from the Selling Shareholders hereunder shall<br \/>\nbe a remedy solely against the Selling Shareholders and not against the Company;<br \/>\naccordingly, the Selling Shareholders agree to the waivers contained in this<br \/>\nSection 12.3.  Each Selling Shareholder further acknowledge that the waivers,<br \/>\nacknowledgments and agreements of such Selling Shareholder contained in this<br \/>\nsection are an essential inducement to the Purchaser in entering into this<br \/>\nAgreement and agreeing to consummate the Transactions.<\/p>\n<p>     12.4 Setoff.<\/p>\n<p>     In addition to any rights of setoff or other rights that any Person may<br \/>\nhave at common law or otherwise, each Person shall have the right to set off any<br \/>\namount that may be owed to it by another under this Section 12 against any<br \/>\namount otherwise payable by such Person hereunder.<\/p>\n<p>     12.5 Defense of Third-Party Claims.<\/p>\n<p>     In the event of the assertion or commencement by any Person of any claim or<br \/>\nProceeding (whether against the Purchaser, the Company, the Selling<br \/>\nShareholders, any other Indemnitee or any other Person) with respect to which a<br \/>\nparty hereto may become obligated hereunder to indemnify, hold harmless,<br \/>\ncompensate or reimburse any Indemnitee pursuant to this Section 12, the party to<br \/>\nbe indemnified (the &#8220;INDEMNIFIED PARTY&#8221;) shall reasonably promptly, but in any<br \/>\nevent within thirty (30) days following the Indemnified Party&#8217;s actual knowledge<br \/>\nthereof, notify the Person providing the indemnification hereunder (the<br \/>\n&#8220;INDEMNIFYING PARTY&#8221;) of such claim or Proceeding by providing notice to the<br \/>\nIndemnifying Party, and the Indemnifying Party may elect to assume control of<br \/>\nthe defense of such claim or Proceeding, provided, however, that if the<br \/>\nIndemnifying Party fails to promptly defend against such claim or Proceeding,<br \/>\nthe Indemnified Party may proceed with the defense of such claim or Proceeding,<br \/>\nand the Indemnifying Party shall bear and pay all costs and expenses (including<br \/>\nattorneys&#8217; fees and costs) in connection with the Indemnified Party&#8217;s defense of<br \/>\nsuch claim or Proceeding (whether or not incurred by the Indemnified Party);<br \/>\nprovided further, that all such expenses paid by the Selling Shareholders, as<\/p>\n<p>                                       48<\/p>\n<p>the Indemnifying Party, will in no event exceed the respective indemnification<br \/>\nlimitations set forth in Section 12.2(a).<\/p>\n<p>          (a) If the Indemnified Party so proceeds with the defense of any such<br \/>\nclaim or Proceeding:<\/p>\n<p>              (i)    all expenses reasonably incurred and relating to the<br \/>\ndefense of such claim or Proceeding (whether or not incurred by the Indemnified<br \/>\nParty) shall be borne and paid exclusively by the Indemnifying Party;<\/p>\n<p>              (ii)   the Indemnifying Party shall make available to the<br \/>\nIndemnified Party any documents and materials in the possession or control of<br \/>\nthe Indemnifying Party that may be necessary to the defense of such claim or<br \/>\nProceeding;<\/p>\n<p>              (iii)  the Indemnified Party shall keep the Indemnifying Party<br \/>\ninformed of all material developments and events relating to such claim or<br \/>\nProceeding;<\/p>\n<p>              (iv)   the Indemnifying Party shall have the right to participate<br \/>\nin the defense of such claim or Proceeding at its own expense; and<\/p>\n<p>              (v)    the Indemnified Party shall not settle, adjust or<br \/>\ncompromise such claim or Proceeding without the prior written consent of the<br \/>\nIndemnifying Party, which consent shall not be unreasonably withheld.<\/p>\n<p>          (b) If the Indemnifying Party so proceeds with the defense of any such<br \/>\nclaim or Proceeding:<\/p>\n<p>              (i)    all expenses reasonably incurred and relating to the<br \/>\ndefense of such claim or Proceeding (whether or not incurred by the Indemnified<br \/>\nParty) shall be borne and paid exclusively by the Indemnifying Party;<\/p>\n<p>              (ii)   the Indemnifying Party shall keep the Indemnified Party<br \/>\ninformed of all material developments and events relating to such claim or<br \/>\nProceeding;<\/p>\n<p>              (iii)  the Indemnifying Party shall not settle, adjust or<br \/>\ncompromise such claim or Proceeding without the prior written consent of the<br \/>\nIndemnified Party, which consent shall not be unreasonably withheld.<\/p>\n<p>     12.6 Exercise of Remedies by Indemnitees Other than the Purchaser and by<br \/>\n          the Selling Shareholders.<\/p>\n<p>     No Person other than an Indemnitee (or any successor or assignee thereof)<br \/>\nshall be permitted to assert any indemnification claim or exercise any other<br \/>\nremedy under this Agreement unless the Purchaser, the Company and the Selling<br \/>\nShareholders (or any successor assignee thereof) shall have consented to the<br \/>\nassertion of such indemnification claim or the exercising of such other remedy.<br \/>\nThe sole remedy available to any Indemnitee or other Person for breaches of this<br \/>\nAgreement or the other Transactional Agreements shall be limited to the rights<br \/>\nset forth in <\/p>\n<p>                                       49<\/p>\n<p>this Section 12. The maximum aggregate amounts payable by the Company or the<br \/>\nSelling Shareholders, as the case may be, to any and all Indemnitees for any and<br \/>\nall Damages arising out of, or in connection with, this Agreement, any<br \/>\nTransactional Agreement, any certificate hereunder, any other document delivered<br \/>\nhereunder, or any of the Transactions, are the amounts specified as limitations<br \/>\nin Section 12.2(a) hereof.<\/p>\n<p>13.  Non-Solicitation.<\/p>\n<p>     If the Merger is not consummated, for a period of one year after the<br \/>\ntermination of this Agreement, neither party will solicit or otherwise take any<br \/>\nactions to induce any of the employees or consultants of the other party to<br \/>\nleave their employment or consulting relationship with the other party so as to<br \/>\nbecome employed by or provide services to the first party.<\/p>\n<p>14.  Purchaser&#8217;s Tax Indemnity.<\/p>\n<p>          (a) Within 10 business days following a Final Determination that the<br \/>\nMerger does not qualify as a &#8220;reorganization,&#8221; within the meaning of Section<br \/>\n368(a) of the Code, Purchaser shall pay to each Selling Shareholder, in cash,<br \/>\nthe Additional Amount applicable to such Selling Shareholder, provided that this<br \/>\namount will be paid only if (i) the Merger does not so qualify solely by reason<br \/>\nof changes or modifications to the NBC Agreements after the date hereof (other<br \/>\nthan any changes or modifications to the NBC Transactions reflected in,<br \/>\notherwise taken account in, or contemplated by the Restated Documents); (ii) the<br \/>\nMerger would have qualified as a &#8220;reorganization&#8221; within the meaning of Section<br \/>\n368(a) if the NBC Transactions were consummated pursuant to the NBC Agreements<br \/>\nand would have so qualified if the NBC Transactions were consummated pursuant to<br \/>\nsuch agreements as changed or modified by changes or modifications to the NBC<br \/>\nTransactions reflected in, otherwise taken account in, or contemplated by the<br \/>\nRestated Documents; and (iii) such Selling Shareholder has not taken a position<br \/>\non any Tax Return that the Merger does not so qualify or otherwise breached a<br \/>\nrepresentation, covenant or warranty provided under Section 10.7 of this<br \/>\nAgreement.<\/p>\n<p>          (b) Notwithstanding anything herein to the contrary, Purchaser shall<br \/>\nhave the right at its own expense, to control, defend, settle, compromise or<br \/>\nprosecute in any manner any audit, examination, investigation, hearing or other<br \/>\nproceeding involving a Selling Shareholder which could give rise to liability to<br \/>\nPurchaser pursuant to Section 14(a) of this Agreement. A Selling Shareholder<br \/>\nshall notify Purchaser in writing within ten days of the commencement of such an<br \/>\naudit, examination, investigation, hearing or other proceeding.<\/p>\n<p>          (c) Notwithstanding the foregoing, the indemnity provided in this<br \/>\nSection 14 shall not exceed $7,000,000. If this limit shall apply, then the<br \/>\nindemnity paid to each Selling Shareholder shall be limited to such Selling<br \/>\nShareholder&#8217;s pro rata share of $7,000,000. Such pro rata share shall be<br \/>\ndetermined based on the amount of each Selling Shareholder&#8217;s Additional Amount.<\/p>\n<p>                                       50<\/p>\n<p>15.  Miscellaneous.<\/p>\n<p>     15.1 Further Assurances.<\/p>\n<p>     Each party hereto shall execute and\/or cause to be delivered to each other<br \/>\nparty hereto such instruments and other documents, and shall take such other<br \/>\nactions, as such other party may reasonably request (prior to, at or after the<br \/>\nClosing) for the purpose of carrying out or evidencing any of the Transactions.<\/p>\n<p>     15.2 Fees and Expenses.<\/p>\n<p>     Subject to the provisions of this Agreement (including the indemnification<br \/>\nand other obligations of the Selling Shareholders pursuant to Section 12), each<br \/>\nparty shall bear and pay all its own Transaction Expenses; provided, that, if<br \/>\nthe Company is unable to pay all fees, costs and expenses incurred on behalf of<br \/>\nit and the Key Employees prior to the Closing, then the unpaid amount shall be<br \/>\npaid from the Holdback Amount.<\/p>\n<p>     15.3 Attorneys&#8217; Fees.<\/p>\n<p>     If any legal action or other legal Proceeding (including arbitration)<br \/>\nrelating to the Transactions or the enforcement of any provision of any of the<br \/>\nTransactional Agreements is brought against any party hereto, the prevailing<br \/>\nparty shall be entitled to recover reasonable attorneys&#8217; fees, costs and<br \/>\ndisbursements (in addition to any other relief to which the prevailing party may<br \/>\nbe entitled).<\/p>\n<p>     15.4 Transfer Taxes; Final Tax Return.<\/p>\n<p>          (a) The Selling Shareholders shall be responsible for sales, use and<br \/>\ntransfer taxes, including but not limited to any value-added, stock transfer,<br \/>\ngross receipts, stamp duty and real, personal or intangible property transfer<br \/>\ntaxes, due by reason of the consummation of the Transactions, including but not<br \/>\nlimited to any interest or penalties in respect thereof.<\/p>\n<p>          (b) In consultation with the Purchaser, the Selling Shareholders shall<br \/>\nactively assist the Company in filing any Company Returns for periods ending on<br \/>\nor before the Closing Date (the &#8220;FINAL RETURNS&#8221;).  The Selling Shareholders<br \/>\nshall cooperate with the Purchaser and the Company&#8217;s accountants to prepare the<br \/>\nFinal Returns in a manner consistent with the Company&#8217;s previously filed<br \/>\nreturns; provided that in all events the Final Returns shall be prepared in a<br \/>\nmanner consistent with applicable law.<\/p>\n<p>     15.5 Governing Law; Arbitration.<\/p>\n<p>          (a) This Agreement is to be construed in accordance with and governed<br \/>\nby the laws of the State of California (as permitted by Section 1646.5 of the<br \/>\nCalifornia Civil Code or any similar successor provision), without giving effect<br \/>\nto any choice-of-law rule that would cause the application of the laws of any<br \/>\njurisdiction other than the State of California to the rights and duties of the<br \/>\nparties.<\/p>\n<p>                                       51<\/p>\n<p>     (b) Any controversy or claim arising out of or relating to this Agreement,<br \/>\nor breach hereof, shall be settled by arbitration administered by the American<br \/>\nArbitration Association in accordance with its then existing commercial<br \/>\narbitration rules, and judgment upon the award rendered by the arbitrator may be<br \/>\nentered in any court having jurisdiction thereof.  The arbitrator shall be<br \/>\nappointed by mutual agreement of all of the parties, but, if the parties fail to<br \/>\nagree, the arbitrator shall be appointed by the American Arbitration Association<br \/>\nin accordance with its then existing rules.  The place of the arbitration shall<br \/>\nbe San Francisco, California, and the governing law shall be the laws of the<br \/>\nState of California, in accordance with Section 15.5(a) of this Agreement.<\/p>\n<p>     15.6 Successors and Assigns.<\/p>\n<p>     Except as otherwise expressly provided herein, the provisions hereof shall<br \/>\ninure to the benefit of, and be binding upon, the successors, assigns, heirs,<br \/>\nexecutors and administrators of the parties hereto and the Indemnitees and shall<br \/>\ninure to the benefit of and be enforceable by each Person who shall be a holder<br \/>\nof Purchaser Stock issued in connection with the Transactions.  None of the<br \/>\nparties hereto may assign any of their rights or obligations hereunder to any<br \/>\nother party (by contract, operation of law or otherwise) without the prior<br \/>\nwritten consent of the other, which consent shall not be unreasonably withheld,<br \/>\nand any attempted assignment in violation thereof shall be void and of no<br \/>\neffect.<\/p>\n<p>     15.7 Entire Agreement.<\/p>\n<p>     The Transactional Agreements, the schedules and the exhibits thereto and<br \/>\nthe other documents contemplated expressly thereby constitute the full and<br \/>\nentire understanding and agreement among the parties hereto and thereto with<br \/>\nregard to the subjects hereof and thereof and supersede all prior agreements and<br \/>\nunderstandings among or between any of the parties relating to the subject<br \/>\nmatter hereof and thereof.<\/p>\n<p>     15.8 Separability.<\/p>\n<p>     In case any provision of this Agreement shall be invalid, illegal or<br \/>\nunenforceable, the validity, legality and enforceability of the remaining<br \/>\nprovisions shall not in any way be affected or impaired thereby.<\/p>\n<p>     15.9 Amendments.<\/p>\n<p>     This Agreement may be amended or modified only upon the mutual written<br \/>\nconsent of the Selling Shareholders, the Company, the Purchaser and Merger Sub.<br \/>\nAny amendment or modification effected pursuant to this Section 15.9 shall be<br \/>\nbinding upon the Selling Shareholders, the Company, the Purchaser and Merger<br \/>\nSub.<\/p>\n<p>     15.10  Notices.<\/p>\n<p>     Any notice or other communication required or permitted to be delivered to<br \/>\nany party under this Agreement shall be in writing and shall be deemed properly<br \/>\ndelivered, given and <\/p>\n<p>                                       52<\/p>\n<p>received when delivered (by hand, by registered mail, by courier or express<br \/>\ndelivery service or by telecopier during business hours) to the address or<br \/>\ntelecopier number set forth beneath the name of such party below (or to such<br \/>\nother address or telecopier number as such party shall have specified in a<br \/>\nwritten notice given to the other parties hereto):<\/p>\n<p>if to the Company:<\/p>\n<p>     Paralogic Software Corporation<br \/>\n     257 Castro Street, Suite 200<br \/>\n     Mountain View, CA 94041<br \/>\n     Attention:  Sunil Sanghavi<br \/>\n     Telecopier: (650) 934-6919<\/p>\n<p>with a copy to:<\/p>\n<p>     Pillsbury Madison &amp; Sutro LLP<br \/>\n     2550 Hanover Street<br \/>\n     Palo Alto, CA 94304<br \/>\n     Attention:  Jorge A. del Calvo, Esq.<br \/>\n     Telecopier: (650) 233-4545<\/p>\n<p>if to the Selling Shareholders, to their addresses set forth on the signature<br \/>\npage hereof;<\/p>\n<p>with a copy to:<\/p>\n<p>     Pillsbury Madison &amp; Sutro LLP<br \/>\n     2550 Hanover Street<br \/>\n     Palo Alto, CA 94304<br \/>\n     Attention:  Jorge A. del Calvo, Esq.<br \/>\n     Telecopier: (650) 233-4545<\/p>\n<p>if to the Purchaser:<\/p>\n<p>     XOOM.com, Inc.<br \/>\n     300 Montgomery Street<br \/>\n     Third Floor<br \/>\n     San Francisco, California 94104<br \/>\n     Attention: Rajesh A. Aji, Esq.<br \/>\n     Telecopier: (415) 445-2526<\/p>\n<p>                                       53<\/p>\n<p>with a copy to:<\/p>\n<p>     Morrison &amp; Foerster LLP<br \/>\n     425 Market Street<br \/>\n     San Francisco, California 94105<br \/>\n     Attention: Bruce Alan Mann, Esq.<br \/>\n     Telecopier: (415) 268-7522<\/p>\n<p>     15.11  Publicity and Use of Confidential Information.<\/p>\n<p>          (a) The Selling Shareholders shall keep strictly confidential, and<br \/>\nshall not use, or disclose to any other Person, any non-public document or other<br \/>\ninformation in the Selling Shareholders&#8217; possession that relates directly or<br \/>\nindirectly to the business of the Company, the Purchaser or any affiliate of the<br \/>\nPurchaser.<\/p>\n<p>          (b) The Company and Selling Shareholders shall not issue or<br \/>\ndisseminate any press release or other publicity concerning any of the<br \/>\nTransactions, or permit any press release or other publicity concerning any of<br \/>\nthe Transactions to be issued or otherwise disseminated by or on behalf of the<br \/>\nCompany or Selling Shareholders, without the Purchaser&#8217;s prior written consent,<br \/>\nand the Company and the Selling Shareholders shall continue to keep the terms of<br \/>\nthis Agreement and the other Transactional Agreements strictly confidential,<br \/>\nexcept any disclosure required by law.<\/p>\n<p>          (c) The Purchaser shall not issue or disseminate any press release or<br \/>\nother publicity concerning any of the Transactions, or permit any press release<br \/>\nor other publicity concerning any of the Transactions to be issued or otherwise<br \/>\ndisseminated by or on behalf of the Purchaser, without the Company&#8217;s prior<br \/>\nwritten consent, and the Purchaser shall continue to keep the terms of this<br \/>\nAgreement and the other Transactional Agreements strictly confidential, except<br \/>\nany disclosure required by law.<\/p>\n<p>     15.12  Counterparts.<\/p>\n<p>     This Agreement may be executed in any number of counterparts, each of which<br \/>\nshall be an original, but all of which together shall constitute one instrument.<\/p>\n<p>     15.13  Delays or Omissions; Waivers.<\/p>\n<p>          (a) No failure on the part of any Person to exercise any power, right,<br \/>\nprivilege or remedy under this Agreement, and no delay on the part of any Person<br \/>\nin exercising any power, right, privilege or remedy under this Agreement, shall<br \/>\noperate as a waiver of such power, right, privilege or remedy; and no single or<br \/>\npartial exercise or waiver of any such power, right, privilege or remedy shall<br \/>\npreclude any other or further exercise thereof or of any other power, right,<br \/>\nprivilege or remedy.<\/p>\n<p>          (b) No Person shall be deemed to have waived any claim arising out of<br \/>\nthis Agreement, or any power, right, privilege or remedy under this Agreement,<br \/>\nunless the waiver of <\/p>\n<p>                                       54<\/p>\n<p>such claim, power, right, privilege or remedy is expressly set forth in a<br \/>\nwritten instrument duly executed and delivered on behalf of such Person; and any<br \/>\nsuch waiver shall not be applicable or have any effect except in the specific<br \/>\ninstance in which it is given.<\/p>\n<p>     15.14  Remedies Cumulative; Specific Performance.<\/p>\n<p>     All remedies, either under this Agreement or by law or otherwise afforded<br \/>\nto the parties hereto, shall be cumulative and not alternative.  Each of the<br \/>\nparties agrees that:<\/p>\n<p>          (a) in the event of any breach or threatened breach by a party of any<br \/>\ncovenant, obligation or other provision set forth in this Agreement, the other<br \/>\nparties shall be entitled (in addition to any other remedy that may be available<br \/>\nto them) to (i) a decree or order of specific performance or mandamus to enforce<br \/>\nthe observance and performance of such covenant, obligation or other provision,<br \/>\nand (ii) an injunction restraining such breach or threatened breach; and<\/p>\n<p>          (b) neither the Purchaser nor any other Indemnitee, on the one hand,<br \/>\nnor the Selling Shareholders, on the other, shall be required to provide any<br \/>\nbond or other security in connection with any such decree, order or injunction<br \/>\nor in connection with any related action or Proceeding.<\/p>\n<p>     15.15  Headings.<\/p>\n<p>     The boldface headings contained in this Agreement are for convenience of<br \/>\nreference only, shall not be deemed to be a part of this Agreement and shall not<br \/>\nbe referred to in connection with the construction or interpretation of this<br \/>\nAgreement.<\/p>\n<p>     15.16  Construction.<\/p>\n<p>          (a) For purposes of this Agreement, whenever the context requires: the<br \/>\nsingular number shall include the plural, and vice versa; the masculine gender<br \/>\nshall include the feminine and neuter genders; the feminine gender shall include<br \/>\nthe masculine and neuter genders; and the neuter gender shall include the<br \/>\nmasculine and feminine genders.<\/p>\n<p>          (b) The parties hereto agree that any rule of construction to the<br \/>\neffect that ambiguities are to be resolved against the drafting party shall not<br \/>\nbe applied in the construction or interpretation of this Agreement.<\/p>\n<p>          (c) As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221;<br \/>\nand variations thereof, shall not be deemed to be terms of limitation, but<br \/>\nrather shall be deemed to be followed by the words &#8220;without limitation.&#8221;<\/p>\n<p>          (d) Except as otherwise specified, all references in this Agreement to<br \/>\n&#8220;Sections,&#8221; &#8220;Exhibits&#8221; and &#8220;Schedules&#8221; are intended to refer to Sections of this<br \/>\nAgreement and Exhibits and Schedules to this Agreement.<\/p>\n<p>                                       55<\/p>\n<p>     IN WITNESS WHEREOF, the parties hereto have executed this AGREEMENT AND<br \/>\nPLAN OF MERGER as of the date set forth in the first paragraph hereof.<\/p>\n<p>THE PURCHASER:                            XOOM.COM, INC.<br \/>\n                                          a Delaware corporation<\/p>\n<p>                                          By: \/s\/ CHRISTOPHER KITZE<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:  Christopher Kitze<br \/>\n                                              Title: Chairman<\/p>\n<p>THE COMPANY:                              Paralogic Software Corporation<br \/>\n                                          a California corporation<\/p>\n<p>                                          By: \/s\/ VIJAY VAIDYANATHAN<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:  Vijay Vaidyanathan<br \/>\n                                              Title: President and Chairman<\/p>\n<p>MERGER SUB:                               XMCM SUB, INC.<br \/>\n                                          a California corporation<\/p>\n<p>                                          By: \/s\/ CHRISTOPHER KITZE<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:  Christopher Kitze<br \/>\n                                              Title: Vice President<\/p>\n<p>SELLING SHAREHOLDER:<br \/>\n                                          By: \/s\/ RAJESH AJI<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\n                                              Title:<\/p>\n<p>SELLING SHAREHOLDER:<br \/>\n                                          By: \/s\/ ROBERT A. ELLIS, TRUSTEE<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:  Robert A. Ellis Revocable<br \/>\n                                                     Trust<br \/>\n                                              Title: Robert A. Ellis, Trustee<\/p>\n<p>SELLING SHAREHOLDER:<br \/>\n                                          By: \/s\/ HELMUT HISSEN<br \/>\n                                              Name:<br \/>\n                                              Title:<\/p>\n<p>SELLING SHAREHOLDER:<br \/>\n                                          By: \/s\/ RUSSELL SCOTT HYZEN<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\n                                              Title:  <\/p>\n<p>SELLING SHAREHOLDER:<br \/>\n                                          By: \/s\/ SHANTI NARAYANAN<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\n                                              Title:    <\/p>\n<p>SELLING SHAREHOLDER:<br \/>\n                                          By: \/s\/ ERNEST PRIESTLY<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\nSELLING SHAREHOLDER:                          Title:                           <\/p>\n<p>                                          By: \/s\/ RAJIV VAIDYANATHAN<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\nSELLING SHAREHOLDER:                          Title:                           <\/p>\n<p>                                          By: \/s\/ SHEENA VAIDYANATHAN<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\nSELLING SHAREHOLDER:                          Title:                           <\/p>\n<p>                                          By: \/s\/ VIJAY VAIDYANATHAN<br \/>\n                                              &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                              Name:<br \/>\n                                              Title:                           <\/p>\n<p>                          AGREEMENT AND PLAN OF MERGER<\/p>\n<p>                                    EXHIBIT A<\/p>\n<p>                               CERTAIN DEFINITIONS<\/p>\n<p>     For purposes of this Agreement:<\/p>\n<p>     ACQUISITION TRANSACTION. &#8220;Acquisition Transaction&#8221; shall mean any<br \/>\ntransaction involving:<\/p>\n<p>     (a)  the sale or other disposition of all or any portion of the Company&#8217;s<br \/>\n          business or assets (other than in the Ordinary Course of Business);<\/p>\n<p>     (b)  the issuance, sale or other disposition of (i) any capital stock of<br \/>\n          the Company, (ii) any option, call, warrant or right (whether or not<br \/>\n          immediately exercisable) to acquire any capital stock of the Company,<br \/>\n          or (iii) any security, instrument or obligation that is or may become<br \/>\n          convertible into or exchangeable for any capital stock of the Company;<br \/>\n          or<\/p>\n<p>     (c)  any merger, consolidation, business combination, share exchange,<br \/>\n          reorganization or similar transaction involving the Company.<\/p>\n<p>     ADDITIONAL AMOUNT. &#8220;Additional Amount&#8221; for any Selling Shareholder shall be<br \/>\nthe excess, if any, of (a) the product of (i) the &#8220;Gain Amount&#8221; and (ii) seventy<br \/>\npercent (70%) of the tax rate applicable to the Selling Shareholder with respect<br \/>\nto the Purchaser Stock acquired in the Merger, over (b) the product of (i) any<br \/>\ncash received (or other proceeds from disposition) and any taxable loss<br \/>\nrecognized by a Selling Shareholder, in respect of its Purchaser Stock acquired<br \/>\nin the Merger, on or before a Final Determination that the Merger does not<br \/>\nqualify as a &#8220;reorganization,&#8221; within the meaning of Section 368(a) of the Code,<br \/>\nand (ii) twenty-nine and three tenths percent (29.3%). For purposes of the<br \/>\npreceding sentence, the &#8220;Gain Amount&#8221; for any Selling Shareholder shall be the<br \/>\nexcess of (a) the product of the (i) Merger Consideration received by such<br \/>\nSelling Shareholder and (ii) the price of Purchaser Stock as shown in the Wall<br \/>\nStreet Journal for the day in which the Effective Time falls, over (b) the tax<br \/>\nbasis of the Selling Shareholder in the stock of the Seller immediately prior to<br \/>\nthe Merger. The Additional Amount shall include any penalty imposed on a Selling<br \/>\nShareholder by a taxing authority which is imposed ONLY because the Merger does<br \/>\nnot qualify as a &#8220;reorganization,&#8221; within the meaning of Section 368(a) of the<br \/>\nCode by reason of material changes or modifications to the NBC Agreements (other<br \/>\nthan any changes or modifications to the NBC Transactions reflected in,<br \/>\notherwise taken account in, or contemplated by the Restated Documents).<\/p>\n<p>     AGREEMENT. &#8220;Agreement&#8221; shall mean the Agreement and Plan of Merger to which<br \/>\nthis EXHIBIT A is attached (including the disclosure schedules and all other<br \/>\nschedules and exhibits attached thereto), as it may be amended from time to<br \/>\ntime.<\/p>\n<p>     ASSET BALANCE. &#8220;Asset Balance&#8221; shall mean $210,000.<\/p>\n<p>                                      A-1<\/p>\n<p>     AUDITED FINANCIAL STATEMENTS. &#8220;Audited Financial Statements&#8221; shall have the<br \/>\nmeaning specified in Section 10.8.<\/p>\n<p>     AVERAGE PURCHASER STOCK PRICE. &#8220;Average Purchaser Stock Price&#8221; shall mean<br \/>\nthe average of the closing sale price of Purchaser Stock on the Nasdaq Stock<br \/>\nMarket for the twenty-five (25) trading days ending on the last trading day<br \/>\nprior to a given date.<\/p>\n<p>     BEST EFFORTS. &#8220;Best Efforts&#8221; shall mean the efforts that a prudent Person<br \/>\ndesiring to achieve a particular result would use in order to ensure that such<br \/>\nresult is achieved as expeditiously as possible.<\/p>\n<p>     CERTIFICATES. &#8220;Certificates&#8221; shall have the meaning specified in Section<br \/>\n3.3(a).<\/p>\n<p>     CLOSING. &#8220;Closing&#8221; shall have the meaning specified in Section 3.5.<\/p>\n<p>     CLOSING DATE. &#8220;Closing Date&#8221; shall have the meaning specified in Section<br \/>\n3.5.<\/p>\n<p>     CODE. &#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended.<\/p>\n<p>     COMPANY. &#8220;Company&#8221; shall mean Paralogic Software Corporation, a California<br \/>\ncorporation.<\/p>\n<p>     COMPANY BOARD. &#8220;Company Board&#8221; shall mean the members of the board of<br \/>\ndirectors of the Company.<\/p>\n<p>     COMPANY CLOSING CERTIFICATE. &#8220;Company Closing Certificate&#8221; shall have the<br \/>\nmeaning specified in Section 4.1(c)(vi).<\/p>\n<p>     COMPANY COMMON STOCK. &#8220;Common Stock&#8221; shall mean the common stock, no par<br \/>\nvalue per share, of the Company.<\/p>\n<p>     COMPANY CONFIDENTIAL INFORMATION. &#8220;Company Confidential Information&#8221; shall<br \/>\nhave the meaning specified in Section 10.2.<\/p>\n<p>     COMPANY CONTRACT. &#8220;Company Contract&#8221; shall mean any contract listed on the<br \/>\nCompany Disclosure Schedule.<\/p>\n<p>     COMPANY DISCLOSURE SCHEDULE. &#8220;Company Disclosure Schedule&#8221; shall have the<br \/>\nmeaning specified in the introductory paragraph to Section 5.<\/p>\n<p>     COMPANY OPTIONS. &#8220;Company Options&#8221; shall mean those options granted by the<br \/>\nCompany, or proposed to be granted prior to the Closing Date, to purchase shares<br \/>\nof the Company Common Stock as set forth on SCHEDULE II attached hereto.<\/p>\n<p>     COMPANY PREFERRED STOCK. &#8220;Company Preferred Stock&#8221; shall have the meaning<br \/>\nspecified in Section 5.3(a).<\/p>\n<p>     COMPANY RETURNS. &#8220;Company Returns&#8221; shall have the meaning specified in<br \/>\nSection 5.14(b).<\/p>\n<p>                                      A-2<\/p>\n<p>     CONSENT. &#8220;Consent&#8221; shall mean any approval, consent, ratification,<br \/>\npermission, waiver or authorization (including any Governmental Authorization).<\/p>\n<p>     CONSTITUENT CORPORATIONS. &#8220;Constituent Corporations&#8221; shall mean the Company<br \/>\nand Merger Sub.<\/p>\n<p>     CONTRACT. &#8220;Contract&#8221; shall mean, with respect to any Person, any written or<br \/>\noral or other contract, arrangement or other agreement to which such Person is a<br \/>\nparty or by which its properties or assets may be bound or affected or under<br \/>\nwhich it or its respective business, properties or assets receive benefits.<\/p>\n<p>     DAMAGES. &#8220;Damages&#8221; shall include any loss, damage, injury, decline in<br \/>\nvalue, lost opportunity, Liability, settlement, judgment, award, fine, penalty,<br \/>\nTax, fee (including any legal fee, expert fee, accounting fee or advisory fee),<br \/>\ncharge, cost (including any cost of investigation) or expense of any nature.<\/p>\n<p>     DEFINED BENEFIT PLAN. &#8220;Defined Benefit Plan&#8221; shall mean either a plan<br \/>\ndescribed in Section 3(35) of ERISA or a plan subject to the minimum funding<br \/>\nstandards set forth in Section 302 of ERISA and Section 412 of the Code.<\/p>\n<p>     DISCLOSURE SCHEDULE UPDATE. &#8220;Disclosure Schedule Update&#8221; shall have the<br \/>\nmeaning specified in Section 8.5(b).<\/p>\n<p>     DISSENTING HOLDER. &#8220;Dissenting Holder&#8221; shall have the meaning specified in<br \/>\nSection 3.7(a).<\/p>\n<p>     DISSENTING SHARES. &#8220;Dissenting Shares&#8221; shall have the meaning specified in<br \/>\nSection 3.7(a).<\/p>\n<p>     EFFECTIVE TIME. &#8220;Effective Time&#8221; shall have the meaning specified in<br \/>\nSection 1.2.<\/p>\n<p>     EMPLOYMENT OFFER LETTER. &#8220;Employment Offer Letter&#8221; shall mean the<br \/>\nemployment offer letter from Purchaser to each of the Key Employees<br \/>\nsubstantially in the form of EXHIBIT D-1.<\/p>\n<p>     END-USER LICENSES. &#8220;End-User Licenses&#8221; shall have the meaning specified in<br \/>\nSection 5.6.<\/p>\n<p>     ENTITY. &#8220;Entity&#8221; shall mean any corporation (including any non profit<br \/>\ncorporation), general partnership, limited partnership, limited Liability<br \/>\npartnership, joint venture, estate, trust or company (including any limited<br \/>\nLiability company or joint stock company).<\/p>\n<p>     ENVIRONMENTAL LAW. &#8220;Environmental Law&#8221; shall mean any federal, state, local<br \/>\nor foreign legal requirement relating to pollution or protection of human health<br \/>\nor the environment.<\/p>\n<p>                                      A-3<\/p>\n<p>     ERISA. &#8220;ERISA&#8221; shall mean the Employee Retirement Income Security Act of<br \/>\n1974, as amended.<\/p>\n<p>     ERNST &amp; YOUNG. &#8220;Ernst &amp; Young&#8221; shall have the meaning specified in Section<br \/>\n10.8.<\/p>\n<p>     ESCROW ACCOUNT. &#8220;Escrow Account&#8221; shall have the mean the account into which<br \/>\nthe Holdback Amount is deposited.<\/p>\n<p>     ESCROW AGENT. &#8220;Escrow Agent&#8221; shall mean Union Bank of California, N.A.<\/p>\n<p>     ESCROW AGREEMENT. &#8220;Escrow Agreement&#8221; shall have the meaning specified in<br \/>\nSection 1.4.<\/p>\n<p>     EXCHANGE ACT. &#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of<br \/>\n1934, as amended.<\/p>\n<p>     EXCHANGE RATIO. &#8220;Exchange Ratio&#8221; shall have the meaning specified in<br \/>\nSection 3.1(b).<\/p>\n<p>     FINAL DETERMINATION. &#8220;Final Determination&#8221; shall mean an unappealable<br \/>\njudgment of a competent federal judicial authority, a final settlement which has<br \/>\nbeen agreed to by Purchaser, or a determination by Purchaser that the Purchaser<br \/>\ndoes not wish to contest the imposition of the tax, provided that Selling<br \/>\nShareholder does not contest the tax. In the event a Selling Shareholder tenders<br \/>\nwritten notice to Purchaser that there is an audit, examination, investigation,<br \/>\nhearing or other proceeding involving a Selling Shareholder which could give<br \/>\nrise to liability to Purchaser pursuant to Section 14 of this Agreement and<br \/>\nPurchaser does not respond within sixty days of receipt by Purchaser of such<br \/>\nwritten notice that Purchaser elects to assume the defense of such action under<br \/>\nSection 14(b), then Purchaser shall be deemed to have elected not to contest the<br \/>\nimposition of the tax, provided that the Selling Shareholder does not contest<br \/>\nthe tax.<\/p>\n<p>     FINAL RETURNS. &#8220;Final Returns&#8221; shall have the meaning specified in Section<br \/>\n15.4.<\/p>\n<p>     FINANCIAL STATEMENTS. &#8220;Financial Statements&#8221; shall have the meaning<br \/>\nspecified in Section 5.8(a).<\/p>\n<p>     FOLLOW-ON OFFERING. &#8220;Follow-On Offering&#8221; shall have the meaning specified<br \/>\nin Section 10.6.<\/p>\n<p>     GAAP. &#8220;GAAP&#8221; shall mean generally accepted accounting principles.<\/p>\n<p>     GOVERNMENTAL AUTHORIZATION. &#8220;Governmental Authorization&#8221; shall mean any:<\/p>\n<p>     (a)  permit, license, certificate, franchise, approval, consent,<br \/>\n          permission, clearance, waiver, certification, designation,<br \/>\n          registration, qualification or authorization issued, granted or given<br \/>\n          by or under the authority of any Governmental Body or pursuant to any<br \/>\n          legal requirement; or<\/p>\n<p>                                      A-4<\/p>\n<p>     (b)  right under any Contract with any Governmental Body.<\/p>\n<p>     GOVERNMENTAL BODY. &#8220;Governmental Body&#8221; shall mean any:<\/p>\n<p>     (a)  nation, principality, state, province, territory, county,<br \/>\n          municipality, district or other jurisdiction of any nature;<\/p>\n<p>     (b)  federal, state, local, municipal, foreign or other government; or<\/p>\n<p>     (c)  individual, Entity or body exercising, or entitled to exercise, any<br \/>\n          executive, legislative, judicial, administrative, regulatory, police,<br \/>\n          military or taxing authority or power of any nature.<\/p>\n<p>     HAZARDOUS MATERIALS. &#8220;Hazardous Material&#8221; shall mean any substance,<br \/>\nchemical, waste or other material which is or may be listed, defined or<br \/>\notherwise identified as hazardous, toxic or dangerous under any legal<br \/>\nrequirement, as well as any asbestos, polychlorinated biphenyls (&#8220;PCBs&#8221;),<br \/>\npetroleum, petroleum product or by-product, crude oil, natural gas, natural gas<br \/>\nliquids, liquefied natural gas, or synthetic gas useable for fuel, and &#8220;source,&#8221;<br \/>\n&#8220;special nuclear,&#8221; and &#8220;by-product&#8221; material as defined in the Atomic Energy Act<br \/>\nof 1954, 42 U.S.C. Sections 2011 ET seq.<\/p>\n<p>     HOLDBACK AMOUNT. &#8220;Holdback Amount&#8221; shall have the meaning specified in<br \/>\nSection 1.4.<\/p>\n<p>     INDEMNIFICATION TERMINATION DATE. &#8220;Indemnification Termination Date&#8221; shall<br \/>\nhave the meaning specified in Section 12.1(a).<\/p>\n<p>     INDEMNIFIED PARTY. &#8220;Indemnified Party&#8221; shall have the meaning specified in<br \/>\nSection 12.5.<\/p>\n<p>     INDEMNIFYING PARTY. &#8220;Indemnifying Party&#8221; shall have the meaning specified<br \/>\nin Section 12.5.<\/p>\n<p>     INDEMNITEE. &#8220;Indemnitee&#8221; shall have the meaning specified in Section<br \/>\n12.2(a).<\/p>\n<p>     KEY EMPLOYEES. &#8220;Key Employees&#8221; shall mean each of Sunil Sanghavi, Helmut<br \/>\nHissen.<\/p>\n<p>     LEASED PREMISES. &#8220;Leased Premises&#8221; shall mean the premises and facilities<br \/>\nidentified in Part 5.9(d) of the Company Disclosure Schedule.<\/p>\n<p>     LIABILITY. &#8220;Liability&#8221; shall mean any debt, obligation, duty or Liability<br \/>\nof any nature (including any unknown, undisclosed, unmatured, unaccrued,<br \/>\nunasserted, contingent, indirect, conditional, implied, vicarious, derivative,<br \/>\njoint, several or secondary Liability), regardless of whether such debt,<br \/>\nobligation, duty or Liability would be required to be disclosed on a balance<br \/>\nsheet prepared in accordance with generally accepted accounting principles and<br \/>\nregardless of whether such debt, obligation, duty or Liability is immediately<br \/>\ndue and payable.<\/p>\n<p>                                      A-5<\/p>\n<p>     MEMBER OF THE CONTROLLED GROUP. &#8220;Member of the Controlled Group&#8221; shall mean<br \/>\neach trade or business, whether or not incorporated, which would be treated as a<br \/>\nsingle employer with the Company under Section 4001 of ERISA or Section 414(b),<br \/>\n(c), (m) or (o) of the Code.<\/p>\n<p>     MERGER. &#8220;Merger&#8221; shall have the meaning specified in Recital A.<\/p>\n<p>     MERGER CONSIDERATION. &#8220;Merger Consideration&#8221; shall have the meaning<br \/>\nspecified in Section 1.3.<\/p>\n<p>     MERGER SUB. &#8220;Merger Sub&#8221; shall mean XMCM Sub, Inc., a California<br \/>\ncorporation.<\/p>\n<p>     MERGER SUB BOARD. &#8220;Merger Sub Board&#8221; shall mean the Board of Directors of<br \/>\nMerger Sub.<\/p>\n<p>     MULTIEMPLOYER PLAN. &#8220;Multiemployer Plan&#8221; shall mean a plan described in<br \/>\nSection 3(37) of ERISA.<\/p>\n<p>     NBC AGREEMENTS. &#8220;NBC Agreements&#8221; shall mean the Agreement and Plan of<br \/>\nContribution and Merger, dated as of May 9, 1999, with Purchaser and others and<br \/>\nan Agreement and Plan of Contribution, Investment and Merger dated as of May 9,<br \/>\n1999, with National Broadcasting Corporation (&#8220;NBC&#8221;) and others pursuant to<br \/>\nwhich the existing businesses of Purchaser and certain assets of NBC and others<br \/>\nwill be combined.<\/p>\n<p>     NBC TRANSACTIONS. &#8220;NBC TRANSACTIONS&#8221; shall mean those transactions<br \/>\ncontemplated by the NBC Agreements.<\/p>\n<p>     OPTION PLAN. &#8220;Option Plan&#8221; shall have the meaning specified in Section<br \/>\n3.1(c)(i).<\/p>\n<p>     OPTION POOL. &#8220;Option Pool&#8221; shall mean the number of shares of Company<br \/>\nCommon Stock reserved for the grant of options under the Option Plan.<\/p>\n<p>     ORDER. &#8220;Order&#8221; shall mean any:<\/p>\n<p>     (a)  order, judgment, injunction, edict, decree, ruling, subpoena, writ or<br \/>\n          award that is or has been issued, made, entered, rendered or otherwise<br \/>\n          put into effect by or under the authority of any court, administrative<br \/>\n          agency or other Governmental Body or any arbitrator or arbitration<br \/>\n          panel; or<\/p>\n<p>     (b)  Contract with any Governmental Body that is or has been entered into<br \/>\n          in connection with any Proceeding.<\/p>\n<p>                                      A-6<\/p>\n<p>     ORDINARY COURSE OF BUSINESS. An action taken by or on behalf of the Company<br \/>\nshall not be deemed to have been taken in the &#8220;Ordinary Course of Business&#8221;<br \/>\nunless:<\/p>\n<p>     (a)  such action is recurring in nature, is consistent with the Company&#8217;s<br \/>\n          past practices and is taken in the Ordinary Course of the Company&#8217;s<br \/>\n          normal day to day operations;<\/p>\n<p>     (b)  such action is taken in accordance with sound and prudent business<br \/>\n          practices;<\/p>\n<p>     (c)  such action is not required to be authorized by the Company&#8217;s<br \/>\n          shareholders, the Company Board or any committee of the Company Board<br \/>\n          and does not require any other separate or special authorization of<br \/>\n          any nature; and<\/p>\n<p>     (d)  such action is similar in nature and magnitude to actions customarily<br \/>\n          taken, without any separate or special authorization, in the Ordinary<br \/>\n          Course of the normal day to day operations of other Entities that are<br \/>\n          engaged in businesses similar to the Company&#8217;s business.<\/p>\n<p>     PERSON. &#8220;Person&#8221; shall mean any individual, Entity or Governmental Body.<\/p>\n<p>     PLANS. &#8220;Plans&#8221; shall have the meaning specified in Section 5.22(a).<\/p>\n<p>     PRE-CLOSING PERIOD. &#8220;Pre-Closing Period&#8221; shall mean the period from the<br \/>\ndate of this Agreement until the Closing Date.<\/p>\n<p>     PREFERRED STOCK. &#8220;Preferred Stock&#8221; shall mean the Company&#8217;s Series A<br \/>\nPreferred Stock, no par value per share.<\/p>\n<p>     PROCEEDING. &#8220;Proceeding&#8221; shall mean any action, suit, litigation,<br \/>\narbitration, Proceeding (including any civil, criminal, administrative,<br \/>\ninvestigative or appellate Proceeding and any informal Proceeding), hearing,<br \/>\ninquiry, audit or investigation that is or has been commenced, brought,<br \/>\nconducted or heard by or before, or that otherwise has involved or may involve,<br \/>\nany Governmental Body or any arbitrator or arbitration panel.<\/p>\n<p>     PROPRIETARY ASSET. &#8220;Proprietary Asset&#8221; shall mean any patent, patent<br \/>\napplication, trademark (whether registered or unregistered and whether or not<br \/>\nrelating to a published work), trademark application, trade name, fictitious<br \/>\nbusiness name, service mark (whether registered or unregistered), service mark<br \/>\napplication, copyright (whether registered or unregistered), copyright<br \/>\napplication, maskwork, maskwork application, trade secret, know how, franchise,<br \/>\nsystem, computer software, invention, design, blueprint, proprietary product,<br \/>\nproprietary right or other technology, intellectual property right or intangible<br \/>\nasset.<\/p>\n<p>     PROPRIETARY INFORMATION, NON-DISCLOSURE AND NON-SOLICITATION AGREEMENT.<br \/>\n&#8220;Proprietary Information, Non-Disclosure and Non-Solicitation Agreement&#8221; shall<br \/>\nmean the agreement in the form of EXHIBIT D-2.<\/p>\n<p>                                      A-7<\/p>\n<p>     PURCHASER. &#8220;Purchaser&#8221; shall mean XOOM.com, Inc., a Delaware corporation.<\/p>\n<p>     PURCHASER BOARD. &#8220;Purchaser Board&#8221; shall mean the Board of Directors of the<br \/>\nPurchaser.<\/p>\n<p>     PURCHASER CLOSING CERTIFICATE. &#8220;Purchaser Closing Certificate&#8221; have the<br \/>\nmeaning specified in Section 4.2(c)(v).<\/p>\n<p>     PURCHASER CONTRACT. &#8220;Purchaser Contract&#8221; shall mean those contracts<br \/>\nrequired by Regulation S-K to be filed in connection with the Purchaser SEC<br \/>\nReports.<\/p>\n<p>     PURCHASER DISCLOSURE SCHEDULE. &#8220;Purchaser Disclosure Schedule&#8221; shall have<br \/>\nthe meaning specified in the introductory paragraph to Section 7.<\/p>\n<p>     PURCHASER OPTION PLAN. &#8220;Purchaser Option Plan&#8221; shall mean the 1998 Stock<br \/>\nIncentive Plan of the Purchaser.<\/p>\n<p>     PURCHASER SEC REPORTS. &#8220;Purchaser SEC Reports&#8221; shall have the meaning<br \/>\nspecified in Section 7.8(a).<\/p>\n<p>     PURCHASER STOCK. &#8220;Purchaser Stock&#8221; shall mean the Common Stock of the<br \/>\nPurchaser, par value $.0001 per share, to be issued in connection with the<br \/>\nTransactions.<\/p>\n<p>     REGISTRATION STATEMENT. &#8220;Registration Statement&#8221; shall have the meaning<br \/>\nspecified in Section 6(m).<\/p>\n<p>     RELATED PARTY. Each of the following shall be deemed to be a &#8220;Related<br \/>\nParty&#8221;:<\/p>\n<p>     (a)  the Selling Shareholders;<\/p>\n<p>     (b)  each individual who is, or who has at any time, been an officer of the<br \/>\n          Company;<\/p>\n<p>     (c)  each member of the family of each of the individuals referred to in<br \/>\n          clause (b) above; and<\/p>\n<p>     (d)  any Entity (other than the Selling Shareholders or the Company) in<br \/>\n          which any one of the Persons referred to in clause (a), (b) or (c)<br \/>\n          above holds (or in which more than one of such individuals<br \/>\n          collectively hold), beneficially or otherwise, a material voting,<br \/>\n          proprietary or equity interest.<\/p>\n<p>     RESTATED DOCUMENTS. &#8220;Restated Documents&#8221; shall mean those drafts to<br \/>\ndocuments related to the NBC Transactions attached hereto as EXHIBIT J .<\/p>\n<p>     RIGHTS AGREEMENT. &#8220;Rights Agreement&#8221; shall mean that certain Registration<br \/>\nRights Agreement by and among the Purchaser and the Selling Shareholders<br \/>\nsubstantially in the form of EXHIBIT C attached hereto.<\/p>\n<p>     SEC. &#8220;SEC&#8221; shall mean the Securities and Exchange Commission.<\/p>\n<p>                                      A-8<\/p>\n<p>     SECURITIES ACT. &#8220;Securities Act&#8221; shall mean the Securities Act of 1933, as<br \/>\namended.<\/p>\n<p>     SELLING SHAREHOLDERS. &#8220;Selling Shareholders&#8221; shall mean those individuals<br \/>\nand Entities listed on SCHEDULE I hereto.<\/p>\n<p>     SELLING SHAREHOLDERS CLOSING CERTIFICATE. &#8220;Selling Shareholders Closing<br \/>\nCertificate&#8221; shall have the meaning specified in Section 4.1(c)(vii).<\/p>\n<p>     SURVIVING CORPORATION. &#8220;Surviving Corporation&#8221; shall have the meaning<br \/>\nspecified in Section 1.1.<\/p>\n<p>     TAX. &#8220;Tax&#8221; shall mean any tax (including any income tax, franchise tax,<br \/>\ncapital gains tax, estimated tax, gross receipts tax, value added tax, surtax,<br \/>\nexcise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax,<br \/>\nproperty tax, business tax, occupation tax, inventory tax, occupancy tax,<br \/>\nwithholding tax or payroll tax), levy, assessment, tariff, impost, imposition,<br \/>\ntoll, duty (including any customs duty), deficiency or fee, and any related<br \/>\ncharge or amount (including any fine, penalty or interest), that is, has been or<br \/>\nin the future may be (a) imposed, assessed or collected by or under the<br \/>\nauthority of any Governmental Body, or (b) payable pursuant to any tax sharing<br \/>\nagreement or similar Contract.<\/p>\n<p>     TAX RETURN. &#8220;Tax Return&#8221; shall mean any return (including any information<br \/>\nreturn), report, statement, declaration, estimate, schedule, notice,<br \/>\nnotification, form, election, certificate or other document or information that<br \/>\nis, has been or in the future may be filed with or submitted to, or required to<br \/>\nbe filed with or submitted to, any Governmental Body in connection with the<br \/>\ndetermination, assessment, collection or payment of any Tax or in connection<br \/>\nwith the administration, implementation or enforcement of or compliance with any<br \/>\nlegal requirement relating to any Tax.<\/p>\n<p>     THRESHOLD. &#8220;Threshold&#8221; shall have the meaning specified in Section 12.2(b).<\/p>\n<p>     TRANSACTION EXPENSES. &#8220;Transaction Expenses&#8221; shall mean all fees, costs and<br \/>\nexpenses, including without limitation all attorneys&#8217; fees, that have been<br \/>\nincurred or that are in the future incurred by or on behalf of a party in<br \/>\nconnection with the sale of the Company Common Stock and the preparation,<br \/>\nexecution and delivery of the Transactional Agreements.<\/p>\n<p>     TRANSACTIONAL AGREEMENTS. &#8220;Transactional Agreements&#8221; shall mean the<br \/>\nAgreement, the Rights Agreement, the Employment and Non-Competition Agreement,<br \/>\nthe Escrow Agreement, the Selling Shareholders and Company Closing Certificates,<br \/>\nthe Purchaser Closing Certificate, and all other agreements, certificates and<br \/>\ninstruments executed or contemplated to be executed by any of the parties hereto<br \/>\nin connection with the Transactions.<\/p>\n<p>     TRANSACTIONS. &#8220;Transactions&#8221; shall mean (a) the execution and delivery of<br \/>\nthis Agreement and the other Transactional Agreements and (b) all the<br \/>\ntransactions contemplated by this Agreement and the other Transactional<br \/>\nAgreements.<\/p>\n<p>                                      A-9<\/p>\n<p>     UNAUDITED INTERIM BALANCE SHEET. &#8220;Unaudited Interim Balance Sheet&#8221; shall<br \/>\nhave the meaning specified in Section 5.8(a)(ii).<\/p>\n<p>                                      A-10<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[9374],"corporate_contracts_industries":[9510],"corporate_contracts_types":[9622,9626],"class_list":["post-43156","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-xoom-inc","corporate_contracts_industries-technology__programming","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43156"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43156"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43156"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}